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ABSTRACT OF DISSERTATION

UNDERSTANDING THE EFFECTS OF EMBRYONIC HYPERGLYCEMIA ON
RETINAL DEVELOPMENT AND MAINTENANCE
Hundreds of millions of people are affected by diabetes worldwide. Whether they
are diagnosed with prediabetes or Type I or II diabetes, there are a variety of
mechanisms in the pathogenesis of diabetes. Diabetes is a disease which consists of
recurring states of hyperglycemia that can be difficult to manage due to either lack of
insulin production or improper utilization of insulin. While these mechanisms of action
differ, complications induced by diabetes occur in both poorly regulated Type I and II.
Common complications of diabetes include nerve damage, kidney damage, and eye
damage. Eye damage specifically is called diabetic retinopathy and occurs in 80% of
individuals with dysregulated diabetes for 20 or more years.
Diabetic retinopathy is the principal cause of adult-onset blindness in the US. The
mechanism by which diabetic retinopathy works is not fully understood. Various
mechanisms have been explored in the understanding of diabetic retinopathy
pathogenesis, but recent work has looked closely at the role of photoreceptors in this
process. Photoreceptors are light sensing cells in the outermost portion of the retina that
capture light signals which are converted into an electrical signal sent through the inner
retinal layers then to the brain via the optic nerve. Each retinal neuron plays a critical
role in this process of relaying electric signals. In the context of hyperglycemia and
diabetes though, photoreceptors cells are unique in that they are disproportionately
metabolically demanding compared to the other retinal neurons. Recent studies have
found photoreceptors degenerate in animal models that experience recurring
hyperglycemia similar to what happens in dysregulated diabetes in adults. Interestingly,
this degeneration affected visual function and preceded vasculature damage. Together, it
is known that recurring hyperglycemia in adults leads to photoreceptor degeneration,
vasculature damage, and progressive blindness. However, few studies are conducted in
the context of a pregnant individual that is experiencing recurring hyperglycemia and
how that impacts the developing embryo. Given that glucose passes through the blood
placental barrier, this is an imperative gap in the literature to fill.

Embryonic development, specifically of the retina, is susceptible to a variety of
complications, from genetic mutations to exposure to teratogenic molecules passed
through the blood placental barrier. Therefore, this dissertation was dedicated to
understanding how hyperglycemia during embryonic development affects retinogenesis,
using different methods including genetic knockout, transgenesis, and high glucose
exposure. Following hyperglycemia induction, the number and morphology of retinal cell
types were analyzed as well as cell death and proliferation. Taken together, this provides
substantial insight to the impact of hyperglycemia on retinal development.
Chapter 1 of this dissertation provides a comprehensive review of how
hyperglycemia affects development in human and animal models in terms of the whole
body and what is known in the eye specifically. In Chapter 2, two animal models of
hyperglycemia (genetically and nutritionally induced) are compared with respect to
retinal development. All retinal cells, cell proliferation, and cell death are assessed in the
two models throughout development and a few weeks post embryonic development to
understand short term effects of hyperglycemia. Chapter 3 utilized a third model for
hyperglycemia induction via a transgenic line called insulin CFP nitroreductase. This line
allows for the temporal ablation of insulin-producing cells in the pancreas, which in turn
induces hyperglycemia, at any point of the fish’s lifetime. With this line, we studied the
long-term effects of hyperglycemia on the retina by inducing hyperglycemia during
embryonic development, raising fish in normoglycemic conditions, and then inducing
hyperglycemia again during young adulthood. This methodology provides an avenue for
understanding how embryonic metabolic programming affects susceptibility to retinal
damage later in life. Chapter 4 is a comprehensive conclusion of findings from Chapters
2 and 3, how these data impact our understanding of hyperglycemia and the retina, as
well as future directions this work guided by the findings. Finally, the Appendix chapter
of this dissertation is a collaboration project with Dr. Jakub Famulski and Dr. Warlen
Pereira Piedade, focused on the role of Siah1, an E3 ubiquitin ligase in retinal
development.
KEYWORDS: zebrafish, retina, development, photoreceptors, hyperglycemia, diabetes
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CHAPTER 1

EMBRYONIC HYPERGLYCEMIA AND RETINAL
DEVELOPMENT

1.1

Introduction
In the United States alone there are 30.3 million people diagnosed with diabetes and

over 80 million diagnosed with prediabetes; together this equates to about 30% of the
population (CDC). Blood glucose and insulin dysregulation, especially for those with
Type I and II diabetes, can induce a state of elevated blood glucose, or hyperglycemia
[1]. Although it is possible to keep blood glucose within a normal range for those with
diabetes, extensive work has shown that even temporary hyperglycemia has long-lasting
effects on metabolic memory, which can lead to complications later in life [2], [3].
Complications of diabetes are known to be the 6th leading cause of death in the United
States, as they affect the body in a variety of ways from nerve damage to increased risk of
kidney and heart disease [4]–[6]. A prevalent complication of recurring hyperglycemia
from dysregulated diabetes is diabetic retinopathy, which causes damage to blood vessels
in the eye and has become the principal cause of acquired blindness in adults [7].
There is abundant research on the effects of hyperglycemia on vasculature of the eye,
but recent work has shifted focus to the retina. Photoreceptors, highly metabolically
demanding light sensing cells in the outer most part of the retina, are becoming a topic of
interest in investigating the pathology of diabetic retinopathy [8]. Although this body of
research is growing with respect to diabetes in adults, minimal work has been done to
investigate the effects of embryonic exposure to hyperglycemia on retinal development
and maintenance. Moreover, there is little research on whether dysregulated glucose
metabolism in the developing retina may lead to aberrant retinal maintenance and
complications later in life. This introductory chapter will describe the complications of
hyperglycemia and its potential impact on the development and maintenance of the
retina, highlighting the few articles focused on embryonic development, and will lay out
the necessary future research directions.

1

1.1 Embryonic hyperglycemia in humans
Embryonic hyperglycemia may stem from multiple sources, such as maternal
insulin resistance leading to excess glucose in the mother’s blood passing through the
placental barrier, and/or lack of embryonic insulin production preventing proper glucose
metabolism [9]. Excess glucose passing through the placental barrier may occur at any
point in embryogenesis, and various studies have linked this phenomenon to defects in
organogenesis and development [10]. Mothers with pre-gestational diabetes are among the
highest at risk for having children with malformations or birth defects, at a rate 2-3-fold
higher than mothers without diabetes [11]. Some of the most common birth defects
associated with pre-gestational diabetes are congenital heart defects and central nervous
system defects [12]. Distinct regions of the brain begin to form as early as 3 weeks into
pregnancy [13], which is too early in development to administer therapeutics.
Gestational diabetes is generally diagnosed late in the second trimester and is
associated with a different set of birth defects due to the timing of onset. During pregnancy,
a mother will become insulin resistant to allow for more glucose to pass through the
placental barrier. The increase in glucose in the placenta stimulates the fetus to produce
insulin which acts as a growth factor and is essential for body growth. In the case of
gestational diabetes, the mother becomes too insulin resistant, causing excess glucose to
pass through the barrier, inducing embryonic hyperglycemia. Some of the long-term
effects of embryonic hyperglycemia include increased risk of obesity, type 2 diabetes,
metabolic syndrome, hyperinsulinemia, macrosomia, and heart disease (Fig. 1).
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Figure 1. 1 Long term effects of embryonic hyperglycemia in humans.

Figure 1.1 Long term effects of embryonic hyperglycemia in humans. Embryonic
hyperglycemia has been linked epidemiologically to multiple health issues later in life
such as increased risk of heart disease, metabolic syndrome, obesity, macrosomia, and
hyperinsulinemia.

3

1.2

Embryonic hyperglycemia in animal models
Evidence from mouse models shows hyperglycemia at early stages of fetal

development, prior to gestational diabetes onset which can be modeled in mice as well, is
strongly correlated with teratogenic effects that impact various stages throughout
development, as early as implantation [9]. The timing, length, and method of induction of
hyperglycemia during development play important roles in the specific effects that
manifest. Various models have been used to study this, including chick, mouse, and most
recently zebrafish. Additionally, various methods have been utilized across these models
including maternal streptozotocin injection prior to and during pregnancy (mouse),
glucose exposure directly to an externally developing embryo (chick and zebrafish), and
more recently, genetic manipulation (zebrafish) [10]–[13]. Mouse models that are utilized
to study embryonic hyperglycemia and the eye can be challenging as the mouse embryo
develops in utero. This makes it difficult to manipulate the intrauterine environment,
particularly in comparison to chick and zebrafish which develop externally. The most
common ways to induce maternal diabetes in mice are streptozotocin injection and leptin
knockout. Streptozotocin injection reflects a Type I diabetes model as it destroys
pancreatic beta cells and thus prevents insulin production. Leptin is a hormone
responsible for signaling satiety and is crucial to glucose homeostasis [14]. When leptin
expression is knocked out, this leads to obesity, hyperglycemia, and eventually models
Type II diabetes in mice [15]. For each model, hyperglycemia is induced in the mother,
then the embryos are dissected at specific time windows to characterize developmental
progress. Considering most human pregnancies are not detected in the first few weeks
after conception, key windows of early development are often missed in assuring tight
regulation of blood glucose. This highlights the importance of utilizing animal models for
studying early development. A study that assessed maternal hyperglycemia during the
first 72 hours of development in mouse embryos showed a significant increase in
embryopathy compared to normoglycemic controls. The group concluded that
hyperglycemia in the first few days of murine development is toxic to the embryo [16].
This study and others have exposed the vulnerability of early embryo development to
hyperglycemia [10], [17]. Further work has shown most stages of development are
susceptible to damage via high glucose exposure.
4

In 2015, a study focusing on the effects of hyperglycemia on heart development
showed that sustained high glucose exposure after fertilization prevented the
establishment of left-right axis formation during heart morphogenesis [18]. When
addressing the mechanism in mouse, specific candidate genes were identified as key
regulators of heart development that displayed altered expression in the presence of high
glucose. These genes include Nkx2.5, KCNE1, and Cx43 [19]. Looking more broadly at
general organogenesis, embryonic hyperglycemia has been linked to aberrant cell cycle
regulation which was associated with congenital malformations [10]. Specifically,
hyperglycemia has been shown to slow the cell cycle via decreased expression of a cell
cycle promoter, cyclin D, and increased expression of a cell cycle inhibitor, p21 [20].
This effect on the cell cycle is thought to contribute to aberrant organogenesis as it
prevents proper cell proliferation to establish growing tissue. Considering the broad
effects of hyperglycemia on embryonic development shown in these studies, it is
imperative to continue characterizing the impact on tissue development, particularly
those tissues which are susceptible to damage later in life such as the retina.

1.3

Zebrafish retinal development
The healthy vertebrate eye contains various tissues which support visual

perception, from the lens which focuses light, to the retina which receives the light signal
and transmits it to the brain. When light meets the lens, it is refracted onto the retina.
Firstly, light contacts the outer segments of photoreceptors where it triggers the
phototransduction cascade which results in a change of membrane potential. This change
signals for a cascade of events to continue transmitting the electrical signal until it
reaches the ganglion cell layer which is comprised of ganglion cells whose axons
fasciculate and become the optic nerve that connects to the brain. Each of the neuronal
cells involved in the visual pathway develop in a conserved manner across most
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vertebrates, beginning with the ganglion cells, followed by amacrine, bipolar, horizontal,
photoreceptors, and Müller glia.
In zebrafish specifically, the formation of the eye and subsequent differentiation
of the neural retina begins with 3 tissues: neuroectoderm, surface ectoderm, and
mesenchyme. The neuroectoderm gives rise to the retina and retinal pigmented
epithelium (RPE) as well as the optic stalk. Surface ectoderm forms the lens and
mesenchyme forms ciliary muscles and vasculature, sclera, corneal endothelium and
stroma, and iris stroma [21]. At 14 hours post fertilization, the neural keel forms and
beginning at 16 hpf, a two layered optic cup begins to form with the retinal
neuroepithelium and RPE. Once 22 hpf is reached, the optic vesicle evaginates into an
optic cup and a lens forms. The RPE becomes a distinct tissue at 28 hpf as well as the
formation of the optic nerve. Retinal cell differentiation begins around 28 hpf with the
ganglion cells in the ventronasal portion of the retina that continue to differentiate in a
fan-like manner [22], [23]. Differentiated ganglion cells express Ath5 and reside in the
ganglion cell layer [24]. Next are the amacrine and horizontal cells which begin
differentiation at 36 hpf and 60 hpf, respectively. Both express pancreas transcription
factor 1a (ptf1a) during terminal progenitor division and following differentiation [25].
Following these inner retinal neurons, the photoreceptors begin to differentiate at 48 hpf
starting with the cone photoreceptors and quickly followed by rod photoreceptors.
Progenitors of photoreceptors express Crx and rods specifically express Nr2e3 while
cones express Thyroid hormone beta (Thrb) and Otx2 [26]. During photoreceptor
differentiation, Müller glia also begin to differentiate at 60 hpf and continue to until 90
hpf [27]. Photoreceptor differentiation proceeds until 72 hpf and maturity for rods is
reached at 21 dpf. Electrical activity within the retina can be detected via
electroretinogram (ERG) which is an electrophysiological tool where electrodes record
the electrical signal sent through the retina in response to light stimulus and the feedback
response is analyzed [28]. At 4 dpf, cones are operational, whereas rod activity can be
detected beginning around 11-15 dpf [29]. Behavioral tests, such as the optokinetic
response (OKR) test, can also be used to assess visual function in zebrafish larvae. OKR
tests take advantage of the zebrafish’s well documented physical response to visual
stimulus called a saccade where the eyes follow the stimulus and then snap back into
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place. An OKR test is done by placing an immobilized fish in the middle of a rotating
drum and counting the saccades [30]. In juvenile and adult fish, continued retinal growth
is maintained by the ciliary marginal zone (CMZ). By 5 dpf, all retinal cells have
differentiated, and the zebrafish larvae switch from yolk dependency for nutrients to
hunting for food. This makes 5 dpf an ideal timepoint to analyze consequences of
disturbances during development on retinal anatomy and morphology.

1.4

Embryonic hyperglycemia and the eye
Although we know hyperglycemia has a severe impact on the eye in adulthood,

the bulk of what is known in the context of embryonic development has been established
only in the last 10 years. In 2016, a study utilizing the chick model found that
hyperglycemia induction during development resulted in eye malformations. The air sac
of chick eggs was injected with 0.2mM of glucose starting at embryo development day
(EDD) 1 and analyzed at EDD 5. First, a significantly smaller eye, or microphthalmia,
was noted in hyperglycemic chicks. Upon genetic analysis, they also found expression of
Pax6, Six3, and Otx2 were significantly downregulated in hyperglycemic chicks.
Downregulation of Pax6 specifically was linked to increased reactive oxygen species
production as its expression was rescued by antioxidant treatment. This was one of the
first studies to link embryonic hyperglycemia with microphthalmia and reactive oxygen
species [11]. Chicks are a valuable vertebrate model to study embryonic hyperglycemia
as their extraembryonic environment is accessible to manipulation. However, the
zebrafish offers an additional advantage in that they are amenable to both genetic
mutation and environmental glucose exposure. Additionally, the zebrafish can regenerate
structures that are susceptible to damage by hyperglycemia such as the retina and heart
[31]. Recently, multiple studies have showcased the utility of zebrafish for studying the
pathogenesis and complications of hyperglycemia.
Zebrafish make for a great model for developmental studies. Being an organism
that develops externally, they provide the unique opportunity for environmental
manipulation at any stage of development. Further, a single pair of mated adults can
produce hundreds of embryos, providing a large sample size for studies. In the context of
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this dissertation, zebrafish are a powerful model for microscopy given their transparency
during development, wide range of genetic tools for generation of mutants and transgenic
lines, and physiological similarities to humans which is useful for thorough disease
modeling. In the case of diabetes research, diabetes can be induced in the zebrafish in
similar fashion to humans including high fat diet [32], genetic knockout of Pdx1 [13], and
high glucose exposure during development [12].
Glucose exposure during embryonic development in zebrafish is growing in
popularity as a method for inducing embryonic hyperglycemia. A study in 2019 showed
submerging zebrafish embryos in 0, 4, and 5% glucose alternating with untreated fish
water every 24 hours from 3 hours post fertilization (hpf) to 120 hpf was sufficient to
induce hyperglycemia [12]. When the eyes and retinas were analyzed at 5 dpf, higher
whole-body glucose was correlated with an increase in ganglion cell and inner nuclear
layer thickness, a decrease in cell proliferation, and an increase in eye size. Looking at
specific cell types, a significant decrease in ganglion and Müller glia cells was noted.
Given the increased inner nuclear layer thickness and decrease in Müller glia cells, the
authors concluded that hyperglycemia resulted in activation of Müller glia cells.
Activated Müller glia would indicate a response due to damage to the retina from
hyperglycemia. Finally, there was a significant increase in inflammation, characterized
by increased mpeg expression. This further supports the finding of hyperglycemia
induced damage specifically to the eye.
1.5

Glucose metabolism and oxidative stress in the retina
Under normoglycemic conditions, glucose from choroidal vasculature passes through

the Retinal Pigment Epithelium (RPE) which contacts photoreceptor outer segments to
provide nutrients and aid in the shedding and recycling of spent outer segment disks.
Photoreceptors take up glucose which is broken down and converted to lactate via
aerobic glycolysis [33]. Byproducts of glycolysis include NADPH, glutamine:fructose-6phosphate amidotransferase (GFAT), dihydroxyacetone phosphate (DHAP), and trios
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phosphates. Upon release from the photoreceptor, lactate functions as a nutrient source
for Müller glia cells and feeds the RPE to suppress glycolysis, in turn increasing glucose
transport to photoreceptors [34]. Other retinal neurons rely on glucose for energy and
function as well. Interestingly, in mammalian models, the only other retinal cell type
known to express glucose transporters (GLUTs) aside from photoreceptors and Muller
glia is ganglion cells [35]. Interestingly, retinal cell metabolism varies across retinal
layers with the highest in the outermost and innermost portions as indicated by high
cytochrome c oxidase distribution [36]. In the outermost part of the retina, as described
earlier, there is disproportionately high energy demand by photoreceptors utilizing
glucose and anaerobic glycolysis [37]. In the inner and ganglion cell layers of the retina,
aerobic glycolysis is more utilized, as indicated by lower production of lactate and H+
[38].
When hyperglycemia is induced, there is a massive increase of glucose flux to
photoreceptors. The increase in glucose consumption by photoreceptors increases the rate
of glycolysis, thereby increasing pyruvate and ATP production. Pyruvate feeds into the
Tricarboxylic Acid (TCA) Cycle, producing NADH via reduction from NAD to convert
isocitrate to alpha-ketoglutarate. NADH feeds into the electron transport chain (ETC)
where it is oxidized at complex I and reacts with reduced flavin. Under normal
conditions, an electron can be passed from flavin to O2 which forms O2- (superoxide)
during NADH oxidation/flavin reduction [39]. When excess NADH is fed into the ETC,
superoxide production is increased, which induces DNA strand breaks. The breaks in
DNA activate poly(ADP ribose) polymerase (PARP). PARP activation then inactivates
GAPDH, which shunts glycolysis byproducts/intermediates into glucose overutilization
pathways such as polyol, hexosamine, protein kinase C (PKC) and AGEs pathways.
Additionally, pentose phosphate pathway upregulation is well documented in neurons in
a hyperglycemic environment which increases NADPH production and further
contributes to ROS production [40], [41]. These then drive downstream events within the
photoreceptor which continues to perpetuate production of ROS as well as expression of
TNF-a, NF-kB, and methylglyoxal which induce inflammation and cell death.
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In terms of vasculature, TNF-a release by photoreceptors under hyperglycemic
conditions induces vasculature damage via alterations in tight junctions, causing them to
be more permeable and to leak [42]. Vascular leakage can disrupt oxygen supply to the
retina, inducing hypoxia and retinal damage [43]. Even in the absence of hypoxia,
increased methylglyoxal expression stabilizes Hypoxia Inducible Factor alpha (HIF1-a)
which in turn causes photoreceptor degeneration and upregulates VEGF expression,
inducing neovascularization [44]. Combined, these pathways cause cell death,
photoreceptor degeneration, vasculature leakage as well as angiogenesis – all of which
are in line with the pathology of diabetic retinopathy (Fig. 2).
Specifically focusing on photoreceptors, it is known that they are one of the most
highly metabolically demanding cells in the body. Recent studies have found photoreceptor
degeneration precedes vasculature damage in animal models. Intriguingly, both rats and
zebrafish display photoreceptor degeneration and glial activation in various adult models
of hyperglycemia induction [8], [45], [46]. One study found hyperglycemia induced
photoreceptor degeneration and reactive oxygen species production, specifically
superoxides, in cone photoreceptors of adult mice [47]. The authors hypothesized the
degeneration of photoreceptors was due to the generation of superoxides, as well as other
possible contributors such as: hypoxia, altered metabolism, and defects induced by the
visual cycle. Considering the significant effects of vasculature damage and photoreceptor
degeneration in cases of hyperglycemia, it is imperative to understand how the two interact
and impact one another. Given the evidence of photoreceptor degeneration preceding
vasculature damage in recurring hyperglycemic models and that rhodopsin loss is known
to exacerbate vascular damage [48], it is highly likely that photoreceptor loss intensifies
vascular damage. With this knowledge though, it is necessary to conduct the next suite of
experiments to identify whether photoreceptor degeneration continues to exacerbate the
vascular damage and how vascular damage in turn impacts the rest of retinal cells on a
molecular level.
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Figure 1. 2 Long term effects of embryonic hyperglycemia in the retina.
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1.6

Metabolic memory and long-term effects of hyperglycemia
In the context of diabetes, metabolic memory refers to the idea that glucose

regulation in early stages of diabetes has lasting effects on the pathology of the disease
and its complications. For instance, tightly maintained blood glucose early on may
prevent the development of complications such as heart disease and vascular damage
later in life. Alternatively, poorly maintained blood glucose from an early stage can
exacerbate and accelerate the progression of complications, even if tight control is
achieved later in life. This concept was established in cell culture [49], then identified in
humans following a massive clinical study by the Diabetes Control and Complications
Trial (DCCT). The studies tracked the health of over 1,000 subjects with Type I Diabetes
over the course of 11 years, then again from 1994 to the present day by the Epidemiology
of Diabetes Interventions and Complications (EDIC). These studies highlighted the
importance of early blood glucose control to prevent long term complications.
Essentially, they found that tight glycemic control via highly regulated insulin
administration reduced the prevalence of complications such as retinopathy, neuropathy,
nephropathy, and atherosclerosis later in life, in comparison to less controlled insulin
administration [50].
Due to the role of glucose as a ubiquitous source of energy for nearly all cells, its
regulation is critical. Unfortunately, a modern, western diet does not support this sort of
control and creates a culture of excess consumption which has led to the devastating
increase in diabetes globally. While millions of people have been diagnosed with
diabetes, there are millions more who are not diagnosed or are pre-diabetic. Many of
these individuals do not have the tools to regulate their blood glucose properly, leading to
poor blood glucose regulation early on which greatly impacts their chances of developing
complications later via metabolic memory.
While the term “metabolic memory” is widely accepted, there is not a widely
agreed upon mechanism of action. In the field, there are a few hypothesized mechanisms:
epigenetic regulation, oxidative stress, chronic inflammation, and non-enzymatic
glycation end products to name a few [3]. Each proposed mechanism circles back to
epigenetic regulation. Recurring hyperglycemia can induce histone hyperacetylation at
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locations in the genome which remain stable and communicate with neighboring cells to
induce a similar effect. Studies in cell culture show that many of the genes overexpressed
due to histone hyperacetylation were those related to inflammation, macrophage
production, apoptosis, and oxidative stress. For instance, a study in 2004 showed, via
chromatin immunoprecipitation assay, that monocytes under hyperglycemic conditions
exhibited acetylated histone H3 and H4 at various lysines at TNF-alpha and COX2
promoters, indicating an increase in transcription which created a direct link between
hyperglycemia, epigenetic regulation, and inflammation [51]. In addition, NFkB-p65 has
also been identified as a gene that undergoes epigenetic changes at the promoter site
under hyperglycemic conditions to increase transcription. NFkB-p65 has been shown to
increase reactive oxygen species (ROS) production in mitochondria by impairing
complex III of the electron transport chain, causing leakage which increases superoxide
and hydrogen peroxide production [52].
In utero, environmental factors can greatly impact developmental outcomes. It has
been shown that embryonic hyperglycemia induces hyperinsulinemia as a response to
excess blood glucose. Hyperinsulinemia so early in development disrupts beta cell
development which may lead to insulin resistance. Conversely, beta cells may undergo
glucose toxicity and exhaustion early in development that depletes insulin granules,
rendering them incapable of secreting insulin. Lack of insulin production leads to a
reduction of insulin receptors [53]. Both scenarios prevent proper glucose uptake
throughout the life of the organism. Hyperglycemic embryos may also experience
epigenetic changes induced by hyperglycemia as described above that sustain through
adulthood, perpetually causing the overproduction of inflammation and ROS. These have
been exhibited specifically in the retina through my own studies where increased ROS
production and hyperinsulinemia have been shown in response to hyperglycemia.
To test for effects of metabolic memory, experiments must be conducted during
development between a control and hyperglycemic embryo or larvae, then repeated later
in adulthood at time points such as sexual maturity (3-months post fertilization) and 1year post development. This would indicate whether changes occurring during
development persist into adulthood, showing evidence of metabolic memory. As
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mentioned above, acetylated histones are a shown epigenetic change directly related to
hyperglycemia. Another way to test metabolic memory effects would be to test for DNA
hypomethylation which can be tested by bisulfite genomic sequencing analysis. DNA
extracted from hyperglycemic larvae would be treated with sodium bisulfite, causing
unmethylated cytosine to be converted to uracil, leaving methylated cytosine unaffected.
PCR for specific sites in the genome followed by sequencing allows for comparison of
methylated sites between control and diabetic conditions, and has been done in humans to
look for evidence of methylation and oxidative stress induced by diabetes [54].
Another indication of metabolic memory linked epigenetic changes is to test for
hyper-acetylated histones using a histone isolation kit. Acetylated histones can be
quantified with an ELISA like colorimetric assay kit. Additionally, acetylation can be
detected via Western blot using anti-acetylated lysine antibody on extracted protein from
tissue of interest. If acetylated histones are identified, qRT-PCR may be used to quantify
expression of genes known to be upregulated upon H3/H4 acetylation, such as TNFalpha, NF-kB, and COX2. The PCRs may also be used to test metabolic memory in the
eye specifically by using RNA extracted from the eye. Finally, advanced glycation end
products (AGEs) are another by product of damage induced by hyperglycemia that may
persist even after normoglycemia is achieved. Therefore, detection of AGEs can be used
to identify metabolic memory. AGEs activity may be quantified by protein extracted
from the eye for Western blot of AGE receptor (rAGE) or ELISA. In mammals, AGEs
may be detected via fluorescence: the serum is diluted in PBS then plated and excited at
370nm with an emission of 445nm. Fluorescence can be quantified and compared
between treatment groups as well as early in development and in adulthood [55]. While
the concept of metabolic memory can be complex, particularly in the context of diabetes,
there are a multitude of tests that can be done to look for evidence of metabolic memory
and how it impacts the current function of the individual.
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1.7

Rationale
Diabetic retinopathy is the leading cause of adult-onset blindness (NEI). This

complication occurs primarily in adults who experience recurring hyperglycemia over the
course of years. While time is an important factor of diabetic retinopathy progression,
pulses of hyperglycemia as short as one month in animal models have been shown to
affect retinal cell types which may contribute to the pathogenesis of diabetic retinopathy
[46], [56]. Photoreceptors and Müller glia in particular seem to be the primary targets of
the effects, as shown by photoreceptor degeneration and evidence of reactive gliosis via
increased GFAP expression [8]. Considering the strong effects of hyperglycemia in
adults, we began to question how hyperglycemia would affect the development of these
cell types and whether that would affect their ability to function properly in adulthood.
Multiple epidemiological studies have shown that hyperglycemia during embryonic
development, or embryonic hyperglycemia, are linked to an increase in type II diabetes,
metabolic syndrome, chronic kidney disease, and heart conditions in adulthood [57].
Unfortunately, epidemiological studies do not address long-term effects of specific cell
types, but molecular animal studies can fill this gap.
In my study, I aim to utilize zebrafish to look specifically at retinal cell types as
they develop and are maintained over time following embryonic hyperglycemia. In
humans, hyperglycemia can be induced in multiple ways; therefore, I generated multiple
models to reflect those possibilities. I characterized a genetic model (pdx1 mutant), and
created a nutritional model which we submerged embryos in glucose +/- dexamethasone
treated fish water. Additionally, I sought to parallel the phenotypes of these models to
better understand the underlying mechanisms by which hyperglycemia affects retinal cell
development. Through these studies, I found hyperglycemia plays a significant role in
retina development and maintenance over time. This is largely due to retinal cell
photoreceptor differentiation delay in hyperglycemic larvae and increased superoxide
production (Chapter 2). Adults which faced embryonic hyperglycemia continue to exhibit
similar phenotypes such as reduced photoreceptors and gliosis. Further, the noted
phenotypes were worsened if the adult experienced embryonic hyperglycemia (Chapter
3). Together, these studies provide sufficient evidence to show embryonic hyperglycemia
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has lasting impacts on the retina on a cellular level, which must be further evaluated to
develop therapeutic targets.
1.8

Specific Aims
I.

Characterize the effect of embryonic hyperglycemia during retinal
development
a. Assess retinal cell type differentiation and morphology in a genetic model,
pdx1
b. Assess retinal cell type differentiation and morphology in a nutritional
model

II.

Elucidate the long-term effects of embryonic hyperglycemia
a. Characterize retinal cell types in adults that experienced embryonic
hyperglycemia
b. Characterize retinal cell types in adults that experienced embryonic
hyperglycemia and hyperglycemia in adulthood

Aim I is included in Chapter 2
Aim II is included in Chapter 3
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CHAPTER 2
EMBRYONIC HYPERGLYCEMIA
PRETURBS DEVELOPMENT OF SPECIFIC RETINAL
CELL TYPES, INCLUDING PHOTORECEPTORS
Kayla F. Titialii-Torres and Ann C. Morris
Department of Biology, University of Kentucky, Lexington, Kentucky 40506

Key words: hyperglycemia, retina, photoreceptors, zebrafish, diabetes
Adapted from: Journal of Cell Science (2021) Embryonic hyperglycemia perturbs
development of specific retinal cell types, including photoreceptors.
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N.B. For this dissertation, figure numbers, headings, and text were modified to match
dissertation style.

2.1

Abstract
Diabetes is linked to various long-term complications in adults, such as neuropathy,

nephropathy, and diabetic retinopathy. Diabetes poses additional risks for pregnant
women, because glucose passes across the placenta, and excess maternal glucose can
result in diabetic embryopathy. While many studies have examined the teratogenic effects
of maternal diabetes on fetal heart development, little is known about the consequences
of maternal hyperglycemia on the development of the embryonic retina. To address this
question, we investigated retinal development in two models of embryonic
hyperglycemia in zebrafish. Strikingly, we found that hyperglycemic larvae displayed a
significant reduction in photoreceptors and horizontal cells, whereas other retinal neurons
were not affected. We also observed reactive gliosis and abnormal optokinetic responses
in hyperglycemic larvae. Further analysis revealed delayed retinal cell differentiation in
hyperglycemic embryos that coincided with increased reactive oxygen species (ROS).
Our results suggest that embryonic hyperglycemia causes abnormal retinal development
via altered timing of cell differentiation and ROS production, which is accompanied by
visual defects. Further studies using zebrafish models of hyperglycemia will allow us to
understand the molecular mechanisms underlying these effects.

2.2

Introduction
Diabetes is a growing epidemic, affecting 34.2 million people in the US in 2018

[58]. High blood sugar (hyperglycemia) is the primary symptom of diabetes and when it
becomes a recurring state, various complications are likely to arise which affect tissues
all over the body [59]. Complications include neuropathies (nerve damage), nephropathy
(kidney disease), stroke, and retinopathy which can cause progressive blindness [60].
While these complications are primarily documented in adults who have experienced
recurring hyperglycemia over many years, hyperglycemia during pregnancy carries its
own set of complications which can have long lasting effects on the offspring [18], [57],
[61].
During pregnancy, glucose passes through the placental barrier from the mother to
fetus; this maternally supplied glucose is necessary for fetal development but in excess it
can also result in embryonic hyperglycemia. Maternal hyperglycemia may come from
existing diabetes prior to pregnancy and/or increased insulin resistance developed during
pregnancy to allow for increased glucose to pass through the placenta, which is essential
for stimulating fetal insulin production to aid in growth [62]. Excess insulin resistance
can lead to gestational diabetes which is not diagnosed until 24 weeks into pregnancy
(and occurs in up to 10% of US pregnancies, [63]). The type and severity of
hyperglycemia related complication varies greatly, depending on when embryonic
hyperglycemia occurs. The most prominently studied complication of embryonic
hyperglycemia is heart malformation or congenital heart defect (CHD). A wide array of
phenotypes are associated with CHD, and it is considered the most common birth defect
associated with diabetic embryopathy [64]. However, other developing tissues and organs
are also vulnerable to the effects of embryonic hyperglycemia, and these have been less
well studied. A previous study found that offspring of mothers with diabetes displayed
significantly thinner inner and outer maculas as well as lower macular volume [65]. In
humans, the macula contains the highest density of cone photoreceptors, suggesting a
potential deleterious effect of diabetic pregnancy on retinal cone photoreceptor
development. Given these data and the strong connection between diabetes and retinal
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degeneration leading to progressive blindness in adults, there is a critical need to study
the effects of hyperglycemia on the developing retina during embryogenesis, using an
animal model where the developing eye is easily accessible.
Zebrafish have recently become a favorable model for studying hyperglycemia
and diabetes due to their relatively easy maintenance, high fecundity, and manipulatable
environment. Diabetes and hyperglycemia can be induced via ablation of pancreatic beta
cells through streptozotocin injection [66] or whole-body immersion in glucose dense
fish water [56]. Using the immersion technique with adult zebrafish, it was demonstrated
that recurring hyperglycemia resulted in a reduction in the number of cone photoreceptors
in the retina, with remaining photoreceptors displaying an abnormal morphology,
including shortened outer segments [46] as well as abnormal electroretinogram responses
[8]. Recent studies utilized a genetic mutant to induce hyperglycemia (pdx1-/- ), which
does not properly produce insulin. Without insulin, glucose is not metabolized as needed,
leading to an increase in free glucose in the bloodstream and subsequent hyperglycemia.
Characterization of the pdx1-/- mutants showed that recurring hyperglycemia in adulthood
resulted in photoreceptor degeneration, defective visual responses [67], and increased
retinal angiogenesis, a hallmark of diabetic retinopathy [68]. While these studies show
the utility of zebrafish to study the ocular complications of hyperglycemia in adults, there
has been less work on the effects of hyperglycemia during embryonic and larval retinal
development. One recent study suggested that exposure to very high levels of exogenous
glucose causes a decrease in retinal ganglion cells and Müller glia as well as an increase
in vasculature leakage in zebrafish larvae [12], providing evidence that embryonic
hyperglycemia has deleterious effects on retinal development. However, the
consequences of embryonic hyperglycemia specifically on photoreceptor development
have not been closely examined. Given that there is mounting evidence that
photoreceptors, which are highly metabolically demanding cells, are major contributors
to the progression of diabetic retinopathy, there is a pressing need to study how
hyperglycemia may impact photoreceptors during embryonic development.
In this study, we specifically explored the consequences of hyperglycemia on cell
type differentiation in the developing zebrafish retina, using two complementary
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approaches. To model chronic hyperglycemia via lack of insulin production, similar to
what is observed in type I diabetes, we utilized pdx1-/- zebrafish, which possess a null
mutation in a gene necessary for beta cell development, and therefore cannot produce
insulin [13]. A recent study showed pdx1-/- zebrafish larvae have microvascular changes
in the ocular hyaloid vasculature at 6 days post fertilization (dpf) [68], however an
examination of photoreceptor and retinal development has not yet been reported for this
mutant. To model hyperglycemia that is representative of type 2 diabetes, we developed a
nutritional model, in which zebrafish embryos are exposed to exogenous glucose and
dexamethasone from 10 hours post fertilization (hpf), just prior to optic vesicle
evagination, until 5 dpf, when retinal development is largely complete. Dexamethasone is
a synthetic glucocorticoid that is used in combination with glucose to elevate whole body
glucose due to its ability to stimulate gluconeogenesis and disrupt glucose transport [69].
In the context of embryonic development, dexamethasone is often given to pregnant
women who are at risk of preterm birth to aid in fetal lung development, and it is known
that low birth weight and preterm babies are highly susceptible to hyperglycemia [70].
Here we report that, in both genetic and nutritional models of embryonic
hyperglycemia, rod and cone photoreceptor cells are significantly decreased in number,
and retinal oxidative stress is increased. Notably, embryonic hyperglycemia was
associated with abnormal visual behavior at 5 dpf. Additionally, the timing of retinal
progenitor differentiation was altered in hyperglycemic larvae, and cone photoreceptor
number remained lower the controls even after a return to normoglycemic conditions.
These findings provide evidence that embryonic hyperglycemia impedes proper retinal
development, leading to short-term, and potentially long-term, visual defects.

2.3
2.3.1

Materials and Methods
Zebrafish Lines and Maintenance

Zebrafish were bred, raised, and maintained in accordance with established
protocols for zebrafish husbandry. All zebrafish lines were bred and raised at 28.5ºC on a
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14-hour light:10-hour dark cycle as previously described [71]. The Tg(3.2TaC:EGFP)
transgenic line (TaC:EGFP), previously described [72], was generously provided by
Susan Brockerhoff (University of Washington, Seattle, WA). The Tg(XlRho:EGFP)
transgenic line (XOPS:GFP), has been previously described, and was obtained from
James Fadool (Florida State University, Tallahassee, FL, USA; Fadool, 2003). The
Tg(gfap: GFP)mi2001 or GFAP:GFP transgenic line [74], was obtained from the
Zebrafish International Resource Center (ZIRC, Eugene, OR). Heterozygous pdx1sa280
adults were generously provided by Tim Mulligan (Johns Hopkins University, Baltimore,
MD). Pdx1 genotype was determined by PCR using the primers 5’TGGCTCATGTGCTCGTGTA-3’ and 5’-GTGCGTGTGAGATTTGGTTG-3’ followed
by RFLP analysis with DraI. Embryos were anesthetized with Ethyl 3-aminobenzoate
methanesulfonate salt (MS-222, Tricaine; Sigma-Aldrich Corp., St. Louis, MO). All
animal procedures were carried out in accordance with guidelines established by the
University of Kentucky Institutional Animal Care and Use Committee and the ARVO
statement on the use of animals in research.

2.3.2

Generating hyperglycemic zebrafish embryos

GFAP:GFP, XOPS:GFP and TaC:eGFP adult fish were in-crossed to generate
embryos that were sacrificed at the following time points: 48, 72, and 96 hpf, and 5 dpf.
To generate hyperglycemic embryos/larvae, 10 hpf embryos were dechorionated with
pronase (Sigma), and randomly sorted into groups of 25 and placed in the following
treatments: untreated fish water, 50 mM glucose, 50 mM mannitol, 10μM dexamethasone
(Sigma), or 50 mM glucose + 10 μM dexamethasone (glucose+dex) in 1x Phenylthiourea
(Sigma) dissolved in fish water. At each time point of interest, heads were removed for
cryosectioning, mRNA, or protein extraction, while the body was used to quantify whole
body glucose concentration. For the pdx1 line, larvae were trisected: heads were used for
retinal sectioning, mid-body area was used to quantify glucose using the glucose assay,
and genomic DNA was extracted from the tail for genotyping.
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2.3.3

2-NDBG submersion for detection of glucose uptake

Larvae were submerged in fish water containing a fluorescent analog of glucose
(2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose) or 2-NDBG
(Invitrogen, Grand Island, NY) at 5 dpf. 2-NDBG was dissolved in DMSO and diluted in
fish to a final concentration of 500µM. Larvae were submerged for 1 hour in a dark
incubator at 28.5ºC then imaged with a Nikon inverted fluorescent microscope (Eclipse
Ti-U, Nikon Instruments).

2.3.4

Glucose concentration quantification

A glucose colorimetric assay kit from Biovision (Biovision, Milpita, CA) was
used to quantify whole body glucose concentration, following the manufacturer’s
instructions. In short, following sacrifice, animals were homogenized in glucose assay
buffer, mixed with a glucose oxidation enzyme and a colorimetric probe, and incubated
for 20 minutes at 37°C. A spectrophotometer was used to quantify glucose concentration.
Reads were translated into pmol/larvae through generation of a standard curve from a set
of samples of defined glucose concentrations.

2.3.5

Cryosections and cell counts

Embryos were fixed overnight in 4% paraformaldehyde, then incubated overnight
in 10% followed by 30% sucrose at 4ºC. Transverse 10µm sections were taken beginning
in the anterior tip of the head, moving posteriorly through the eye. For imaging and cell
quantification, only sections containing an optic nerve were used for consistency.
Photoreceptors in the dorsal, central, and ventral portions of the retina were quantified
and normalized to the curvilinear length of the outer nuclear layer. For the HuC/D,
PKCα, and Prox1 quantification, counts were conducted on 50µm wide regions of
interest, 50µm dorsal to the optic nerve for consistency. For the Müller glia shape
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analysis, images of retinal sections from both nutritional and genetic models on the
GFAP:GFP background were uploaded into the Nikon Imaging Analysis Program.
Within the program, the ratio of normally shaped to total Müller glial cell bodies was
quantified using a standardized wide oval shape fitted to the wildtype GFP-positive
Müller glia, followed by software auto-detection of similar shapes within the images.
Images were taken using a 20x objective on a Leica SP8 Confocal microscope or a Nikon
Eclipse inverted fluorescent microscope (Eclipse Ti-U, Nikon Instruments). At least 5
embryos were analyzed per treatment/genotype, and at least 2 separate biological
replicates were performed for each experiment.

2.3.6

Immunohistochemistry, TUNEL and EdU Assay

Sectioning and immunohistochemistry were conducted as previously described
[75] and immunolabeled sections were imaged on either a Nikon inverted (Nikon Ti-U)
or confocal microscope (Leica SP8, Leica). The following antibodies were used: antiZpr3 (photoreceptor outer segments, mouse, 1:100, ZIRC), anti-Huc/D (ganglion and
amacrine cells, mouse, 1:40, ZIRC), anti-PKCα (bipolar cells, mouse, 1:100, Santa Cruz
Biotechnology, Dallas, TX), and anti-Prox1 (horizontal cells, rabbit, 1:1000, Acris, San
Diego, CA). Alexa fluor conjugated secondary antibodies (Invitrogen) and Cy-conjugated
secondary antibodies (Jackson ImmunoResearch, West Grove, PA) were used at 1:200
dilution. Slides were incubated in 4’,6-diamidino-2-phenylindole (DAPI) to label nuclei
(1:10,000 dilution, Sigma). TUNEL assay was conducted with ApopTag Fluorescin
Direct In Situ Apoptosis Detection Kit (Millipore, Billerica, MA) on retinal cryosections
according to manufacturer's instructions. EdU assay was conducted with the EdU Cell
Proliferation Assay Kit (EdU-555, Millipore, Billerica, MA). Embryos were soaked in
0.75mM EdU for 2 hours at room temperature from 48-50 hpf, then washed in fresh fish
water, and raised to 5 dpf. Heads were cryosectioned and the Clik-It assay was conducted
on retinal cryosections according to the manufacturer’s instructions.
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2.3.7

Statistical Analysis

Data were checked for normal distribution via a skewness test in Excel; statistical
analysis consisted of ANOVA followed by two-factor, unpaired t -test, using GraphPad
software. P-values less than 0.05 were considered significant and are indicated by *; p<
0.01 is indicated by **, and p<0.001 by ***. Boxplots were generated using R (version
3.6.2)/R studio (version 1.2.5033) ggplot2 package [76]. Figures 2 and 9 were created
using Biorender (biorender.com). All figures were constructed using Photoshop (Adobe
version 21.0.2).

2.3.8

Western blot analysis

Protein was extracted from the heads of 25 pooled 5dpf larvae from each
nutritional model treatment by homogenizing in RIPA buffer and Complete EDTA mini
tablets (Roche) which contain protease inhibitors. Following extraction, protein was
quantified with a Bradford assay. For the Western blot, 30µg of protein from each sample
was loaded onto a pre-cast gel (Bio-Rad) and run to separate proteins by size, then
transferred to a nitrocellulose membrane. The membrane was blocked for 30 minutes at
room temperature then incubated overnight at 4ºC with the following antibodies: β-actin
(1:500, Santa Cruz) then GFAP (1:1000, GENETEX, GTX128741). Membranes were
then incubated in secondary antibody(1:500, Santa Cruz) at room temperature for one
hour, developed with (Bio-rad) and imaged. Bands were quantified using ImageJ [77],
normalized to β-actin bands, and a t-test was used to determine significant differences in
band intensity.

2.3.9

Metabolic pathway analysis

A Zebrafish Glucose Metabolism RT2 Profiler PCR Array (Qiagen, location) was
used to quantify 86 different enzymes involved in pathways related to glucose
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metabolism (glycolysis, TCA cycle, electron transport chain, etc.) according to the
manufacturer’s instructions. Briefly, mRNA was extracted, and cDNA generated as
previously described [71], from larval heads at 5 dpf for all treatment groups and pdx1
genotypes. cDNA, SYBR Green, and ultra-purified water were mixed and pipetted into
the plate and a Roche Light Cycler (Roche, city) was used to run a program consisting of
45 cycles, 95ºC for 15 seconds, 60ºC anneal for 60 seconds. Gene expression was
quantified with Roche Light Cycler Analysis program and normalized to the
housekeeping gene, beta-actin.

2.3.10 ROS production visualization and ROS inhibitor treatment

Treated and control 5 dpf larvae were submerged in 5mM MitoSOX ROS probe
(Invitrogen, Carlsbad, CA) for 20 minutes at 28°C in the dark. Larvae were washed 3
times in fish water, mounted in 4% low melting agarose/1% tricaine, and imaged with a
Leica SP8 confocal microscope. Following imaging, eyes were microdissected for retinal
sections and imaged on the Leica SP8 Confocal microscope. ROS production was
quantified by fluorescent pixel density using ImageJ. Diphenyleneiodonium (DPI,
D2926, Sigma) was included with nutritional model treatments at 25µM and larvae were
analyzed as described above.

2.3.11 Optokinetic Response Test

Optokinetic Response Test was conducted as described by [30]. Larvae were
assessed at 5 dpf, 1 at a time for 1 minute at 6 rotations per minute. Each larva was tested
4 times, twice in each direction of the rotating drum, and averaged. Saccadic eye
movements were quantified and compared across treatments and genotypes with an
ANOVA/unpaired t-test.
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2.4

Results
2.4.1

Hyperglycemia is detectable in pdx1 mutant larvae at 5 dpf

Prior studies of pdx1 mutant zebrafish have demonstrated that at 5 dpf, mutant
larvae have elevated whole body glucose, aberrant hyaloid vasculature, and grow to be
significantly smaller compared to their wildtype and heterozygous siblings [13], [68].
Using the pdx1sa280 mutant line described by Kimmel et al, we found that pdx1 mutants
displayed elevated whole-body glucose levels as early as 4 dpf (data not shown) and
confirmed that they have significantly elevated whole-body glucose at 5 dpf (Fig. S2.1A).
We measured whole-body glucose rather than blood glucose because the total blood
volume of a 5 dpf zebrafish larvae is less than a microliter [78]. We measured pdx1
mutant eye size and found that it was proportional to their body size when compared with
wild type larvae, indicating that the mutation and accompanying hyperglycemia does not
cause microphthalmia (Fig. S2.1B-D). However, further analysis at the cellular level
revealed interesting abnormalities in the developing retina.

2.4.2

Pdx1 mutant larvae have reduced numbers of photoreceptors

To determine whether hyperglycemia impacts photoreceptor development, we
imaged and quantified red/green cone photoreceptors at 5 dpf in wildtype and pdx1-/retinas, using the the Zpr1 antibody. Red/green cones displayed a significant decrease in
number (Fig. 2.1B, C) in hyperglycemic compared to wildtype retinas (Fig. 2.1A). In the
ventral region cones possessed stunted outer segments and thinner cell bodies (Fig.
2.1B’) than those in wildtype larvae (Fig. 2.1A’). To image and quantify rods, we crossed
heterozygous pdx1sa280 adults onto the XOPS:GFP transgenic background, in which rod
photoreceptors are fluorescently labeled [73]. We observed a significant decrease in rod
photoreceptors of pdx1-/- larvae at 5 dpf compared to wildtype and heterozygous siblings
(Fig. 2.1F). Looking closely at the rod photoreceptors in the ventral retina, the outer
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segments appeared to be much shorter and thinner (Fig. 2.1E’ arrowheads) when
compared to wildtype or heterozygous retinas (Fig. 2.1D’). The dorsal retina also
contained fewer rod photoreceptors in mutants (Fig. 2.1E) compared to wildtype (Fig.
2.1D).
Quantification revealed a significant decrease in both rod and cone photoreceptors
in pdx1 mutants at 5 dpf (Fig. 2.1C and 2.1F). The average number of red/green double
cone photoreceptors was reduced by over 20% which was particularly striking in the
ventral portion of the retina (average of 13/100µm in WT or het vs. 9 in pdx1-/- mutants),
and the average number of rods was decreased by 45% (average of 5.5/100µm in
wildtype or het vs. 3 in pdx1-/- mutants). Taken together, we conclude that hyperglycemic
pdx1 mutants have significantly less photoreceptors than normoglycemic larvae of the
same age, and the photoreceptors that are present in pdx1 mutant retinas display an
abnormal morphology.
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Figure 2. 1 Photoreceptors display reduced numbers and abnormal morphology in pdx1
mutant
larvae at 5 dpf

Figure 2.1: Photoreceptors display reduced numbers and abnormal morphology in
pdx1-/- larvae at 5 dpf. Red/green double cones were visualized with the Zpr1 antibody
(A-B); the ventral portion of the retina showed differences in morphology and spacing of
red/green double cones in pdx1-/- larvae (B’). pdx1-/- larvae showed a significant
decrease in cone photoreceptors in both the dorsal and ventral retina (C). Rod
photoreceptors were visualized using the XOPS:GFP transgene (D-E) and were
significantly reduced in pdx1-/- larvae in both the dorsal and ventral retina (F). The ventral
portion of the retina is emphasized in D’ and E’. Sample size: 5 animals per sample, 3
biological replicates. Graphs show mean ± s.e.m.; ANOVA followed by t-test: p=0.0238
(C, dorsal), p=0.0001 (C, ventral), p=0.0001 (F, dorsal), p=0.0014 (F, ventral). D, Dorsal;
V, Ventral; ONL, Outer Nuclear Layer; INL, Inner Nuclear Layer; GCL, Ganglion Cell
Layer; L, Lens. Scale bars: 50µM (A, B) and 20µM (A’, B’). *p<0.05; **p<0.01.
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2.4.3

Induction of hyperglycemia in developing zebrafish via glucose and
dexamethasone exposure

While the pdx1 mutant provides insight into hyperglycemic phenotypes resulting
from a genetic defect in insulin producing cells, we also wanted to determine whether
embryonic and larval hyperglycemia induced by altered nutrient uptake had similar
effects on retinal development. With this approach, we can model the effects of a direct,
in utero, exposure to elevated glucose that may occur in cases of maternal diabetes, and
which involves excess glucose flow across the placenta [79]. To that end, we submerged
zebrafish embryos in fish water containing glucose +/- dexamethasone from 10 hpf (just
prior to optic vesicle evagination from the forebrain) until 5 dpf (when retinal
development is largely complete; experimental workflow shown in Fig. S2.2A). To avoid
nonspecific effects of high glucose on embryo development, we conducted a series of
dose responses for glucose concentrations and selected 50mM as it was the lowest
concentration which resulted in whole body glucose elevation. This is consistent with a
previous study, which used 55mM glucose treatments to induce hyperglycemia and
which resulted in abnormal vasculature development [80]. Other studies involving a
glucose submersion technique with zebrafish to induce hyperglycemia have used higher
glucose concentrations that ranged from 110mM to 277mM [8], [12].
Treatment of zebrafish embryos with glucose alone produced a significant
increase in whole body glucose in comparison to untreated embryos and to embryos
exposed to mannitol (osmolarity control; Fig. S2.2B), however we found that exposure to
glucose alone resulted in highly variable levels of hyperglycemia. To combat this, we
added dexamethasone to the glucose treatment. Dexamethasone is a synthetic
glucocorticoid that has been shown to disrupt glucose transport into cells, preventing
proper breakdown of glucose and increased free glucose in the blood [81].
Dexamethasone is also frequently given antenatally to facilitate fetal lung maturation
[82]. Our results show the combination of glucose and dexamethasone treatment provides
a much tighter range of significantly elevated whole-body glucose values (Fig. S2.2B).
Additionally, dexamethasone treatment alone did not significantly affect whole-body
glucose in comparison to untreated and mannitol controls (Fig. S2.2B).
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When comparing the gross morphology of larvae from the different treatment
groups, we observed some variation in body length as well as yolk and eye size.
However, when eye size was normalized to body size, there was no significant difference
in ocular proportions across groups, indicating that our experimental conditions do not
cause microphthalmia (Fig. S2.2C-D). Moreover, using a fluorescent glucose analog (2NDBG) we confirmed that exposure to exogenous glucose leads to glucose uptake in the
eye (Fig. S2.2E). Taken together, our results show that a combination of glucose and
dexamethasone exposure reliably produces hyperglycemia in zebrafish larvae. From this
point forward we will mostly present data from the mannitol and glucose+dex treatment
groups.
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Figure 2. 2 Photoreceptors display reduced number and abnormal morphology in glucose
+ dex treated larvae at 5 dpf.

Figure 2.2 Photoreceptors display reduced number and abnormal morphology in glucose
+ dex treated larvae at 5 dpf. Eyes were dissected and imaged by confocal microscopy, or
larvae were cryosectioned to visualize retinal photoreceptors. Cone photoreceptors were
visualized using the TαC:eGFP trangenic line (A-B”) and rod photoreceptors were
visualized using the XOPS:GFP transgenic line (D-E”). Confocal z-stacks of whole eyes
(A, B) reveal different distributions of cone photoreceptors throughout the eye. Retinal
sections show a significant reduction in cone photoreceptors in glucose+dex treated
larvae compared to controls (B’, C). Magnified images of the sections reveal long outer
segments in mannitol treated embryos (A”) and truncated outer segments glucose+dex
treated larvae (B”). Confocal stacks of the XOPS:GFP treated larvae (D, E) revealed
large patches of reduced or missing rod photoreceptors. Retinal sections confirmed the
significant reduction in number of rod photoreceptors (F) in glucose+dex treated larvae
(E’) compared to controls (D’). In addition, truncated outer segments were found in
glucose + dex treated (E”) compared to mannitol treated larvae (D”). Sample size: 10
animals per sample, 3 biological replicates. Graphs show mean ± s.e.m.; ANOVA
followed by t-test: p=0.0001 (UT-glucose), p=0.0001 (UT-glucose+dex). D, Dorsal; V,
Ventral; ONL, Outer Nuclear Layer; INL, Inner Nuclear Layer; GCL, Ganglion Cell
Layer; L, Lens. Scale bars: 50µM (A, A”, D, D”) and 10µM (A’, D’). * p<0.05; **
p<0.01.
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2.4.4

Decreased retinal photoreceptors in a nutritional model of embryonic
hyperglycemia

With the establishment of a nutritional model to compare to the pdx1 mutant, we
conducted similar analyses on photoreceptor development. Progeny of XOPS:GFP and
TaC:eGFP (a transgenic line that fluorescently labels all cone photoreceptors;[72]) adult
in-crosses were used in treatments to assess photoreceptor number and morphology.
Similar to the pdx1 mutant, we observed a significant decrease in both cone and rod
photoreceptors of hyperglycemic larvae at 5 dpf (Fig. 2.2C, F). Cone photoreceptors were
decreased by 23% in glucose treated and 28% in glucose+dex treated retinas compared to
those treated with the mannitol control (Fig. 2.2C), whereas rods were decreased by 34%
in glucose treated and 45% in glucose+dex treated retinas (Fig. 2.2F). Compared to pdx1
mutants, the decrease in cones was larger in the nutritional model, which may be because
the TaC:eGFP transgene used for these experiments labels all cone photoreceptor
subtypes (red, green, blue, and UV), whereas only red/green cones were detected by the
Zpr1 antibody used with the pdx1 larvae. In contrast, the reduction in rods was
comparable in the glucose+dex treated larvae and pdx1 mutant larvae. Confocal
microscopy of whole eyes from control and hyperglycemic larvae revealed a large
decrease in the number of rod photoreceptors in hyperglycemic compared to mannitol
treated larvae (Fig. 2.2D, E). In addition, the confocal images showed that, similar to the
pdx1 mutant retinas, the outer segments of both cone and rod photoreceptors appeared
stunted compared to controls, with wider inner segments (Fig. 2.2B”, E”). Taken
together, our results show that embryonic hyperglycemia induced by exogenous glucose
results in a reduction of photoreceptors, similar to what is noted in pdx1 mutants, further
supporting a significant impact of embryonic hyperglycemia on photoreceptor
development.
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Figure 2. 3 Hyperglycemic larvae have truncated outer segments and altered visual
behavior at 5 dpf.

Fig. 3 Hyperglycemic larvae have truncated outer segments and altered visual behavior at
5 dpf. Immunolabeling for outer segments with Zpr3 showed a decrease in density of
outer segments in both hyperglycemic models (B, E), with a particularly striking
difference in the ventral portion of the retina compared to controls (A, D). An optokinetic
response (OKR) test was conducted on larvae at 5 dpf . Hyperglycemic larvae showed a
decrease in saccades compared to controls (C, F). Sample size (A-B): 10 animals per
sample, 3 biological replicates. Sample size (D-E): 5 animals per sample, 3 biological
replicates. Sample size (C): 5 animals per sample, 2 biological replicates; (F): 5 animals
per sample, 4 biological replicates. Graphs show mean ± s.e.m.; ANOVA followed by ttest: p=0.0001 (C), p=0.0001 (F). D, Dorsal; V, Ventral; ONL, Outer Nuclear Layer;
INL, Inner Nuclear Layer; GCL, Ganglion Cell Layer; L, Lens. Scale bars: 10µm (A).
**p<0.01.
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2.4.5

Hyperglycemic larvae exhibit visual defects
Our results from both models indicate that embryonic hyperglycemia causes

photoreceptor defects in the larval retina, specifically in overall number and in outer
segment morphology. To further assess outer segments, we used the Zpr3 antibody,
which specifically labels the outer segments of rod photoreceptors and the Rh2expressing member of the double cones [83]. The results confirmed that rods and cones
from hyperglycemic larvae have shorter outer segments compared to wild type larvae at 5
dpf (Fig. 2.3A-B, 2.3D-E). Histological staining with hematoxylin and eosin (H&E) on
control and hyperglycemic retinal sections also supports this finding (Fig. S2.3). The
purpose of outer segments is to capture light and, via the phototransduction cascade,
convert it to an electrical signal to be sent through the retina to the brain [84]. Both pdx1
mutant and glucose+dex treated larvae displayed abnormally short photoreceptor outer
segments. Without full, elongated outer segments, we hypothesized that hyperglycemic
larvae may experience subtle visual defects [85]. Therefore, we performed an optokinetic
response (OKR) assay to measure larval visual response. Comparison of the number of
ocular saccades per minute across pdx1 genotypes revealed a significant reduction of eye
movements in the pdx1 mutants compared to their wildtype and heterozygous siblings
(Fig. 2.3C). Similarly, glucose+dex treated larvae also showed a significant decrease in
OKR performance at 5 dpf compared to untreated and mannitol treated larvae (Fig. 2.3F).
Glucose treated larvae showed a wide range in response, reflective of the variability in
their photoreceptor number and morphology. Together, these results show that the
photoreceptor defects observed in hyperglycemic larvae are associated with reduced
visual responses. While we cannot exclude the possibility that the reduced OKR is due to
abnormalities in the extra-ocular muscles or other sensory deficits, the photoreceptor
phenotypes we documented support a connection to the visual behavior defects.
Moreover, the similarity in phenotype between pdx1 mutants and glucose+dex treated
larvae, with respect to photoreceptor number, photoreceptor morphology, and visual
acuity, indicates that these phenotypes are due to hyperglycemia. Therefore, we next
wanted to delve into the mechanisms by which these phenotypes arise.
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Figure 2. 4 Signs of reactive gliosis in hyperglycemic larvae.

Figure 2.4: Signs of reactive gliosis in hyperglycemic larvae. Treated and pdx1+/- adults
were crossed onto the GFAP:GFP transgenic background to visualize Müller glia. At 5
dpf, whole mount confocal images (A, C, E) and retinal sections (B, D, F) revealed an
increase in the number of Müller glia in glucose treated retinas (C, C’). Glucose+dex
treated larvae displayed large, irregular shaped nuclei (E’, F). Quantification showed an
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increase in number of Müller glia in glucose treated (G) and a significant decrease in the
proportion of normal Müller glia in glucose+dex treated retinas (H). Western blot for
GFAP revealed increased expression in glucose and glucose + dex treated larvae (I).
Retinal sections of pdx1 mutant larvae crossed onto the GFAP:GFP transgenic
background at 5 dpf (J-L) showed no difference in number of Müller glia (M) but a
significant increase in the size of Müller glia cell bodies (N), and a reduction in normal
shaped Müller glia in pdx1 heterozygotes and mutants (O). Sample size (G): 5 animals
per sample, 2 biological replicates; (H): 5 animals per sample (8 in glucose+dex); (I): 20
animals per sample; (M-O): 5 animals per sample. Graphs show mean ± s.e.m; ANOVA
followed by t-test: p=0.0101 (H), p=0.0001 (N), p=0.001 (wildtype-heterozygote),
p=0.0018 (wildtype-mutant). ONL, Outer Nuclear Layer; INL, Inner Nuclear Layer;
GCL, Ganglion Cell Layer. Scale bars: 10µm. *p<0.05.
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2.4.6

Apoptosis is modestly elevated in hyperglycemic larval retinas

Hyperglycemia has been shown to induce cell death via apoptosis and autophagy
as well as to increase susceptibility to necrosis [86]–[88]. Therefore, we wanted to
quantify and compare programmed cell death in control and hyperglycemic larvae. Using
the TUNEL assay we detected apoptotic cells in retinal sections at 5 dpf. We found an
increase in apoptotic cells with both the genetic (Fig. S2.4C) and nutritional models, but
only the nutritional model showed a statistically significant increase (Fig. S2.4F). Cell
death was primarily observed in the INL and to a lesser extent in the ONL (Fig. S2.4B,
E). Looking at additional timepoints leading up to 5 dpf, we found cell death began to
significantly increase at 4 dpf (Fig. S2.4AE), which aligns with the first time point at
which we see elevation in whole body glucose in pdx1 mutants and glucose+dex treated
larvae. Although there was a significant increase in apoptosis in hyperglycemic retinas,
the total number of TUNEL+ cells per retinal section was low across all treatments and
timepoints (Fig. S2.4G-AE).

2.4.7

Hyperglycemic larval retinas exhibit signs of reactive gliosis

Sections of control and hyperglycemic GFAP:GFP (a transgenic line in which
Müller glia cells are GFP tagged) larvae revealed an increase in average number of
Müller glia in glucose treated larvae (+17%) at 5 dpf and a slight increase in the
glucose+dex treated larvae (+11%) compared to untreated and mannitol treated controls
(Fig. 2.4G). Looking at the distribution of Müller glia within the inner nuclear layer,
glucose+dex treated larvae displayed an irregular localization of Müller cell bodies (Fig.
2.4F) compared to the linear pattern of cell bodies in mannitol and glucose treated retinas
(Fig. 2.4B, D). Moreover, whereas Müller glial cell bodies possessed the expected
compact polygonal shape in mannitol and glucose treated retinal sections, the Müller glial
cell bodies of glucose+dex treated retinas appeared swollen, twisted, or heart-shaped,
which could represent signs of reactive gliosis (Fig. 2.4F). For a better understanding of
Müller glia morphology, we utilized whole-mount confocal microscopy to visualize
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Müller glia in 3-D space. We found the increase of Müller glia in glucose treated larvae
was evident throughout the eye (Fig. 2.4C, C’), while the shape and size of Müller glia
were comparable to mannitol treated retinas (Fig. 2.4A, A’). Whole mount imaging of
glucose+dex treated larvae revealed a variety of abnormal cell body shapes throughout
the eye (Fig. 2.4E, E’) which were also larger than glucose and mannitol treated. This
finding was supported by using image analysis to calculate the ratio of regular/ovalshaped to total Müller cell bodies across treatments (Fig. 2.4H). Lastly, a Western blot
revealed a significant increase in GFAP expression in glucose+dex treated larvae (Fig.
2.4I). Together, these results indicate a gliotic response in the glucose+dex treated retinas
at 5 dpf. We also imaged retinal sections from 5 dpf pdx1 larvae that were crossed onto
the GFAP:GFP background. Unlike glucose and glucose+dex treated larvae, pdx1
mutants did not exhibit an increase in the number of Müller glia (Fig. 4M). Interestingly
though, we did find that Müller glia cell bodies in pdx1-/- retinas were significantly larger
than their wildtype and heterozygous counterparts (Fig. 2.4N) and displayed a variety of
abnormal shapes similar to glucose+dex treated larvae, with some disorganization in
patterning (Fig. 2.5L, O). To determine whether there was an increase in Müller glial
proliferation in hyperglycemic retinas, larvae were exposed to EdU at 5 dpf. We did not
observe any co-localization of EdU+ cells with Müller glia (Fig. S2.7A-E), indicating
that the reactive gliosis in hyperglycemic retinas was not accompanied by significant cell
proliferation. Taken together, our results suggest that embryonic hyperglycemia induces a
gliotic response within the larval retina. Furthermore, exogenous exposure to glucose
causes a slight increase in Müller glial number that is not observed in pdx1 mutant
retinas, suggesting that this effect may be due to elevated levels of insulin signaling in
our nutritional model.
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Figure 2. 5 Increased superoxide production in hyperglycemic larvae at 48 hpf

Figure 2.5: Increased superoxide production in hyperglycemic larvae at 48 hpf. Treated
larvae were submerged in a superoxide probe and imaged with by fluorescence
microscopy. An increase in superoxide production was observed throughout glucose and
glucose+dexamethasone treated heads (G), particularly within the eye (B, C), compared
to controls (A). Retinal sections showed a modest increase in superoxides in glucose+dex
(F) compared to untreated and glucose treated (E, E; p=0.10). No differences were noted
in pdx1 mutant larvae (L) when comparing wildtype (H) and mutants (I). Increased
superoxide production was observed in the retina of glucose+dex treated larvae
specifically near the forming marginal zone (F). Sample size (A-C): 5 animals per
sample, 2 biological replicates; (D-F): 10 animals per sample; (H-K) 5 animals per
sample, 2 biological replicates. Graphs show mean ± s.e.m; ANOVA followed by t-test.
D, Dorsal; V, Ventral; A, Anterior; P; Posterior. Scale bars: 100µm (A); 50µm (B).
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2.4.8

Horizontal cells are reduced in hyperglycemic larvae while bipolar, amacrine, and
ganglion cell numbers are unchanged

To determine whether embryonic hyperglycemia resulted in altered numbers of
other retinal neurons, we performed immunohistochemistry with antibodies that label
various retinal cell types. Horizontal cells are located in the outermost part of the inner
nuclear layer, and synapse directly to photoreceptors. We detected horizontal cells with
the Prox1 antibody which also labels progenitor cells in the inner nuclear layer.
Horizontal cells were identified by their location and distinct oblong shape. There was a
30% decrease in the number of Prox1+ horizontal cells per 100µm in pdx1 mutant retinas
compared with wildtype (Fig. S2.5A-C). In the nutritional model, both glucose and
glucose+dex treated embryos displayed a 40% and 50% decrease, respectively, in
horizontal cell number (Fig S2.5J-L). Bipolar cells, which also synapse directly with
photoreceptors and transfer the visual signal from photoreceptors to ganglion cells [89],
did not show a difference in average number per 100µm when comparing wildtype to
pdx1 mutants (labeled with PKCa antibody; Fig. S2.5D-F) or in glucose and glucose+dex
treated larvae compared to controls (Fig. S2.5M-O). Next, we quantified the number of
ganglion and amacrine cells, using the HuC/D antibody. There was no significant
difference in amacrine cell number across genotypes (Fig. S2.5G-I) or treatments (Fig.
S2.5P-R). Similarly, we found no significant differences across genotypes or treatments
in the number of retinal ganglion cells (Fig. S2.5G-I and S2.5P-R). Additionally, we did
not find any significant changes in number or morphology of retinal cell types with
dexamethasone treatment alone (Figure S2.5S-AA). These results suggest that abnormal
retinal cell type differentiation in hyperglycemic larvae is limited to photoreceptors and
horizontal cells, with the remaining inner retinal neurons developing in normal numbers.
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2.4.9

Reactive oxygen species production is increased in hyperglycemic larvae via
dysregulation of glucose metabolism-related pathways

Hyperglycemia has been shown to induce increased levels of reactive oxygen
species (ROS), unstable oxygens that cause DNA damage and cell death [90]. A recent
study showed ROS production is a key component of retinal development through
regulation of a switch between cellular proliferation and differentiation [91]. Further,
studies in adult mice and retinal explants have shown that recurring hyperglycemia leads
to an increase in ROS production, specifically in photoreceptors [47], [92]. To determine
whether ROS production was increased in the retinas of hyperglycemic larval zebrafish
we used Mitosox, an in-vivo probe for superoxides. We found a trend towards increased
ROS production in both glucose and glucose+dex treated embryos at 48hpf (p=0.10), a
key time point for the onset of photoreceptor differentiation (Fig. 2.5D-F, G). By 5 dpf
there was a significant increase in ROS in pdx1 mutants and glucose+dex (Fig. S2.6B,
D). While ROS probe signal was observed at various places throughout the head, at 48
hpf it was especially prominent in the eyes of hyperglycemic larvae, and within the retina
was detected at the border of the future ciliary marginal zone (Fig. 52.C, F’ and S6D).
Retinal sections at 5dpf showed the ROS in the retina to be specifically located among
the outer segments of photoreceptors (Fig. S2.6F, H, arrows). In contrast, wildtype and
untreated larvae had long, straight outer segments which did not show ROS probe
colocalization (Fig. S2.6E, G).
To get a better idea of the metabolic factors specifically impacted by embryonic
hyperglycemia, we examined whether expression of enzymes involved in glucose
metabolism was altered using a glucose probe array at 5 dpf. Interestingly, we found that
expression of key glucose metabolism enzymes connected to ROS production, such as
succinate dehydrogenase and glucose-6-phosphatase, were upregulated in the heads of
glucose and glucose+dex treated larvae as well as pdx1 mutants compared to untreated
and wildtype controls (Fig. S2.6K, L). The dysregulation of these enzymes can have
detrimental effects on cellular metabolism, particularly in the context of hyperglycemia.

41

Figure 2. 6 Hyperglycemic larvae exhibit increased retinal progenitor cell proliferation
and delayed differentiation.

Figure 2.6: Hyperglycemic larvae exhibit increased retinal progenitor cell proliferation
and delayed differentiation. Hyperglycemic embryos were exposed to EdU from 48-50
hpf then raised to 5 dpf and the cryosectioned. Glucose and Glucose+Dex treated larvae
exhibited a significant increase in the percent of EdU+ cells in the GCL and significant
decrease in the percent of EdU+ cells in the ONL (C, D, F) compared to untreated and
mannitol treated larvae (A, B). The total number of EdU+ cells per 100µm did not
significantly differ across treatments (E). Pdx1 mutant larvae displayed a significant
increase in the number of EdU+ cells per 100 µm compared to wildtype (I). The
42

distribution of EdU+ cells also showed a significant increase in the GCL and decrease in
the ONL in the mutants (H) compared to wildtype (G, J). Sample size (A-F): 3 animals
per sample (7 in glucose); (G-J): 3 animals per genotype. Graphs show mean ± s.e.m.
ANOVA followed by t-test: p=0.0047 (F, GCL, glucose), p=0.0138 (F, GCL,
glucose+dex), p=0.0035 (F, ONL, glucose), p=0.0231 (F, ONL, glucose+dex), p=0.0001
(I), p=0.0377 (J, GCL), p=0.0023 (J, ONL). ONL, Outer nuclear layer; INL, inner
nuclear layer; GCL, ganglion cell layer. Scale bars: 10µm. *p<0.05; **p<0.01.
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2.4.10 Embryonic hyperglycemia perturbs the timing of retinal cell differentiation

We next sought to understand whether hyperglycemia was affecting the cell cycle
and differentiation of retinal cells during development. Previous work has suggested
embryonic hyperglycemia suppresses the cell cycle via altered expression of Cyclin D1
and p21, reducing cell proliferation and differentiation [93]. As mentioned above, ROS
production has also been shown to regulate cell cycle exit in the developing retina [91].
To investigate the timing of retinal progenitor differentiation in our two models of
developmental hyperglycemia, we tracked the fate of cells which were proliferating from
48-50 hpf. During this window of retinal development, photoreceptor progenitors are
beginning to exit the cell cycle and differentiate. Ganglion and amacrine cells have
mostly differentiated before 48 hpf, leaving primarily early photoreceptors and later
neurons of the inner nuclear layer to differentiate in the targeted time window [94]. We
exposed developing control and hyperglycemic embryos to EdU from 48-50 hpf and
collected larvae at 5 dpf to visualize the fate of the EdU positive cells based on their
location in the mature retina. We observed that the majority of EdU positive cells were
located in the inner nuclear layer across all treatments and genotypes, which aligns with
known developmental timing (Fig. 2.6A, B, F, G and J). For untreated, mannitol treated,
and wildtype larvae, there was also a large proportion of EdU positive cells among the
photoreceptor nuclei of the outer nuclear layer, indicating that, as expected, many of the
proliferating RPCs at 48-50 hpf ultimately differentiated into photoreceptors (Fig. 2.6A,
B, F, G, and J). Very few EdU+ cells were in the ganglion cell layer at 5 dpf (Fig. 2.6F,
J), consistent with the majority of retinal ganglion cells having already exited the cell
cycle at the time of EdU exposure. In contrast, in hyperglycemic retinas, the second
highest concentration of EdU positive cells was observed in the ganglion cell layer (Fig.
2.6C, D, F), which suggests that unlike the controls, retinal ganglion cells had not yet
exited the cell cycle at the time of EdU administration. To verify this phenotype was due
to a delay in retinal ganglion cell differentiation (as opposed to an increase in displaced
amacrine cells in the ganglion cell layer), we immunolabeled for amacrine cells using the
5E11 antibody, but did not detect any amacrine cells in the ganglion cell layer (Fig.
S2.7F-J). Moreover, there were significantly fewer EdU positive cells in the outer
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nuclear layer (ONL) of hyperglycemic retinas at 5 dpf compared to controls, and the
intensity of the EdU signal was also lower in cells of the ONL, suggesting that these cells
were derived from retinal progenitors that had gone through more cell divisions than their
counterparts in control retinas. Intriguingly, the total number of EdU+ cells was
significantly increased in pdx1 mutants compared to their wildtype siblings, but this was
not observed in glucose or glucose+dex treated larvae (Fig. 2.6E vs. 2.6I). This is the first
phenotype to be strikingly different between the genetic and nutritional model, suggesting
that there could be a differential role of insulin in retinal progenitor cell (RPC)
proliferation and differentiation. Taken together, these data indicate that embryonic
hyperglycemia causes a delay in cell cycle exit and differentiation of RPCs. Since we did
not observe a difference in ganglion, amacrine, and bipolar cell number between control
and hyperglycemic retinas at 5 dpf, these cell types must “catch up” to normoglycemic
levels of differentiation by 5 dpf. However, hyperglycemia appears to have prolonged
impact on the number of retinal photoreceptors and horizontal cells.
To determine whether reducing ROS could rescue photoreceptor number in
hyperglycemic retinas, we first treated the nutritional model and pdx1 embryos with
superoxide dismutase but had difficulty establishing a treatment concentration which did
not induce harmful side effects (data not shown). Next, we treated hyperglycemic
embryos with the antioxidant methylene blue [95]. Methylene blue co-treatment
produced a modest increase in cone photoreceptors in glucose treated as well as
glucose+dex treated larvae compared to no co-treatment (data not shown). Lastly, we
utilized diphenyleneiodonium (DPI) which is an NADPH oxidase inhibitor [96].
Treatment of hyperglycemic larvae with DPI significantly increased the number of rod
photoreceptors, detected by immunolabeling with the 4C12 antibody (Fig. S2.8G). The
increase in photoreceptors after antioxidant treatment supports our hypothesis that ROS
production contributes to the decrease in photoreceptors in hyperglycemic retinas.
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Figure 2. 7 Cone photoreceptors are persistently reduced in juveniles that experienced
embryonic hyperglycemia.

Figure 2.7: Cone photoreceptors are persistently reduced in juveniles that experienced
embryonic hyperglycemia. Treated larvae were placed in normal fish water at 5 dpf, then
imaged at 12 dpf to visualize photoreceptors. Zpr1 immunolabeling revealed persistently
reduced number of red/green cones (C, G) and rods (F, H) in larvae that had previously
experienced glucose + dex and glucose treatment compared to untreated and glucose
treated (A, B, D, E). Sample size (G): untreated (n=6), glucose (n=5), glucose+dex (n=7).
Sample size in (H): untreated (n=13), glucose (n=10), glucose+dex (n=11). Graphs show
mean ± s.e.m. ANOVA followed by t-test: p=0.0004 (G), p=0.0001 (H). D, Dorsal; V,
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Ventral; ONL, Outer Nuclear Layer; INL, Inner Nuclear Layer. Scale bars: 50µm (A, C,
F). ***p<0.001.
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Figure 2. 8 Proposed model for how hyperglycemia alters retinal development.

Figure 2.8: Proposed model for how hyperglycemia alters retinal development.
Hyperglycemia causes an increase of glucose flux to photoreceptors. Elevated glucose
consumption by photoreceptors increases the rate of glycolysis, thereby increasing
expression of pathway enzymes, as supported by the glucose probe array data.
Upregulation of glucose-6-phosphatase in particular is indicative of pentose phosphate
pathway activation which can mediate ROS production. AGEs and ROS production have
also been linked to glyceraldehyde-3-phosphatase upregulation which can cause DNA
damage, PARP activation, and apoptosis in retinal cells. Pyruvate feeds into the
Tricarboxylic Acid (TCA) Cycle, producing NADH which feeds into the electron
transport chain (ETC). When excess NADH is fed into the ETC, superoxide production is
increased, which can induce DNA strand breaks, cell death, and disruption in retinal cell
differentiation.
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2.4.11 Larvae that experienced embryonic hyperglycemia show a persistent decrease in
cone photoreceptors after return to normoglycemia

The EdU pulse-chase experiment revealed a delay in retinal cell type differentiation
which resulted in a decrease of photoreceptors at 5 dpf. To evaluate whether larvae could
recover to produce photoreceptors at equivalent numbers to controls, we placed
hyperglycemic larvae back into normal fish water at 5 dpf and collected them seven days
later at 12 dpf. We examined retinal sections by immunohistochemistry and found that
red/green cone photoreceptors were still significantly reduced in glucose+dex treated
larvae compared to controls (Fig. 2.7C). Similarly, the number of rod photoreceptors was
also still significantly reduced in glucose+dex treated retinas compared to controls (Fig.
2.7H). The persistent reduction in both photoreceptor types is indicative of potential longterm consequences of hyperglycemia on retinal cell maintenance and vision. This is
particularly important considering the susceptibility of photoreceptors to damage in adult
models of hyperglycemia.

2.5

Discussion
Diabetic retinopathy is a prevalent complication of diabetes and a principal cause

for acquired blindness in adults [7]. A growing body of research has demonstrated that
the degeneration of photoreceptor cells actually precedes the retinal vasculature defects in
diabetic retinopathy [1]. This underscores that the photoreceptors are a critical focal point
for initiating retinal pathology as a result of chronic hyperglycemia. As the population of
people with diabetes rapidly grows, research efforts must also be focused on studying the
consequences of diabetes for pregnant mothers and the retinal development of their
offspring.
While there is abundant research on heart development in hyperglycemic
embryos, little work has focused on the retina specifically. In humans, one study showed
that offspring of diabetic pregnancies had significantly thinner inner and outer macula as
well as lower macular volume, suggesting the potential for harmful effects of diabetic
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pregnancy on retinal cone photoreceptor development [65]. These data highlight the need
to visualize the effects of embryonic hyperglycemia on photoreceptor number and
morphology in more detail. Our study can fill this gap by combining whole mount
imaging and retinal sections to visualize, quantify, and assess the morphology of retinal
cells that have developed under hyperglycemic conditions. This is the first study to
characterize the development of photoreceptors specifically across two models of
embryonic hyperglycemia. One of the most striking findings was the decrease in
photoreceptor number in hyperglycemic larvae, with the remaining photoreceptors
displaying stunted outer segments – these findings were observed in both nutritionally
and genetically induced hyperglycemic models, and in both cases were associated with a
reduced optokinetic response compared to controls. Interestingly, although the
photoreceptors were reduced across the entire hyperglycemic retina, photoreceptor outer
segments near the marginal zone (the site of post-embryonic neurogenesis in zebrafish
retina) appeared somewhat more normal in length than those in the central retina (eg. Fig.
2.3E). This could suggest that photoreceptors produced from the margin initially
differentiate normally, but then succumb to degenerative changes as they age. Further
structural analysis in different portions of the retina could help us to better understand
differentiation versus maintenance issues induced by hyperglycemia.
Our results demonstrate how embryonic hyperglycemia affects the retina short
term, but we were also interested in long term effects. Looking at retinal sections of
treated embryos from the nutritional model at 12 dpf, we found that both rod and cone
photoreceptors continued to be reduced in number even after the larvae were returned to
normoglycemic conditions. This indicates an issue in photoreceptor programming,
metabolism, and/or maintenance which may result in longer-term visual defects as well
as potential susceptibility to degeneration. Considering photoreceptor degeneration is an
early consequence of persistent hyperglycemia in adult zebrafish, it will be important to
study how photoreceptors in zebrafish that experienced embryonic hyperglycemia
respond to a “second hit” of hyperglycemia as adults. Further, understanding how
embryonic hyperglycemia affects the retina both short and long term is imperative to
identifying and timing therapeutics during development to prevent lasting vision
problems.
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In addition to photoreceptor phenotypes, a recent study utilizing zebrafish to study
retinal development showed that exposure to high levels of glucose causes a decrease in
retinal ganglion cells and Müller glia as well as an increase in infiltrating macrophages
[12]. That study utilized a different time course of submersion and a much higher glucose
concentration than our study. These differences in methodology may explain our
discrepant findings in Müller glia cell number, with our model showing not only a
slightly higher number of Müller glia in hyperglycemic zebrafish, but also an abnormal
morphology suggestive of reactive gliosis. We also did not observe a reduction in retinal
ganglion cell number in either model, which could be due to the lower glucose
concentration used, or to different methods to visualize the ganglion cells.
Given the abnormal Müller glia morphology and the elevated cell death in the
inner nuclear layer of hyperglycemic retinas, it is possible that reactive gliosis is a
consequence of the decrease in photoreceptors or the altered metabolic environment, or a
combination of both considering the role and needs of Müller glia in the retina.
Interestingly, the only other class of retinal neuron that showed differing numbers or
morphology in our study were the horizontal cells, which were reduced in pdx1 mutants,
glucose treated, and glucose+dex treated larvae. The reduction in horizontal cells may be
directly related to the reduction in photoreceptors, as previous studies have shown that
horizontal cells play a role in cone/rod distribution and synaptogenesis [97].
Considering the link between hyperglycemia, ROS production, and cell death, we
hypothesized that the decrease in photoreceptors could be due to apoptosis. While we did
observe an increase in apoptotic cells in hyperglycemic larvae, the TUNEL+ cells were
not localized to the outer nuclear layer where photoreceptors reside. Rather, most of the
TUNEL+ cells were found in the inner nuclear layer. The TUNEL+ cells in the INL
could represent Müller glia phagocytosis of dying photoreceptors in hyperglycemic
retinas, as has been observed in other models of photoreceptor degeneration [98]–[100]
which may also account for the apparent gliotic response. Alternatively, they could be
due to engulfment of dying cells by microglia. In any case, because the overall number of
TUNEL+ cells was relatively low at all time points, it is likely that additional factors
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contribute to the decrease in photoreceptor number in response to hyperglycemia, such as
altered photoreceptor cell differentiation.
A recent study by Albadri et. al., showed retinal cell developmental delay can be
induced by lipid peroxidation products such as 4-HNE, which downregulate HDAC1 to
keep cells in a proliferative state, preventing differentiation [3]. Production of ROS such
as hydrogen peroxide is an upstream event leading to lipid peroxidation, and in human
endothelial cell lines modeling hyperglycemia [101]. The link between photoreceptors
and ROS production has yet to be elucidated in terms of mechanism. Given our
observation of increased ROS in hyperglycemic retinas at 48 hpf and 5 dpf, we
hypothesize that genetic or nutritionally induced embryonic hyperglycemia results in
increased ROS production which may cause retinal cell differentiation delay, and
abnormal photoreceptor morphology.
Indeed, utilizing EdU birth-dating, we found that hyperglycemic larvae exhibited
a striking deviation from the expected timing of RPC cell cycle exit during what should
have been the window of photoreceptor differentiation. The significant increase in EdU+
cells in the retinal ganglion cell layer indicates a lag in retinal cell type differentiation in
hyperglycemic larvae that is likely a major contributor to the decreased number of
photoreceptors. In pdx1 mutants, we also found a significant increase in the overall
number of EdU+ cells that was not observed in our nutritional model, which indicates
loss of pdx1 specifically results in an increase in RPC proliferation. Whether this is
related to the lack of insulin producing cells in pdx1 mutants warrants further
investigation. Importantly, while RGCs and other retinal neurons eventually overcome
this delay and differentiate in comparable numbers to control retinas at 5 dpf,
photoreceptors remain reduced relative to controls even after an additional period of
normoglycemic conditions. This result suggests that while most retinal neurons exhibit
adaptive plasticity in their developmental timing, photoreceptors may be particularly
sensitive to early metabolic derangement. Taken together, our data now connect
embryonic hyperglycemia with increased ROS production, increased RPC proliferation,
and extended perturbations to photoreceptor differentiation.
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Given our ROS data in the nutritional model, we tested whether an antioxidant
(DPI) could rescue photoreceptor number in hyperglycemic larvae. We found that
addition of DPI in our nutritional model increased the number of rod photoreceptors, with
outer segment morphology that better resembled controls (Fig. S2.8F). Interestingly, the
density of rods in normoglycemic retinas exposed to DPI was reduced compared to
controls (Fig. S2.8D), indicating that normal photoreceptor development may require be a
baseline level of ROS. We hypothesize that a combination of antioxidants and ROS
inhibitors with a more targeted delivery method could be necessary to rescue the decrease
in photoreceptors specifically. Further, analysis of the particular forms of ROS as well as
other reactive compounds that are produced in response to hyperglycemia is needed to
identify better targets for pharmacologic intervention.
In a hyperglycemic state, there is an influx of glucose undergoing glycolysis
which can alter the expression of various enzymes in the glycolytic pathway, that can
have further downstream effects (Lund et al., 2019; [34]) [90]. Using a glucose probe
array, we found a significant increase in enzymes that play important roles in NADH
production that feeds into the ETC where it is oxidized at complex I. When excess
NADH is fed into the ETC, superoxide production is increased, which we noted in our
hyperglycemic larvae. Superoxide can induce DNA damage [103] and delays in cell
differentiation. Given our results, we created a model that connects the metabolic effects
of hyperglycemia to the photoreceptor phenotypes we observed (Fig. 8). We propose that
hyperglycemia induces delayed photoreceptor differentiation early in retinal development
while a gliotic response is induced later via ROS production and cell death. It is also
possible that hyperglycemia contributes to the photoreceptor and Müller glia phenotypes
via indirect effects, such as hypoxia; these possibilities must be further explored to fully
understand the mechanism of action of embryonic hyperglycemia in the retina.
Embryonic development requires a complex coordination of events at the cellular
level which can be altered through metabolic stressors. As hyperglycemia becomes
increasingly common, it is necessary to understand how it affects development of all
tissues. Given the known deleterious effects of chronic hyperglycemia, examining retinal
development in a hyperglycemic state is critical. Our findings clearly show that
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hyperglycemia negatively impacts retinal development, and suggest a potential
mechanism of action, which may inform the search for therapeutic targets. Our future
studies will include elaborating on our embryonic hyperglycemia models through
metabolic assays and alternative “rescue” experiments. We also look forward to studying
how the hyperglycemic larval retina continues to develop, maintain itself, and function
long term.
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2.7

Supplemental Figures

Figure S2. 1 5dpf pdx1 mutant larvae are hyperglycemic with normal overall morphology

Figure S2.1: 5 dpf pdx1 mutant larvae are hyperglycemic with normal overall
morphology. Progeny of pdx1+/- adults were sacrificed at 5 dpf. Genomic DNA was
extracted from the remaining tail to genotype via PCR followed be RFLP. Whole body
glucose was significantly elevated at 5 dpf (A). Images of whole larvae showed normal
gross eye morphology and size across genotypes (B-D). Sample size: 10 animals per
replicate, from 3 biological replicates; graph shows mean±s.d (ANOVA followed by ttest, p = 0.0496). Scale bar: 100µm. *p<0.05.
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Figure S2. 2 Methodology to induce hyperglycemia in embryos and larvae

Figure S2.2: Methodology to induce hyperglycemia in embryos and larvae (A). Embryos
were dechorionated and randomly assorted into groups of 25, then submerged in one of
the following treatments: untreated, 50mM mannitol, 10µM dexamethasone, 50mM
glucose, 50mM glucose + 10µM dexamethasone (glucose+dex). Beginning at 24 hpf,
each treatment was refreshed by replacing with freshly made solutions every 24 hours
until 5 dpf. At 5dpf, larval heads were used for cryosectioning the retina, while the rest of
the body was used for a glucose colorimetric assay (A). Body glucose concentration was
elevated in glucose and glucose+dex treated larvae compared to untreated, mannitol, and
dexamethasone controls (B). Whole bodies of 5 dpf treated larvae showed no significant
differences in eye morphology (C) in relation to body size across treatments (D). A
fluorescent analog of glucose (2-NDBG) was observed throughout the eye after one-hour
submersion while none was observed in the eyes of the DMSO control (E). Sample size
(B): 20 animals per replicate, 3 biological replicates, graph shows mean ± s.e.m.,
ANOVA followed by t-test, p = 0.0003. Sample size in C-D: untreated (n=5), mannitol
(n=5), dexamethasone (n=12), glucose (n=8), glucose+dex (n=7); ANOVA followed by
t-test. Scale bar: 500µM. *p<0.05.
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Figure S2. 3 Abnormal photoreceptor morphology in hyperglycemic larvae.

Supplemental Figure 3: Abnormal photoreceptor morphology in hyperglycemic larvae.
H&E staining was performed on retinal sections from all treatments and pdx1 genotypes.
Glucose+dex treated and pdx1 mutant larvae exhibited shorter photoreceptors (compare
brackets in A vs. D, E vs. F). Sample size: 5 animals per replicate, 2 biological replicates.
ONL, Outer Nuclear Layer; INL, Inner Nuclear Layer; OS, outer segments. Scale bar:
10µm.
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Figure S2. 4 Apoptosis is increased in the retinas of hyperglycemic larvae.

Figure S2.4: Apoptosis is increased in the retinas of hyperglycemic larvae. Pdx1 larvae
were genotyped, then both Pdx1 and treated larvae were sectioned at 5 dpf; a TUNEL
assay was used to visualize apoptotic cells. At 5dpf, the number of TUNEL+ cells was
elevated in hyperglycemic larvae (B, E) compared to controls (A, D). Statistically
significant elevation in apoptotic cells was observed in glucose+dex treated larvae (F).
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Treated larvae were sectioned every 12 hours from 48 hpf to 5 dpf, and a TUNEL assay
was conducted to visualize apoptotic cells. At 48 houurs, few TUNEL+ cells are
observed throughout all treatments (G-L). By 60 and 72 hpf, apoptosis was observed in
glucose and glucose+dex treated embryos only, primarily noted in the GCL and INL (OR, T-V). Minimal apoptosis was noted at 84 hpf across all treatments (Z), and a
significant increase in apoptosis was observed at 96 hpf in glucose+dex treated embryos
(AD-AE). Sample size (A-C): 5 animals per sample. ANOVA followed by t-test. Sample
size (D-F): 5 animals per replicate, 2 biological replicates, Graphs show mean ± s.d.
ANOVA followed by t-test, p = 0.0410 (F). Sample size (G-AE): 5 animals per replicate,
2 biological replicates, graphs show mean ± s.d. ANOVA followed by t-test, p = 0.0145
(AE). D, Dorsal; V, Ventral; ONL, Outer Nuclear Layer; INL, Inner Nuclear Layer;
GCL, Ganglion Cell Layer; L, Lens. Scale bars: 50µm (A). *p<0.05.
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Figure S2. 5 Dexamethasone has no effect on retinal cells while horizontal cells are
significantly reduced in both models of hyperglycemia.

Figure S2.5: Dexamethasone has no effect on retinal cells while horizontal cells are
significantly reduced in both models of hyperglycemia. Pdx1 larvae were first genotyped
then sectioned along with treated larvae at 5 dpf. Both were immunolabeled and imaged
to visualize inner retinal neurons. Prox1 immunolabeling (A-B) revealed a significant
reduction in the number of horizontal cells in pdx1-/- (C) as well as glucose and
glucose+dex treated larvae (K-L) compared to wildtype (A) and mannitol (J),
respectively. Bipolar (D-E), ganglion, and amacrine cell numbers (G-H) were not
different across pdx1 genotypes (F, I) and treatments (M-R). Rod and cone
photoreceptors were visualized using the TaC:eGFP (S) and XOPS:GFP (T) transgenic
lines, respectively, and showed no significant change in cell number comparted to
untreated controls (U). Horizontal cells, stained by Prox1, (V) and Müller glia, visualized
using the GFAP:GFP transgenic line (W) also showed no differences in number (X).
Bipolar, ganglion and amacrine cells, immunolabeled with PKCa (Y) and HuC/D (Z),
respectively, showed no significant differences in number (AA). White dashed boxes
indicate region of retina where counts and analysis were conducted on each section.
60

White box in panel A indicates horizontal cells, arrows in panel B indicate gaps in
horizontal cells. Sample size (A-I): 5 animals per sample, 3 biological replicates, graphs
show mean ± s.d. ANOVA followed by t-test, p = 0.001 (C). Sample size (J-R): 5
animals per sample, 3 biological replicates, graphas show mean ± s.d. ANOVA followed
by t-test, p = 0.0058 (glucose), p = 0.0001 (glucose+dex). Sample size (S-AA): 5 animals
per sample, 2 biological replicates, graphs show mean ± s.d. ANOVA followed by ttest.D, Dorsal; V, Ventral; ONL, Outer Nuclear Layer; INL, Inner Nuclear Layer; GCL,
Ganglion Cell Layer; L, Lens. Scale bars: 100µM, 10µM (B), and 20µM. **p<0.01.
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Figure S2. 6 Increased superoxide production and abnormal glucose metabolism in 5dpf
hyperglycemic larvae

Figure S2.6: Increased superoxide production and abnormal glucose metabolism in 5dpf
hyperglycemic larvae. Pdx1 and treated larvae were submerged in a superoxide probe and
imaged with by fluorescence microscopy (A, C). Fluorescence was noted particularly in
the heads and eyes of hyperglycemic larvae (B, D). Retinal sections of control and
hyperglycemic XOPS:GFP larvae revealed colocalization of the superoxide probe among
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the outer segments of rod photoreceptors in hyperglycemic retinas (F, H; arrows). A
significant increase in superoxide production was observed throughout hyperglycemic
larval heads (I, J). Expression of select key enzymes involved in glucose metabolism
were analyzed via qRT-PCR and showed upregulation in glucose and glucose+dex
treatment (K) as well as pdx1 mutant larvae (L). Sample size (A-J): 5 animals per sample,
3 biological replicates, graphs show mean ± s.d. t-test: p = 0.0122 (I), p = 0.0001 (J).
Sample size (K): 50 animals per sample, pooled from 2 separate treatments, graphs show
mean ± s.d. Sample size (L): 30 animals per sample, pooled from 3 separate crosses. D,
Dorsal; V, Ventral; ONL, Outer Nuclear Layer; INL, Inner Nuclear Layer. Scale bars:
100µm (A) and 10µm (E). *p<0.05; **p<0.01.

.
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Figure S2. 7 Hyperglycemia does not cause proliferation of Müller glia or displacement
of differentiating retinal neurons.

Figure S2.7: Hyperglycemia does not cause proliferation of Müller glia or displacement
of differentiating retinal neurons. At 5dpf, treated and pdx1 larvae on the GFAP:GFP
transgenic background were submerged in EdU for 2 hours then sectioned and imaged.
Images revealed no co-localization between Müller glia and EdU in any treatment or
genotype (A-C; D-E). Immunolabeling with the 5E11 antibody was performed on all
treatments and genotypes to detect amacrine cells; no displaced amacrine cells were
observed in the ganglion cell layer of hyperglycemic retinas. Sample size: 5 animals per
sample, 2 biological replicates. D, Dorsal; V, Ventral; ONL, Outer Nuclear Layer; INL,
Inner Nuclear Layer; GCL, Ganglion Cell Layer. Scale bar: 25µm (A), 10µm (F).
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Figure S2. 8 Addition of the ROS inhibitor DPI to nutritional model results in increased
rods in hyperglycemic larvae.

Figure S2.8: Addition of the ROS inhibitor DPI to nutritional model results in increased
rods in hyperglycemic larvae. Nutritional model embryos were co-treated with the ROS
inhibitor diphenyleneiodonium (DPI). Glucose and Glucose+Dex treated embryos that
also received DPI treatment showed an increase in rod photoreceptors, detected with the
4C12 antibody (C, D) at 5dpf (E) compared to no DPI treatment. Sample size: 5 animals
per sample, 3 biological replicates, graphs show mean ± s.e.m. ANOVA followed by ttest: p=0.0001 (UT-glucose), p=0.0001 (UT-glucose+dex), p=0.0003 (UT-UT+DPI),
p=0.0001 (glucose-glucose+DPI), p=0.0001 (glucose+dex-glucose+dex+DPI). ONL,
Outer Nuclear Layer; INL, Inner Nuclear Layer. Scale bar: 10µm. *p<0.05.
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3.1

Abstract
Embryonic development is a critical window of time that plays a significant role in

determining the long-term health of an individual. Careful balance of genetic expression
and metabolic processing are key to successful development but can be negatively
impacted by disruptions such as hyperglycemia. Embryonic hyperglycemia can occur in
cases of diabetic pregnancy, genetic mutation, or maternal hyperglycemia during key
windows of development as glucose passes through the placental barrier. Previous studies
in zebrafish have shown that regardless of induction method, embryonic hyperglycemia
has significant impact on retinal cell development and function [104]. Given the role of
metabolism in cellular programming though, it is necessary to determine how embryonic
hyperglycemia affects the retina through adulthood. To address this, we utilize the insCFP:NTR transgenic zebrafish to ablate insulin expressing cells via metronidazole (Mtz)
treatment which induces hyperglycemia at distinct times during development and
adulthood. First, we examined the retinas of larvae that experienced embryonic
hyperglycemia. Then, we raised hyperglycemic and control larvae in normoglycemic
conditions and either induced hyperglycemia again or continued with normoglycemic
treatment. This allowed us to assess the long-term impacts of embryonic hyperglycemia,
and to determine whether it plays a significant role in adult retinal cell maintenance
compared to adults that only experienced hyperglycemia in adulthood. Through analysis
of each treatment combination, we found hyperglycemia during development to have a
significant effect on retinal maintenance and susceptibility to hyperglycemia induced
retinal complications in adulthood. These findings are the first to provide a functional

model for long-term effects of embryonic hyperglycemia as well as evidence of
developmental metabolic programming on specific retinal cell types. With our data, we can
begin to identify targeted approaches to mitigating retinal complications of recurring
hyperglycemia.

3.2

Introduction
Recurring hyperglycemia, a hallmark of diabetes, affects over 400 million people

globally, at varying stages throughout life and can induce serious complications [58]. A
prime example of a specific complication is diabetic retinopathy, which is the leading
cause of adult-onset blindness in the US [105]. The prevalence of diabetic retinopathy is
a major public health issue, but studies on a molecular and cellular level are limited in
humans. Therefore, animal models have served a critical role in identifying targets on a
molecular level to aid in preventing and mitigating the devastating effects of
hyperglycemia within the eye. Animal studies have provided crucial information about
the pathogenesis of diabetic retinopathy, but we have yet to uncover the mechanism of
action which is key in prevention. Further, most studies have focused solely on eye
complications in adults and neglect the significant impacts hyperglycemia can have when
experienced during key windows of development. For instance, it has been shown that
children who experience hyperglycemia during fetal development are at higher risk of
developing Type 2 diabetes, obesity, and cardiac disease [106]. These conclusions were
drawn from epidemiological data on humans and have helped inform proper care and
prevention methods but have not provided enough information to develop targeted
therapeutics, particularly concerning complications that affect specific tissues like the
eye.
Zebrafish, a relatively new model in the context of diabetes and the eye, has
proven to be effective due to the ease of environmental and genetic manipulation,
imaging tools, as well as genetic analysis. With the zebrafish being diurnal and having a
cone dominant retina, similar to the cone rich human fovea, strong correlations can be
made when drawing conclusions from studies with the zebrafish retina. Further, zebrafish
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offer efficient, timely methods for multigenerational and long-term studies when
compared to other vertebrate models such as mice. From the zebrafish, it has been shown
that embryonic hyperglycemia has a significant impact on retinal development on a
cellular level [12], [68], [104]. Hyperglycemic zebrafish embryos exhibit aberrant
photoreceptor, ganglion, horizontal, Müller glia and vasculature development in both
genetic and nutritional models. Given these significant phenotypes via differing models
of hyperglycemia induction, we utilized zebrafish in our study to explore the long-term
effects of hyperglycemia.
While there are multiple established models of inducing embryonic
hyperglycemia, we sought a different approach as the existing models did not serve our
specific goals of this study. With the pdx1 mutant model, we would be addressing the
impact of constant hyperglycemia (unless insulin treatment was involved at timed
intervals), and the glucose submersion model can be difficult to continue in adulthood.
Instead, we took advantage of a third model of hyperglycemia induction, the insCFP:NTR transgenic zebrafish line. With the ins-CFP:NTR zebrafish, we can temporally
ablate pancreatic beta cells by adding metronidazole (Mtz) to fish water which interacts
with nitroreductase expressed by the insulin promoter, turning it cytotoxic. Due to the
zebrafish’s ability to regenerate their pancreas, once metronidazole is removed from the
water, the insulin expressing beta cells regenerate and begin to function within a few days
[107]. Such control over insulin expression, and in turn glycemia, at any point after 3 dpf
provides a great opportunity for efficient long-term experiments. For our study, this
method was especially attractive due to the ease of induction of hyperglycemia at any
stage, allowing for the induction of hyperglycemia during embryonic development and
again in adulthood while the juvenile stage is normoglycemic. With this methodology, we
could address if embryonic hyperglycemia induces damage that fish can recover from and
affects susceptibility to diabetes and eye related complications if hyperglycemia is
experienced again in adulthood. These questions were addressed through the generation
of 9 different treatment groups which provided appropriate controls including
hyperglycemia just during development or adulthood, both, and neither. Throughout this
study, we refer to these treatment groups by their embryonic treatment listed first
followed by adult treatment. For example, a fish in which Mtz treatment was given to
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induce hyperglycemia during development and again in adulthood is denoted by
Mtz/Mtz.
Following adult treatment, we used the eyes for RNA and protein extraction,
tissue fixation, and the collected blood from the eye socket. With these materials, we
assessed genetic expression of various proteins via Western blot, imaged retinal cells
with immunohistochemistry, characterized retinal structure with histology, and attempted
blood glucose quantification. From these analyses, we first conclude Mtz treatment to be
effective in inducing embryonic hyperglycemia as well as phenotypes strongly associated
with diabetic retinopathy. We also found that Mtz/Mtz adults were most affected,
exhibiting the lowest survival rate, largest decrease in rod and cone photoreceptors, and
activation of Müller glia. Zebrafish that experienced hyperglycemia only in adulthood
also exhibited mild reactive gliosis and decrease in photoreceptors, but not to the extent
of adults that also experienced embryonic hyperglycemia. This difference in phenotype
supports our hypothesis that embryonic hyperglycemia increases susceptibility to retinal
complications of recurring hyperglycemia later in life. Importantly, this highlights the
potential importance of early therapeutic interventions when embryonic hyperglycemia
occurs.

3.3

Methods
3.3.1 Zebrafish Lines and Maintenance
All zebrafish lines were bred and raised at 28.5ºC on a 14-hour light:10-hour dark

cycle as previously described [71]. The Tg(ins:CFP-NTR)s892 fish, hereafter called
ins:CFP-NTR, has been previously described [108] and was graciously provided by
Jeffrey Mumm (Johns Hopkins University). The Tg(gfap:GFP)mi2001 or GFAP:GFP
transgenic line was obtained from the Zebrafish International Resource Center (ZIRC,
Eugene, OR). The Tg(fi1a: EGFP)y1Tg transgenic line, hereafter referred to as fi1:GFP,
was previously described [109] and was obtained from the Zebrafish International
Resource Center (ZIRC). Zebrafish were bred, raised, and maintained in accordance with
established protocols for zebrafish husbandry. Embryos were anesthetized with Ethyl 369

aminobenzoate methanesulfonate salt (MS-222, Tricaine; Sigma-Aldrich Corp., St.
Louis, MO). All animal procedures were carried out in accordance with guidelines
established by the University of Kentucky Institutional Animal Care and Use Committee

3.3.2

Generating hyperglycemic zebrafish larvae and adults
ins:CFP-NTR;GFAP:GFP and ins:CFP-NTR;Fli1:GFP adult fish were in-crossed

to generate embryos and randomly sorted into groups of 25 and placed in the following
treatments: untreated fish water, DMSO, and 5mM metronidazole dissolved in fish water.
At 5dpf, larvae were placed in bowls with 100mL of untreated fish water and raised to 6
weeks post fertilization (wpf). At 6wpf, each group of treated fish was randomly
subdivided into three groups consisting of untreated, DMSO, and 5mM metronidazole
treatment. Fish were placed in respective treatments for 4 days, then put into untreated
fish water for 4 days, and then back into respective treatments. This was repeated for 4
weeks, when fish were then euthanized in MS-222. Eyes were removed for RNA and
protein extraction or fixed in PFA for immunohistochemistry.

3.3.3

Immunohistochemistry
Immunohistochemistry was conducted as previously described [75] and imaged

on a confocal microscope (Leica SP8, Leica). The following antibodies were used: anti4C12 (rod photoreceptors, mouse, 1:100, Jim Fadool) and anti-Zpr1 (red/green cone
photoreceptors, 1:20, mouse, ZIRC). Alexa fluor conjugated secondary antibodies
(Invitrogen, Grand Island, NY) and Cy-conjugated secondary antibodies (Jackson
ImmunoResearch, West Grove, PA) were used at 1:200 dilution and DAPI to label nuclei
(1:10,000, Sigma, St. Louis, MO).
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3.3.4

Cryosections and cell counts
Embryos were fixed overnight in 4% paraformaldehyde, then incubated overnight

in 10% followed by 30% sucrose at 4ºC. Transverse 10µm sections were taken beginning
in the anterior tip of the head, moving posteriorly through the eye. For imaging and cell
quantification, only sections containing an optic nerve were used for consistency. All cell
counts were done in 100x25µm regions of interest in 3 sections of the retina: dorsal
(100µm from dorsal start of Ciliary Marginal Zone, CMZ), central (100µm dorsal to
optic nerve), and ventral portions (100µm from ventral end of CMZ) and normalized to
the curvilinear length of the outer nuclear layer. Images were taken using a 20x objective
on a Leica SP8 Confocal microscope or a Nikon Eclipse inverted fluorescent microscope
(Eclipse Ti-U, Nikon Instruments). At least 5 adults were analyzed per treatment and 5
separate biological replicates were performed for each experiment. Statistics were
conducted using ANOVA followed by Poisson Regression Analysis in R and two-factor,
unpaired t-test using GraphPad software. P-values less than 0.05 were considered
significant and are indicated by *, p< 0.01 is indicated by **, and p<0.001 by ***.
Boxplots were generated using R (version 3.6.2)/R studio (version 1.2.5033) ggplot2
package. All figures were constructed using Photoshop (Adobe version 21.0.2).

3.3.5

Western Blot
Protein was extracted from eye tissue by homogenizing in RIPA buffer and

Complete EDTA mini tablets (Roche) which contain protease inhibitors. Following
extraction, protein was quantified with a Bradford assay. For the Western blot, 30µg of
each sample protein was loaded onto a pre-cast gel (Bio-rad) and run to separate proteins
by size, then transferred onto a nitrocellulose membrane. The membrane was blocked for
30 minutes at room temperature then incubated overnight at 4ºC with the following
antibodies: β-actin (1:500, Santa Cruz), GFAP (1:1000, GENETEX), and mTOR (1:500,
Sigma). Membranes were then incubated in secondary antibody at room temperature for
one hour, developed with (Bio-rad) and imaged. Bands were quantified using imageJ,
normalized to β-actin bands, and a t-test was used to analyzed quantification differences.
71

3.4

Results
3.4.1

Larval Mtz treatment induces hyperglycemia and early signs of vasculature
degeneration

Previous work has shown Mtz effectively ablates the pancreas within 36 hours of
treatment in zebrafish larvae [107]. In this study, we submerged embryos in 5mM Mtz
from 48 hpf to 5 dpf to ablate the pancreas and induce hyperglycemia. DMSO or
untreated (UT) fish water were used as controls (Fig. 1A). By 5 dpf, we did not detect
CFP expression in the region where the pancreas would normally be located (Fig. 1C)
while untreated and DMSO controls had a detectable CFP-expressing pancreas (Fig. 1B).
Dose response experiments showed that less than 5 mM Mtz did not fully ablate the
pancreas within 36 hours, while concentrations above 5 mM had a significantly lower
survival rate (data not shown). Therefore, 5 mM Mtz was used as the treatment
concentration for all subsequent experiments as survivability was similar to controls, but
ablation was effective. Further, given the consistent vasculature phenotype we noted in
our nutritional model [104], another glucose submersion model of embryonic
hyperglycemia [12], and in the pdx1 mutant [68], we first characterized the vasculature of
the Mtz treated larvae for comparison by crossing ins-CFP:NTR zebrafish onto the
Fli1:GFP transgenic line (which labels all vasculature with GFP) and imaged whole
heads at 5 dpf using fluorescence microscopy. Untreated and DMSO larvae displayed
thin, normally distributed vasculature which formed a basket behind the lens (Fig. 1A,
A’). Mtz treated larvae exhibited widened vasculature and sprouting (Fig. 2B’), similar to
pdx1 mutants and larvae treated with glucose + dexamethasone. The widened vasculature
is representative of weakened vasculature, generally due to loss of pericytes as seen in
early stages of diabetic retinopathy [110]. Together, these data support the use of insCFP:NTR fish as a model with phenotypes that reflect other models of hyperglycemia
induction.
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Figure 3. 1 Methodology to induce hyperglycemia in ins-CFP:NTR larvae

Figure 3.1 Methodology to induce hyperglycemia in ins-CFP:NTR larvae (A). Larvae
submerged in DMSO showed no effect on pancreas development (B, B’) while 5mM Mtz
from 48 hpf to 5 dpf sufficiently ablated the pancreas (C, C’). Fluorescence in C’ is
autofluorescence and not pancreas related.
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Figure 3. 2 Hyperglycemic larvae exhibit early signs of abnormal vasculature

Figure 3.2: Hyperglycemic larvae exhibit early signs of abnormal vasculature. InsCFP:NTR fish were crossed with the Fli1:GFP transgenic line to visualize vasculature.
Mtz treated larvae had wider vasculature (B’, white arrows) compared to DMSO (A’).
Vasculature also showed early signs of branching and sprouting (B’, bracket). Sample
size = 5 per treatment group. D, Dorsal; V, Ventral. Scale bars: 10µm.
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3.4.2

Hyperglycemic, Mtz treated larvae have reduced cone photoreceptors and
ganglion cells
With the establishment of Mtz treatment as a model, we next sought to characterize

retinal cell types. Like the models previously characterized in Chapter 2, we began with
light sensing photoreceptor cells. Given the metabolic demand of photoreceptors, and our
previous data from other models, we hypothesized they would be impacted by Mtz
treatment. We found rod photoreceptor morphology and cell number did not significantly
differ across treatment groups using a 4C12 antibody (Fig. 3H). Inner segments of rods
were normally shaped in Mtz treated retinas, with elongated outer segments (Fig. 3G)
compared to DMSO and untreated retinas (Fig. 3E, F). Contrastingly, red-green cone
photoreceptors (visualized with the Zpr1 antibody) were significantly reduced in number
in Mtz treated retinas (Fig. 3D). Looking closely at the morphology of the cones though,
we did not note consistent abnormalities (Fig. 3A-C) when comparing across treatments.
With only a decrease in cell number and not aberrant morphology, this may be indicative
of cell death or delayed differentiation. Aside from photoreceptors, we also visualized
ganglion and amacrine cells with the HuC/D antibody (Fig. 4). Amacrine cells were not
significantly affected when compared across treatment groups (Fig. 4C). Interestingly, we
did find a significant decrease in ganglion cells in Mtz treated larvae (Fig. 4C). Given the
role of ganglion cells in transmitting the retinal visual signal to the brain, this may be an
indicator of poor visual function.
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Figure 3. 3 Cone photoreceptors are decreased in hyperglycemic larvae

Figure 3.3: Cone photoreceptors are decreased in hyperglycemic larvae. insCFP:NTR treated larvae were sectioned and stained with Zpr1 and 4C12 to visualize rods
and cone, respectively. Number of cones were similar in UT and DMSO treatments (A,
B) while Mtz treated larvae displayed significantly less red/green double cones (C, F).
Rod photoreceptor number did not significantly differ across treatments (E-G), but the
Mtz treated larvae showed a trend towards fewer rods (H). ONL, Outer Nuclear Layer;
INL, Inner Nuclear Layer; GCL, Ganglion Cell Layer. * indicates p<0.05
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Figure 3. 4 Ganglion cells are decreased in hyperglycemic larvae

Figure 3.4: Ganglion cells are decreased in hyperglycemic larvae. ins-CFP:NTR
treated larvae were sectioned and stained with HuC/D to visualize ganglion cells (A, B).
Mtz treated larvae displayed significantly less ganglion cells (C). INL, Inner Nuclear
Layer; GCL, Ganglion Cell Layer. Scale bars: 10µm. * indicates p<0.05
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3.4.3

Second hit survival and diabetes induction
At 5dpf, the hyperglycemic Mtz treated larvae already show retinal and

vasculature damage when compared to untreated and control larvae. By this point, larvae
stop depending on their yolk for survival and begin hunting for their food. Therefore, we
stopped treatments at 5 dpf and raised the fish in untreated fish water to reflect the end of
embryonic hyperglycemia and transition to raising normoglycemic fish. Once the fish
reached 6 wpf, we subdivided each of the original three treatment groups into untreated,
DMSO and Mtz treated and placed them into the new treatments in 1-liter tanks. After the
subdivision, there were 9 groups based on their treatment history as denoted by “embryo
treatment/adult treatment”: UT/UT, UT/DMSO, UT/Mtz, DMSO/UT, DMSO/DMSO,
DMSO/Mtz, Mtz/UT, Mtz/DMSO, and Mtz/Mtz. There was a minimum of 5 fish in each
treatment group. Fish remained in the treatment for 4 days, then were transferred to
untreated fish water for 3 days, and the back to treatment for 4 days again – this treatment
cycle continued for 4 weeks. This method was ideal for our model because zebrafish can
regenerate their functioning pancreas within two weeks of pancreatic cell death [111].
Through dose response studies, we found 5 days to be the maximum time at which adult
fish can be in Mtz and not experience toxicity, whether the fish were transgenic or
wildtype (data not shown). Therefore, the 4-day cycling allows for pancreas
degeneration, partial regeneration, and then induced degeneration – the constant back and
forth keeps blood glucose high through low insulin production while not inducing
toxicity via constant Mtz exposure. When the 4 weeks of treatment ended, eyes were
removed from adults for tissue fixation to visualize retinal structure and layers as well as
RNA and protein extraction, and blood collection from the eye cavity (Fig. 5A). Before
these analyses, we first tracked survival of the fish throughout the treatments. We noted a
trend towards decreased survival in adults treated with Mtz (UT/Mtz, DMSO/Mtz, and
Mtz/Mtz) with the lowest survival rate in the Mtz/Mtz group (Fig. 5B). Although the
survival rate was lowest in Mtz/Mtz, no more than 2 fish died during a treatment (Fig.
5B). The decreased survival in the Mtz/Mtz group suggests a deleterious impact of
embryonic hyperglycemia on survivability through adulthood.
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Following characterization of gross morphology, we looked to detect the onset of
diabetes. In humans, diabetes is diagnosed via HBA1c, a measure of glucose attached to
hemoglobin. Unfortunately, we cannot collect enough blood from the fish to reliably
measure HBA1c. Therefore, we attempted blood sugar measurement using a glucometer.
However, the glucometer readings were too variable to make this a reliable measure of
hyperglycemia. Finally, we approached diagnosis via Western blot for mTOR which is
highly expressed in the progression of diabetes [112]. Results from the Western blot
showed an increase in mTOR expression in DMSO/Mtz, Mtz/UT, and Mtz/Mtz adults
(Fig. 5D). Together, we conclude our treatment paradigm induces recurring
hyperglycemia effectively and experiencing hyperglycemia during embryonic
development could render the adult more susceptible to diabetes and retinal
complications.
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Number of living fish

Figure 3. 5 Methodology, survival, and proof of principal of second hit treatment regime

Figure 3.5: Methodology, survival, and proof of principal of second hit treatment
regime. Ins-CFP:NTR embryos were subdivided and treated with either untreated,
DMSO, or 5mM treated fish water until 5 dpf. At 5dpf, larvae were placed in untreated
fish water and raised to 6 wpf, at which time the juveniles were subdivided again into
untreated, DMSO, or 5mM treatment groups, resulting in all combinations of
hyperglycemia during embryonic development, adulthood, and controls (A). Survival rate
showed a decrease in survivability in hyperglycemic adults, with the poorest survival in
hyperglycemic adults that also experienced embryonic hyperglycemia (B). mTOR
expression was increased in all hyperglycemic adults, as well as adults that experienced
embryonic hyperglycemia (C, D).
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3.4.4

Retinal structure of adults
Prior to assessing specific retinal cell types, we first aimed to characterize the

overall retinal structure. Due to the large size of the adult retina, we imaged the retina in
three, 100µm2 regions across the retinal sections: dorsal (100µm proximal to the end of
the dorsal ciliary marginal zone), central (100µm dorsal to the optic nerve), and ventral
(100µm ventral to the optic nerve). For each section, we measured the width of the
different nuclear layers (outer, inner, and ganglion) and compared across sections (Fig.
S1, graphs not shown). We found the central regions had the most striking difference in
retinal layer thickness across treatment groups and confirmed this with a DAPI nuclear
stain (Fig. 6). In the central retina, differences in inner nuclear layer thickness were most
apparent in DMSO/Mtz and Mtz/Mtz retinas (Fig. 6H, I), which were much wider than
untreated controls. Furthermore, the outer nuclear layer was significantly thinner in
UT/Mtz, Mtz/UT and Mtz/Mtz retinas. Differences in these layers were also present in
the dorsal and ventral regions, but they were not significant (Fig.S1, graph not shown).
Due to the significant differences noted particularly in the central retina, which is a
remnant of the larval retina [113], the primary focus of further analyses was on the
central retina.
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Figure 3. 6 Nuclear layer differences across treatment

Figure 3.6: Nuclear layer differences across treatments. Schematic of adult retinal
sections and portions imaged, central retinal sections were used for figures. Adults
that experienced embryonic Mtz treatment (Mtz/UT, Mtz/DMSO, and Mtz/Mtz )
displayed significantly thinner outer nuclear layer (D, G, J, L). Hyperglycemic adults
(UT/Mtz, DMSO/Mtz, and Mtz/Mtz) had larger inner nuclear layers (H-J). Brackets label
where width of layers was measured. ONL, Outer Nuclear Layer; INL, Inner Nuclear
Layer; GCL, Ganglion Cell Layer. Scale bars: 10µm. * indicates p<0.05
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3.4.5

Photoreceptors are decreased in Mtz treated adults
The thinner outer nuclear layer in adults treated with Mtz suggested that

photoreceptors could be reduced in diabetic adults. We first looked at rod photoreceptors
with a 4C12 antibody and found a trend towards decreased rods in hyperglycemic adults
(G-I) and a significant decrease in adults that experienced larval Mtz treatment,
regardless of adult treatment (Fig. 7C, F, I) compared to UT/UT. These results directly
correlate with the width measurements of the nuclear layers, which were thinner in these
treatments, except for DMSO/Mtz. For cone photoreceptors, we used the Zpr1 antibody
and found a trend towards decreased red/green cones in hyperglycemic adults (Fig. 8GI). Adults that were hyperglycemic during development also showed a decrease in cones
(Fig. 8F, I). These results indicate that adults with induced recurring Mtz treatment
experience photoreceptor damage. Interestingly though, if Mtz treatment is experienced
during embryonic development and adulthood, or even just development, there is a
reduction in number photoreceptors observed in adulthood. Together, we conclude that
embryonic Mtz treatment has long-term negative impacts on the adult retina, which is
exacerbated by adult Mtz treatment for cones, but not rods. This could be reflective of the
level of cone photoreceptor reduction observed in cones during development. Data from
the nutritional model presented in Chapter 2 indicated that treatments with most
significant reductions in photoreceptors exhibited persistent reduction even a week after
treatment. Therefore, considering the cones were significantly reduced but not rods, in
this model, it is possible that the exacerbation in cone phenotype in adults is reflective of
embryonic reductions.
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Figure 3. 7 Rod photoreceptors are decreased in adults that experienced embryonic Mtz
treatment

Fig. 7: Rod photoreceptors are decreased in adults that experienced embryonic Mtz
treatment. ins-CFP:NTR adults were sectioned and stained with 4C12 to visualize rod
photoreceptors. Adults that experienced embryonic Mtz treatment (Mtz/UT, Mtz/DMSO,
and Mtz/Mtz ) had less rod photoreceptors than adults that were normoglycemic as
embryos (A, B, D, E, G, H). Hyperglycemic adults also have less rod photoreceptors,
regardless of glycemia during embryonic development (G-I, J). ONL, Outer Nuclear
Layer; INL, Inner Nuclear Layer. Scale bars: 10µm. * indicates p<0.05
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Figure 3. 8 Cone photoreceptors are persistently decreased in adults that experienced
embryonic Mtz treatment

Fig. 8: Cone photoreceptors are persistently decreased in adults that experienced
embryonic Mtz treatment. ins-CFP:NTR adults were sectioned and stained with Zpr1 to
visualize rod photoreceptors. Adults that experienced embryonic Mtz treatment
(Mtz/DMSO, and Mtz/Mtz ) had less cone photoreceptors than adults that were
normoglycemic as embryos (F, I). Hyperglycemic adults also have a trend towards less
cones photoreceptors, regardless of glycemia during embryonic development (G-I). ONL,
Outer Nuclear Layer; INL, Inner Nuclear Layer. Scale bars: 10µm. * indicates p<0.05
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3.4.6

Müller glia are activated in Mtz treated adult zebrafish
A larger inner nuclear layer has been attributed to the onset of reactive gliosis, as

that layer of the retina accommodates the dividing, proliferating, and differentiating
Müller glia cell bodies. We assessed Müller glia activation via imaging of GFAP:GFP
fish crossed onto the ins-CFP:NTR line. All adults that experienced Mtz treatment during
embryonic development exhibited an increase in the number of Müller glia with
abnormal morphology (Fig. 9C, F, I, J). DMSO/Mtz and Mtz/Mtz showed the highest
expression of GFAP, but the number of Müller glia with abnormal morphology was
highest in Mtz/Mtz. Additionally, we conducted a Western blot with the GFAP antibody
and found a significant increase in GFAP protein in DMSO/Mtz and Mtz/Mtz retinas
(Fig. 9K, L). The increase in number of abnormally shaped Müller glia indicated
potential reactive gliosis in all adults that experienced embryonic Mtz treatment, while
the Western blot more definitively represents the onset of reactive gliosis. Therefore, we
conclude that fish that experienced Mtz treatment at both stages of life undergo reactive
gliosis, potentially due to the decrease in photoreceptors or pancreas ablation directly
influencing Müller glia cell metabolism.
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Figure 3. 9 Signs of reactive gliosis in hyperglycemic adults

Figure 3.9: Signs of reactive gliosis in hyperglycemic adults. ins-CFP:NTR fish were
crossed onto the GFAP:GFP transgenic background to visualize Müller glia. Adults that
experienced embryonic Mtz treatment (Mtz/UT, Mtz/DMSO, and Mtz/Mtz ) displayed
large, irregular shaped nuclei (C, F, I). Additionally, UT/Mtz, DMSO/Mtz, and Mtz/Mtz
showed increased GFAP expression (J, K). ONL, Outer Nuclear Layer; INL, Inner
Nuclear Layer. Scale bars: 10µm. * indicates p<0.05
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3.5

Discussion
Developmental programming refers to the notion that metabolic imbalances

experienced during key windows of development have consequences that persist through
adulthood [114]. A particularly common metabolic imbalance experienced during human
development is hyperglycemia, which has been shown to increase susceptibility to
diabetes, obesity, and other metabolic syndromes. Embryonic hyperglycemia may be
induced due to excess glucose passing through the placental barrier when the mother
becomes too insulin resistant like in gestational diabetes or due to a genetic mutation
which prevents insulin production [115]. Complications of embryonic hyperglycemia
have been primarily focused on fetal heart development, but with the high rate of eye
related complications in adulthood, it is imperative to explore how the fetal eye develops
in the presence of high glucose and whether metabolic programming plays a role in
susceptibility to ocular complications later in life.
In this study, we are the first to characterize a model of embryonic hyperglycemia
in the context of retinal development using the ins-CFP:NTR transgenic zebrafish. Given
the utility of zebrafish in retinal studies, ability to easily induce hyperglycemia, and rapid
aging, we can effectively study insulin deficient related retina complications short and
long-term. To begin, we characterized the developmental effects of Mtz treatment on the
retina by treating ins-CFP:NTR embryos with Mtz to ablate the pancreas throughout
retinal cell development. We found Mtz treated larvae had significantly less cone
photoreceptors at 5dpf, which was also found in two other models of embryonic
hyperglycemia – glucose + dexamethasone treatment and pdx1 mutants [104].
Interestingly, the other two models also exhibited a reduction in rod photoreceptors,
which was not observed in Mtz larvae. Additionally, we found a significant decrease in
ganglion cells in Mtz treated larvae, which differed from the other models previously
mentioned. Contrastingly, the glucose submersion model developed by Singh et al
showed an increase in ganglion cells via whole mount imaging [12]. The differences
observed across this model were likely due to the modes of hyperglycemia induction. In
the glucose submersion models, insulin is still being produced, whereas pdx1 mutants do
not produce pancreatic insulin, and ins-CFP:NTR fish do not express insulin from any
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source beginning at 48 hpf. Zebrafish begin expressing insulin as early as 4 hpf. By 48
hpf, insulin is strongly expressed in the head [116]. The insulin produced at these early
stages is not from the pancreas as it has not formed yet, indicating alternative sources of
insulin in the zebrafish. The unique phenotype of the ins-CFP:NTR retina may be due to
the complete lack of insulin production beginning at 48 hpf, whereas pdx1 mutants lack
insulin production from even earlier stages as pdx1 is expressed in the head as well [117].
It is possible these larvae experience a significant, stark decrease in insulin production as
soon as ganglion cells have differentiated and in turn experience cell death as
photoreceptors are differentiating, which may impact differentiation. There are multiple
experiments that could tease out the mechanisms, such as EdU pulse chase where EdU is
administered at 48 hpf for 2 hours then washed out and raised to 5 dpf. This experiment
would provide a snapshot of how the fate of cells proliferating at the time of Mtz
treatment are affected by the ablation of insulin producing cells. Additionally, TUNEL
staining for apoptosis of the retina at various time points from 48 – 72 hpf would be
helpful in elucidating whether retinal cell survival is impacted by initial decrease in
insulin and subsequent induction of hyperglycemia. Both experiments are necessary to
understand the mechanism by which Mtz treatment affects retinal cell development.
Aside from retinal cells, we also characterized vasculature development at 5 dpf
to compare with pdx1 and nutritional models. Mtz treated larvae showed early signs of
vasculature degeneration pathology such as widened vasculature and increased
branching. The widened vasculature is likely due to the loss of pericytes which uphold
the ultrastructure [118]. Additionally, sprouting generally occurs when the body signals
for vascular growth due to detected degeneration [119]. These phenotypes are hallmarks
of diabetic retinopathy so it is interesting to see in larval stages with a relatively short
window of Mtz treatment, in comparison to the length of time an adult would take to
exhibit similar traits. Vasculature degeneration this early on also highlights the
importance of therapeutic interventions to prevent persistent vasculature issues.
Following our characterization of the larval Mtz treated retina, we continued to
raise multiple biological replicates of treated larvae in untreated fish water to 6 wpf. At 6
weeks, treatment groups were subdivided again, and treatments started again. We tracked
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survival throughout the second treatment or “second hit” and found fish that experienced
embryonic and adult Mtz treatment (Mtz/Mtz) had the lowest survival rate, with adultonly Mtz treatment (UT/Mtz and DMSO/Mtz) having the second and third lowest
survival rates. We concluded that Mtz treatment in adulthood lowered survival and
having experienced embryonic Mtz treatment created a higher susceptibility to early
lethality. After 4 weeks of on/off treatment, protein was extracted from eyes, eye tissue
was fixed, and blood was collected.
Extracted protein was used to quantify expression of insulin and mTOR. We
expected and observed a decrease in insulin expression in Mtz treated adults (data not
shown), which also served as proof of principal for pancreas ablation. mTOR was used as
an indicator of diabetes onset as it is highly expressed in the pathogenesis of diabetes
[120]. DMSO/Mtz and Mtz/Mtz showed significantly higher expression of mTOR
compared to UT/UT, which we interpret as the induced onset of diabetes. Together, our
data support the second hit treatments as effective methods to model insulin ablation,
similar to diabetes.
With our model established, we began to assess retinal structure with hematoxylin
and eosin (H&E) stain. We imaged 3 different regions of the retina and after measuring
the width of each nuclear layer in images using both methods, we found a consistent
increase in inner nuclear layer width of DMSO/Mtz and Mtz/Mtz adults as well as a
decrease in outer nuclear layer thickness of UT/Mtz, Mtz/UT, Mtz/DMSO, and Mtz/Mtz
in central retina sections (Fig. S1, graphs not shown). A wider inner nuclear layer may be
attributed to reactive gliosis, which is supported by the increase in GFAP expression in
these treatment groups, occurring in the inner nuclear layer as the Müller glia would be
enlarged, dividing, and proliferating [121]. As for the outer nuclear layer, the thinness
could be correlated with fewer photoreceptors. Given the central retina is a remnant of
the embryonic retina which exhibited a decrease in cone photoreceptors and a trend
towards decrease in rods, it is possible this phenotype either persisted from the larval
state, or that the central retina was more susceptible to a decrease in photoreceptors.
Considering the foundation of this thesis was based on the observation that
photoreceptor degeneration precedes vasculature defects in the pathogenesis of diabetic
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retinopathy, we started our retinal cell analysis with photoreceptors. Rod photoreceptors
were visualized with a 4C12 antibody and showed a significant decrease in number in
adults that experienced embryonic Mtz treatment, regardless of adult treatment. Cone
photoreceptors stained with the Zpr1 antibody were decreased in DMSO/Mtz and
Mtz/Mtz. The Mtz/Mtz and Mtz/DMSO data support the hypothesis that embryonic
insulin ablation increases vulnerability to photoreceptor decrease in adulthood,
particularly when faced with Mtz treatment again when looking at the cones. Intriguingly,
for rods, adult Mtz treatment does not seem to intensify the decrease in cell number for
those that were hyperglycemic during development. This could be due to the timing of
Mtz administration. During development Mtz treatment begins at 48 hpf, a critical
window of photoreceptor progenitor proliferation and specification. The lack of insulin
during this time and subsequent hyperglycemia as these cell types mature could
significantly impact their metabolic programming, inducing long-term defects and
inability to properly maintain over time. Adult treatments are over a course of a month
which may be sufficient time to strongly impact cone photoreceptors while rods may
require more time to induce degeneration. The cycling method could also have a more
significant effect on cones compared to rods in terms of their molecular function, causing
differences in degeneration and/or regeneration rate. Additionally, photoreceptor
decreases in UT/Mtz fish show that Mtz treatment in adulthood is correlated with poor
photoreceptor maintenance. Having the various treatment combinations allows for
clarification of the impact embryonic Mtz treatment has versus adult or a combination.
Thus far, the data have provided strong evidence to highlight the importance of
developmental programming.
Finally, due to the increase in inner nuclear layer width and decrease in
photoreceptors, we imaged Müller glia on the GFAP:GFP transgenic background. We
found an increase in abnormally shaped and enlarged Müller glia as well as abnormal
morphology in Mtz/UT, Mtz/DMSO, and Mtz/Mtz retinas. These Müller glia phenotypes
show that embryonic insulin ablation may sensitize Müller glia to react to any kind of
disturbance or that the Mtz treatment creates persistently abnormal Müller glia. GFAP
protein quantification showed an increase in Mtz/Mtz and DMSO/Mtz adults.
DMSO/Mtz images did not show an increase in number of Müller glia (graph not shown),
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but the cells were twisted and not the characteristic oblong shape. Together, we conclude
adult Mtz treatment can induce reactive gliosis and that embryonic Mtz treatment
exacerbates its expression.
Upon review of phenotypes of each treatment, we found the most severe
differences in retinal structure, cell maintenance, and genetic expression in fish that
experienced Mtz treatment during embryonic development and adulthood. Adult Mtz
treatment had significant impact on specific cell types such as increased GFAP
expression and decreased number of rods and cones, which may go hand in hand as a
decrease in photoreceptors could signal Müller glia to respond and regenerate rods.
Additionally, embryonic Mtz treatment affects cones specifically in this model, and both
Müller glia and rods in our other models. All cell types showed differences regardless of
adult treatment. Therefore, we can conclude the Müller glia and photoreceptors are
affected by Mtz treatment in adulthood as well as developmental programming. Analysis
of photoreceptors weeks after second hit treatment stops at 10 wpf could help decipher
whether photoreceptor numbers eventually become comparable to UT/UT. If they did
not, this would be sufficient to pinpoint embryonic insulin ablation as a critical
determinant of rod photoreceptor cell maintenance and susceptibility to response. Further
studies are also necessary to determine vasculature phenotype and whether it parallels,
precedes, exacerbates, or is exacerbated by the decrease in photoreceptors. This can be
done by imaging retinal flat mounts of treated ins-CFP:NTR fish on the Fli1:GFP
transgenic background as well as photoreceptors at least every week throughout and after
the adult second hit treatment window. That way, the progression of retinal phenotypes
can be tracked alongside vasculature to extract an accurate timeline of events.
Additionally, fluorescence-activated cell sorting may be used to sort out and extract RNA
for sequencing from photoreceptors, Müller glia, and vasculature at specific timepoints to
create gene expression profiles as hyperglycemia persists. These genetic profiles would
be imperative in identifying therapeutic targets for retinal complications, as we could
effectively pinpoint specific pathways that are dysregulated and select appropriate
interventions. Finally, we could use the expression analysis to select interventions that
may differ between hyperglycemia induced during development and adulthood provided
differences among treatment combinations. Together, this model provides sufficient
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foundation to study how hyperglycemia during development impacts retinal
complications in adulthood – a necessary study to properly elucidate the mechanism by
which hyperglycemia, at various stages in life, affects the retina.
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3.6

Supplementary Figures

Figure S3. 1 Retinal layer thickness differences across treatments and sections of the
retina

Figure S3.1 Retinal layer thickness differences across treatments and sections of the
retina. Retinal sections of each treatment group were stained with hematoxilin & eosin.
Each panel within the treatment group represents the retinal structure of the treatment
group in that region. Sections from the central retina show the most consistent
differences, particularly in the INL and ONL of the Mtz treated embryos and adults; red
asterisks denote significant differences in layer width. D, Dorsal; C, Central; V, Ventral;
RPE, Retinal Pigmented Epithelium; POS, Photoreceptor Outer Segments; PIS,
Photoreceptor Inner Segments; ONL, Outer Nuclear Layer; INL, Inner Nuclear Layer;
GCL, Ganglion Cell Layer.
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CHAPTER 4
SHORT AND LONG-TERM
CONSEQUENCES OF EMBRYONIC
HYPERGLYCEMIA ON RETINAL CELLS
4.1

Summary and Discussion
Nearly 10% of the global human population is affected by diabetes and

prediabetes, which correlates directly with increased instances of hyperglycemia [7].
Whether this hyperglycemia is sporadic or recurring depends on the ability to be
diagnosed and treated, which is not widely accessible [122]. As access to healthcare is
not universal globally, this leads to cases where an individual may be experiencing
recurring hyperglycemia and not be aware. Unfortunately, dire consequences are
associated with recurring hyperglycemia which range from nerve and kidney damage to
visual deterioration. These complications have been documented in humans and animal
models such as mouse and zebrafish. In vertebrates specifically, complications of the eye
are most notably in reference to vascular damage, known as diabetic retinopathy.
Diabetic retinopathy is the leading cause of adult-onset blindness in the US and occurs in
80% of adults who have experienced recurring hyperglycemia for 15 or more years [123].
Currently, there are no treatments or remedies for the progressive loss of vision, which
underscores the importance of understanding the pathogenesis and progression of diabetic
retinopathy on a molecular level.
Over time, it is thought that hyperglycemia induces cell death in pericytes which
uphold the structural integrity of vasculature in the eye, leading to fluid leakage and
progressive blindness. Additionally, as the vasculature degenerates, expression of genes
that induce vasculature generation, such as VEGF, increase, creating more vasculature.
However, the newly created vasculature is also weak, and results in a web of weak,
leaking vasculature which advances the progression towards blindness. Various studies
have assessed pathogenesis of diabetic retinopathy [124], [125], but none have fully
elucidated the mechanism of action. Intriguingly, recent studies have focused on the role
of photoreceptors in this process and have shown photoreceptor degeneration may
precede vasculature degeneration in vertebrate models [42], [46], [48], [67]. Whether the
degeneration of photoreceptors plays a role in vasculature damage is unknown, but it
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highlights a significant gap in the literature which may be imperative in understanding
the pathogenesis of diabetic retinopathy.
While most studies on diabetic retinopathy utilize mouse models and cell culture,
a great emerging model is the zebrafish. Compared to other models, the zebrafish are
cost-efficient to maintain, produce large clutches, are diurnal, and come with a wide array
of genetic tools that can quickly produce multiple generations of mutants or transgenic
animals [126]. Importantly, for this dissertation, zebrafish have highly similar organ
function compared to humans [127]. Together, these characteristics provide an ideal
model to study retinal complications of metabolic diseases. Further, because the zebrafish
can regenerate their retina, they can be utilized to understand how the retina may recover
from damage induced by hyperglycemia. The regenerative abilities of the zebrafish retina
stem from the Müller glia, which, upon injury or degradation, asymmetrically divide into
a de-differentiated daughter cell then differentiate to replace lost cells in the retina [128].
As Müller glia respond to damage, assessing their morphology, expression profile, and
number is a key indicator of damage response. Importantly, the Müller glia can
repopulate damaged and dying photoreceptors which is necessary to restore vision.
Considering all these traits, the goal of this dissertation is to assess retinal cell
differentiation, function, and maintenance in zebrafish that experience hyperglycemia
during key windows of retinal development as well as adulthood.
To address the goal of this dissertation, 3 different models of hyperglycemia were
utilized: a genetic mutant, nutritional model, and a transgenic line. For the genetic model,
the pdx1 mutant line (sa280) was provided by Robin Kimmel [13]. Pdx1 is a transcription
factor necessary for beta cell development and maturation as well as duodenal
development [129]. Without beta cells, pdx1 mutants do not produce insulin, inducing
hyperglycemia as early as 4 dpf (data not shown) which sustains throughout their
lifetime, modeling a type I diabetes phenotype. This line was used to evaluate retinal cell
development without insulin. To parallel this, a nutritional model was developed in the
lab. The nutritional model consisted of submerging embryos in glucose +/dexamethasone to induce hyperglycemia. It is important to parallel these models as
hyperglycemia is induced in both but in two different methods, primarily the lack of
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insulin (pdx1) and hyperinsulinemia (nutritional). Both models are sufficient for
embryonic and larval investigation of the effects of embryonic hyperglycemia on retinal
development, but a third line was utilized to elucidate long-term effects of
hyperglycemia. In the transgenic line, ins-CFP:NTR [107], a cyan fluorescent protein and
nitroreductase expression are driven by the insulin promoter, which allows for the
pancreatic insulin expressing beta cells to be visualized using CFP and addition of
metronidazole to the water temporally ablates the pancreas inducing hyperglycemia
within a few days. Since zebrafish can regenerate their pancreatic beta cells, when
metronidazole is removed from the fish water the pancreas regenerates and insulin
production resumes. With this model, hyperglycemia can be induced at any point of the
zebrafish’s life following initial pancreas formation/development (3dpf). Therefore,
hyperglycemia can be induced during development then again in adulthood to mimic a
“second hit” experience of hyperglycemia and elucidate whether embryonic
hyperglycemia affects retinal maintenance when hyperglycemia is induced in adulthood.

4.2

Short-term effects of embryonic hyperglycemia on retinal cells
Embryonic hyperglycemia has been shown to affect susceptibility to diabetes,

obesity, and metabolic syndromes in humans via epidemiological studies [130]. Animal
models have provided a closer examination of effects from heart development to eye
morphogenesis. Within the last three years, an influx of studies has focused on eye and
retina development [11], [12], [20], but the underpinnings of the effects have yet to be
fully understood on a molecular level. In Chapter 2 of this dissertation, the effects of
embryonic hyperglycemia on retinal development were characterized and the molecular
mechanisms explored via the genetic pdx1 model and a nutritional model. We found a
significant decrease in number of light-detecting photoreceptor cells in the retinas of
hyperglycemic fish for both models. Additionally, the photoreceptors that did develop
had abnormal morphology – truncated outer segments and slimmer cell bodies.
Considering photoreceptors are highly metabolically active and have been previously
shown to be susceptible to damage via hyperglycemia, this result was not surprising, but
it is intriguing that hyperglycemia could induce such a significant change so early in
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development. Aside from photoreceptors, horizontal cells were also decreased in number.
Given that horizontal cells synapse with photoreceptors, it made sense that less
photoreceptors correlate with a decrease in horizontal cells. Müller glia cells were the
final cell type to be affected, with not only an increase in number but abnormal
morphology in both the glucose +/- dexamethasone and pdx1 mutant larvae. With the
significant impact on photoreceptors and Müller glia, the remainder of Chapter 2 was
focused on these cell types.
Photoreceptors are highly metabolically demanding cells and have an intricate
relationship with Müller glia regarding metabolism [131]. Using a glucose probe array,
which quantifies RNA expression of various genes linked to glucose metabolism via
qPCR, we identified an increase in multiple genes that are key in regulating glucose over
utilization pathways such as polyol, AGEs, pentose phosphate, PKC, etc. These pathways
lead to increased inflammation, neovascularization, vascular permeability, and reactive
oxygen species (ROS) production [132]. Inflammation, neovascularization, and vascular
permeability are key traits of diabetic retinopathy, while photoreceptor degeneration
specifically in hyperglycemic models has been linked to an increase in ROS, particularly
superoxide, within photoreceptors [47][133]. Our study showed an increase in
superoxides in both models at 5dpf, in photoreceptor outer segments. While we only had
a probe for superoxides, we sought to identify other ROS that could be generated via
rescue rather than detection. Utilizing a variety of ROS inhibitors which target different
forms, we treated both models and used photoreceptor number and morphology as an
output. Treatment with diphenyleneiodonium (DPI), which targets NADPH oxidase and
superoxides, increased rod photoreceptors in glucose + dexamethasone treated larvae.
Superoxide dismutase (which targets superoxides) increased cone photoreceptors (data
not shown), and methylene blue (which targets NADPH oxidase) did not significantly
affect photoreceptors (data not shown). Taken together, these data show how strong of a
role ROS has on hyperglycemia induced photoreceptor damage and specific types of
ROS play a larger role than others in inducing these photoreceptor phenotypes. Also, it is
known that ROS can target lipid membranes for degradation, which may explain why
lipid rich outer segments are stunted in hyperglycemic larvae - through degradation via
ROS [134].
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From this, we begin to characterize the mechanism by which the number of
photoreceptors is affected in our models. Reactive oxygen species play a variety of roles,
primarily inducing cell death via DNA damage [135]. We initially believed this may be
the reason for the decrease in photoreceptors, but analysis of apoptosis revealed only a
small increase in hyperglycemic retinas. This led us to question what additional role ROS
could be playing in retinal development. A study in 2019 outlined the intricacies of ROS
in retinal cell differentiation, specifically demonstrating that ROS is necessary for cellular
proliferation but in excess prevented exit from the cell cycle and subsequent
differentiation within the retina [91]. With this in mind, we looked at ROS during a key
window of photoreceptor proliferation to differentiation switch and found increased ROS
in glucose + dexamethasone treated retinas. These data support a potential role for ROS
in cell cycle early in development, but since pdx1 did not yield similar results, we needed
further elucidation.
Does hyperglycemia or lack of insulin play a significant role in cellular
differentiation of the retina? Retinal development in the zebrafish is a highly conserved
process which has specific time windows when each retinal cell type transitions from
proliferation to differentiation. Therefore, we utilized an EdU pulse-chase to label and
follow the fate of retinal cells that should be specified for photoreceptors based on the
time window of EdU administration. We found a significantly smaller portion of EdU
labeled cells in the outer nuclear layer, where only photoreceptors reside, in
hyperglycemic larvae of both models compared to normoglycemic animals. Additionally,
the hyperglycemic larvae had a significantly larger portion of EdU labeled ganglion cells,
which should have mostly differentiated prior to EdU administration. With these data, we
conclude hyperglycemia delays retinal cell differentiation which results in reduced
number of photoreceptors as they are a later born cell type. Photoreceptors are not the
last-born cell type though; the Müller glia are the final cells to begin differentiating and
are also impacted by hyperglycemia.
In both models, hyperglycemic larvae had an increase in abnormally shaped
Müller glia (quantified via shape analysis) and increased GFAP expression via Western
blot. Both analyses indicate the retina is likely undergoing reactive gliosis where it is
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responding to hyperglycemia induced damage. Considering the decrease in
photoreceptors, Müller glia could be in the process of repopulating these cells, but the
lack of TUNEL+ cells does not fully support this theory. Alternatively, exploring the
metabolism of Müller glia is paramount to understanding the induction of gliosis. Müller
glia utilize lactate as a nutrient source, which has been shown to come from
photoreceptors as a result of glycolysis. A glucose assay can be conducted with cDNA
extracted from FACS sorted Müller glia cells following hyperglycemia induction. Mass
spectrometry could also be done with sorted Müller glia from hyperglycemic retinas to
detect differences in metabolites produced between normo- and hyperglycemic fish.
Further, a time course of these experiments would provide information on the progression
of Müller glia metabolic changes when hyperglycemia is experienced. In the case of
hyperglycemia though, it is possible that either excess lactate is produced in correlation
with an influx of glucose as well as an increase in ROS production which the Müller glia
respond to.
A week following hyperglycemia treatments in the nutritional model, we showed
a persistent decrease in rod and cone photoreceptors. Although the juveniles were placed
back into normal fish water for 7 days, the rods and cones were still affected. This is a
crucial finding as it suggests photoreceptors are not only impacted during development,
but that there are long term effects. Various studies have shown children of diabetic
mothers or those that experienced hyperglycemia during fetal development have a higher
rate of cognitive delay, refractive error, and myopia - which may be linked to poor vision
[136]. Understanding how these defects continue is paramount in properly treating and
preventing further complications later in life, a question which is addressed in Chapter 3
(Fig. 4.1).
Finally, whole mount imaging with the Fli1:GFP transgenic line which labels
vasculature showed Mtz treated larvae develop widened, sprouting hyaloid vasculature –
both key phenotypes in early stages of diabetic retinopathy. Glucose+dexamethasone
treated larvae also exhibited similar phenotypes (data not shown). Additionally, a recent
study characterizing the hyaloid vasculature of pdx1 mutants at 5dpf showed a similar
phenotype, but much more dramatic sprouting and branching compared to wildtype
101

larvae [68]. Although the focus of this dissertation was specifically on the retina and not
vasculature, we found it important to assess the vasculature to begin addressing which
phenotype, retinal or vasculature, comes first and whether one exacerbates the other.
Thus far we have concluded that they occur in tandem, with both reaching significance at
5 dpf, so now that leaves the question as to how they interact. Do photoreceptors secrete
factors which further damage vasculature? Does weakened vasculature lower efficiency
of glucose and oxygen transport to the Retinal Pigmented Epithelium and subsequently
the retina, inducing hypoxia, reactive oxygen species and retinal cell damage primarily to
photoreceptors? The answer may include components of both which lead to severe
photoreceptor and vasculature damage if hyperglycemia continues. Potential experiments
to begin answering these questions include fluorescent dye delivery to ocular vasculature
with live imaging to track delivery efficiency to the retina using lightsheet microscopy,
visual assays to test for hypoxia in the retina, and transcriptomic analysis of factors
secreted by photoreceptors of hyperglycemic larvae.
There are multiple experiments that can be done to further tease out the
mechanism of how the observed developmental phenotypes occur. Given our transgenic
lines for photoreceptors and Muller glia, the follow up studies can easily start with a suite
of imaging techniques. First, super-resolution microscopy can be utilized for all three
transgenic lines to image the mitochondria. This is an important step as mitochondria
may undergo fission under the duress of ROS induced by hyperglycemia [137]. Superresolution microscopy is a reasonable, cost-effective method to observe this phenomenon
and draw conclusions about how ROS is likely impacting these cell types. Another more
detailed, structural analysis option would be serial block face scanning electron
microscopy (SBF-SEM). SBF-SEM is a technique that requires significantly more
preparation and a dedicated staff but yields unparalleled structural information for
individual cells. Like SEM, electrons coat the sample, and the feedback is used to build
an image. An important difference in SBF-SEM is that the sample is being sectioned
during this process, allowing for images to be collected of the external surface as well as
all internal surfaces. The result is a 3-dimensional rendering of an individual cell which
would provide impeccable detail as to the structure of mitochondria. Aside from
mitochondria analysis, SBF-SEM may also be used to visualize the ultra-structure of the
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photoreceptor outer segments as well as the cell bodies of the Müller glia. For the
photoreceptors, we noted a slimmer inner segment and truncated outer segment which
was consistent across biological replicates. With SBF-SEM, we can finely assess which
portions of the photoreceptor are most affected externally and how that reflects internal
organelles and structures. For instance, the truncated outer segments may show
degradation of the lipid membranes or signs of dying organelles preventing proper
function. As for Müller glia, we found a great deal of abnormally shaped cell bodies in
pdx1 mutant and glucose + dexamethasone treated larvae which can be finely analyzed
with SBF-SEM. We would likely distinguish dividing Müller glia via external structure
as well as the division of internal organelles. This could also be a key experiment for
characterizing various Müller glia cell shapes to generate an atlas that coordinates
external phenotype with internal structures. These studies are ideal for characterizing
morphology, and the next step would ideally link morphology with transcriptomics and
function.
Transcriptomic analysis can be done using Fluorescence-activated Cell Sorting
(FACS) of rods, cones, and Müller glia from hyperglycemic fish of both models. With
the isolated cells, RNA can be extracted to collect the transcriptomic profile via
sequencing of these cell types experiencing either nutritional or genetic induced
hyperglycemia. Specifically, genes related to ROS, glycolysis, TCA cycle, and electron
transport chain should be analyzed. In photoreceptors, opsin genes, insulin receptors, and
glucose transporters should also be assessed. Opsins are necessary for visual function and
are informative in uncovering whether hyperglycemic larvae are visually responsive on a
molecular level. Additionally, while we know glucose transporter 1 (GLUT1) is the
primary transporter in mouse photoreceptors [34], it is unknown which is utilized in
zebrafish and this can be discovered via qPCR, or ideally Western Blot. A more time
consuming, but informative study would be to do glucose uptake studies following
glucose transporter (slc2a) morpholino knockdown and using a fluorescent glucose to test
uptake. Lightsheet imaging could appropriately capture glucose uptake in the retinal cells
and GLUT1 followed by GLUT4 would be tested first as they are the most likely
candidates. Finally, insulin receptor expression would be interesting to quantify
considering the presence and absence of insulin in the different models. With a strong
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transcriptomic profile of the various cell types most affected by hyperglycemia, we can
better understand how gene expression is altered in hyperglycemic larvae compared to
untreated and wildtype. This will be of benefit in identifying potential therapeutic targets
to mediate the impact hyperglycemia has on photoreceptors. For instance, our glucose
probe array using whole head tissue provided the data which led us to target ROS as a
potential source of damage to the hyperglycemic retina. A more targeted approach with
cell specific mRNA would be ideal. Also, sequencing would provide a much more
thorough understanding of how various pathways are altered in hyperglycemic versus
normoglycemic larvae and provide a fuller picture of the mechanisms involved. Once
targets are identified, the same methods can also be used to test the effectiveness and
efficiency of developed therapeutic targets and their potential consequential effects.
Characterization of cell function and interactions are necessary to uncover the full
story of how photoreceptors and Müller glia are affected by embryonic hyperglycemia.
Due to the transparent nature and small size of zebrafish larvae, live imaging is quite
accessible using light sheet microscopy. To focus back on differentiation, a time lapse
video from 48-96 hpf would be informative in uncovering the rate of photoreceptor
differentiation and Müller glia activity in real time. Both rod and cone photoreceptors
differentiate in this window, so a time lapse video would reveal each during
differentiation and elongation, as well as document any that do not mature or display
abnormal differentiation. Prior to this experiment, the light refraction of glucose +/dexamethasone fish water must be tested to assure it will not interfere with the quality of
imaging. Following this, 48 hpf TαC:eGFP then XOPS:GFP embryos would be mounted
in capillaries and positioned so that the eye is in focus. The fish would remain mounted
as confocal stacks taken every hour for 48 hours. The videos would reveal photoreceptor
differentiation rate, potential degeneration, and morphological development. A similar
analysis with the Müller glia could also be done with this set-up, but the focus would be
identifying whether these cells differentiate abnormally or differentiate properly and
begin to undergo gliosis related morphological changes. That question is key to teasing
out whether Müller glia are directly affected by hyperglycemia through aberrant
differentiation or are responding to signals produced by a hyperglycemic environment.
As informative as this experiment would be, major limitations include size of time-lapse
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video, growth of the larvae which will alter the field of view, and potential movement of
the larvae as they develop which can ruin the initial imaging set-up. If the experiment is
executed carefully and properly, it can provide imperative information concerning
photoreceptors and Müller glia.
Evaluation of visual function of hyperglycemic larvae is necessary to elucidate the
impact of morphology and count phenotype. In Chapter 2, this was addressed using an
optokinetic response test which can provide information on subtle visual defects. More
precise assessment of specific visual function of each cell type may be done via
electroretinogram on each treatment and genotype across both models. With
electroretinogram, analysis of the function of individual cell types can be done which will
better address the specific aspects of the visual pathway that are affected by
hyperglycemia. Together the proposed experiments would elucidate mechanistic and
cellular consequences of embryonic hyperglycemia on the retina which cannot be done as
effectively in other models.
Finally, alternative hypotheses should be tested to affirm the observed phenotypes
are due to hyperglycemia. For instance, some indirect effects of the treatments could be
contributing to the noted phenotypes. A common phenotype noted consistently across
models and research groups is aberrant vasculature early in development. It is possible
that the damaged vasculature is preventing proper nutrients from being delivered to the
retina, inducing hypoxia and photoreceptor degeneration. This hypothesis can be tested
by more precisely timed imaging of vasculature development beginning at 48 hpf, at least
every 12 hours, until 5 dpf. Imaging can be paired with Evans blue dye injection to
identify timing of vasculature leaking, if that is occurring, onset which could be
correlated with photoreceptor phenotypes. If vasculature begins to leak early in
development, this could affect retinal cell differentiation, as noted with the EdU assay,
but if it is later in development, the leakage could induce photoreceptor degeneration.
Each experiment would need to be followed by Western blot for Hypoxia Inducible
Factor 1a with eye protein lysate. This suite of experiments is also an important step to
validating the hyperglycemic models as well.
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4.3

Long-term effects of embryonic hyperglycemia on retinal cells
As laid out in Chapter 2, we have shown embryonic hyperglycemia has a

significant impact on development of the vertebrate retina. We provided sufficient
evidence to show these effects may persist into juvenile stages, but it is important to look
further into adulthood as well. In Chapter 3 of this dissertation, we delve into these longterm effects in young adulthood using ins-CFP:NTR fish (Fig 1). With the ins-CFP:NTR
zebrafish, we can temporally ablate pancreatic beta cells by adding metronidazole (Mtz)
to fish water which interacts with nitroreductase expressed by the insulin promoter,
turning it cytotoxic. Due to the zebrafish’s ability to regenerate their pancreas, once
metronidazole is removed from the water, the insulin expressing beta cells regenerate and
begin to function within a few days. Such control over insulin expression, and in turn
glycemia, at any point after 3 dpf provides a great opportunity for efficient long-term
experiments. We carried experiments out by randomly sub-dividing ins-CFP:NTR
embryos at 48 hpf into three treatment groups: untreated, DMSO, and 5mM Mtz.
Embryos remained in treatment until 5 dpf and whole-body glucose measurements
showed Mtz treatment was effective in inducing hyperglycemia. We then moved on to
analyze retinal cell types and morphology.
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Figure 4. 1 Visual representation of data from Chapter 2 which support questions posed
in Chapter 3

Figure 4.1: Visual representation of data from Chapter 2 which support questions
posed in Chapter 3.
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First, Mtz treated larvae exhibited normal gross morphology with an eye size
proportionate to body size compared to untreated and DMSO controls. Vasculature
imaging of the whole eye revealed a phenotype like pdx1 mutants and glucose+dex
treated larvae, such as widening, sprouting, and initial stages of branching. Such early
signs of vasculature damage highlight the significance of this work, as the vasculature
plays a major role in the function of the retina. Looking specifically at the retina, Mtz
larvae differed phenotypically from pdx1 and nutritional model larvae. The two cell types
most affected by Mtz treatment were cone photoreceptors and ganglion cells, which were
both decreased. Decreased cone photoreceptors, but not rods, was an interesting
phenotype considering both were affected in the other models. Previous studies in adult
zebrafish models of hyperglycemia have also shown cone photoreceptors to be more
susceptible to damage compared to rods, citing ROS production (superoxides) primarily
in cone photoreceptors [47]. An important follow up to elucidate the cone specific affect
would be utilization of the superoxide probe on ins-CFP:NTR larvae crossed onto the
TαC:eGFP and XOPS:GFP transgenic backgrounds to discern whether cone
photoreceptors produce more superoxide than rods, or if at all.
Aside from photoreceptors, the only other affected cell type was ganglion cells,
which were decreased in Mtz treated larvae. Epidemiological studies in humans and some
animal models have shown ganglion cell damage and loss over time with recurring
hyperglycemia [138]–[140]. While this ganglion cell result is well supported in the
literature, it is interesting to not see the same outcome in the pdx1 model, considering
both models experience insulin deficient induced hyperglycemia. There were differences
across models in terms of phenotypes observed at 5dpf, which were important to compare
to identify underlying mechanisms (Fig. 2). We hypothesized insulin production early in
development which is not knocked down with the timing of Mtz treatment may explain
the differences in ins-CFP:NTR phenotypes compared to pdx1. Studies have shown
insulin production from the brain (hypothalamus and cerebral cortex) in humans that may
also be present in zebrafish [141], but whether this is regulated by Pdx1 has yet to be
elucidated. Studies have shown Pdx1 is expressed in zebrafish heads at 3 dpf, but that is
too late to account for differences between the models. Western blot or whole mount
immunohistochemistry for insulin at various timepoints from 48 hpf to 5 dpf would
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readily determine whether some insulin is still produced in pdx1 mutants outside of the
pancreas and the source. A side-by-side comparison of glycemia between all models
would be an effective way to understand some of the variation noted between models.
Although the differences in phenotype have not been fully elucidated, the cone
photoreceptor and vasculature phenotypes support the use of ins-CFP:NTR as an
adequate model of embryonic hyperglycemia thus we continued with our second hit study
where we induced hyperglycemia for a second time in adulthood.
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Figure 4. 2 Effects of embryonic hyperglycemia across three different models
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Figure 4.2. Effects of embryonic hyperglycemia across three different models.
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For each fish in the second hit study, only eyes are utilized for analysis. We first
focused on retinal cell number and morphology by conducting immunohistochemistry
and histology on retinal sections. Immediately, we noted striking differences in the
thickness of retinal layers across the treatment groups. The inner nuclear layer was
thicker in retinas of DMSO/Mtz and Mtz/Mtz adults, which is interesting considering
other studies looking at retinal thickness in relation to hyperglycemia attribute the
phenotype to reactive gliosis. Next, we looked at the outer nuclear layer which houses
photoreceptor nuclei. UT/Mtz and Mtz/Mtz adults displayed a thinner outer nuclear layer.
Intriguingly, all adults that experienced embryonic Mtz treatment (Mtz/UT, Mtz/DMSO,
and Mtz/Mtz) had a thinner outer nuclear layer. With these data, we concluded that both
adult and embryonic induced hyperglycemia affected retinal structure and morphology,
supporting our hypothesis that embryonic hyperglycemia plays an important role in
retinal programming which has long-term impacts.
Next, we looked at rod and cone photoreceptors using immunohistochemistry. We
found rods were significantly decreased in all adults that experienced embryonic
hyperglycemia, regardless of adult treatment as well as a trend towards decreased rods in
UT/Mtz and DMSO/Mtz. Cone photoreceptors showed a trend towards decrease in
DMSO/Mtz and UT/Mtz while Mtz/DMSO and Mtz/Mtz were significantly reduced. The
decrease in photoreceptors noted in both DMSO and Mtz treated adults that experienced
embryonic hyperglycemia supports a role for embryonic programming in significantly
affecting the retina long-term, regardless of adult treatment. Interestingly, there seems to
be an exception of cone photoreceptors which do not show a decrease in Mtz/UT adults,
indicating potential recovery from embryonic cone decrease if adults are left untreated.
Further experiments to elucidate the response of photoreceptors to embryonic and adult
hyperglycemia first include collecting samples at least once per week throughout adult
treatment. Rods, cones, autophagy, and cell death may be stained for and imaged at each
of these time points. Photoreceptors and cell death can be visualized using
immunohistochemistry and by TUNEL assay, respectively. Autophagy may be assessed
via a transgenic line TaC:LC3:GFP which induces green fluorescent protein expression in
cone photoreceptors that express LC3, a key gene in the autophagy pathway [142].
Crossing ins-CFP:NTR fish with TaC:LC3:GFP will provide crucial information in
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narrowing the method of apoptotic induction. In addition to method of cell death, if that
is the culprit causing decreased photoreceptors, the analyses described above would also
reveal the rate at which photoreceptor cells are decreasing. Paralleling these data with the
onset of hyperglycemia is essential to understand how the timing of photoreceptor
phenotypes aligns with blood glucose levels. Also understanding the timing by which
photoreceptors begin to show differences in number between treatment groups is critical
in elucidating how hyperglycemia during development and adulthood impacts the
maintenance of photoreceptors. These studies can be followed up by staining for
photoreceptor progenitor markers as well as EdU pulse chase experiments would indicate
if the photoreceptors were being regenerated, which may also be affected by
hyperglycemia. Finally, a cell proliferation marker such as PCNA would partially address
the question of induced regenerative response or not. Decreased photoreceptors at this
stage in the life of a zebrafish would almost always induce a gliotic response and
subsequent repopulation of photoreceptors via Müller glia. Therefore, our next step was
to evaluate Müller glia morphology and GFAP expression across treatments.
Müller glia number was increased with enlarged nuclei in all adults that
experienced Mtz treatment as embryos. Mtz treated adults displayed some aberrant
morphology, but not a significant increase in number. With only a significant response in
the embryonic hyperglycemic adults, these data provided further support for the
importance of embryonic glycemic homeostasis as it looks to have a lasting impact. This
result also supports our hypothesis that embryonic hyperglycemia sensitizes the retina to
respond to minimal damage. Additional work is necessary to elucidate if Müller glia do
not recover from gliosis in embryonic stages and exhibit persistent gliosis. Examining
fish two weeks post second hit treatment would address whether the reactive gliosis
resulted in repopulated photoreceptors and Müller glia morphology returned to a more
normal shape. This paired with timed in situs for photoreceptor progenitors following
Mtz treatment as well as an EdU pulse chase to determine if photoreceptors progenitors
are being produced following hyperglycemia induction. Comparing the potential
progenitor production across treatments also provide key insights to how embryonic
hyperglycemia may affect programming in relation to regenerative capacity. Finally, a
functional experiment such as electroretinogram is necessary to determine retinal cell
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function. All can and should be done in these models as this would make for a key
finding in these studies by providing discernment of specific embryonic programming
impact.
Following initial retinal cell assessment, we evaluated protein expression via
Western blot. Quantification of protein expression is imperative to functional
conclusions. We first tested for mTOR as an indicator of diabetes. In humans, blood
could be used to measure blood glucose and HBA1c levels, which would serve as a
method of diagnosis for diabetes. Unfortunately, blood collection has not yielded enough
sample to properly use these testing techniques, so mTOR was our best option. An
important caveat to note is the other factors aside from diabetes increase mTOR
expression such as inflammation, neurodegeneration, and increased circulating nutrients
[143] which may affect results from Western Blots. We found increased mTOR
expression has been highly correlated with diabetes and was significantly increased in
DMSO/Mtz as well as Mtz/Mtz fish. The high expression of mTOR in Mtz/Mtz fish
could be interpreted as embryonic hyperglycemia serves as a primer that sensitizes adults
to diabetes rather than prevents. Interestingly, the DMSO/Mtz showed the highest
increase while UT/Mtz showed minimal expression. This could indicate DMSO having
an effect on larval development, but that is not supported in the bulk of zebrafish
literature. Therefore, repeated Western Blots may be necessary to consistently quantify
mTOR expression. Next, we blotted for GFAP as an indicator of reactive gliosis. GFAP
expression was second highest in Mtz/Mtz, with DMSO/Mtz being the highest and
followed by UT/Mtz and Mtz/UT. Interestingly, this supports the previous sensitization
hypothesis, while reflecting immunohistochemistry data for GFAP, and calling to the
importance of shape analysis of Müller glia. Although the number of Müller glia was not
significantly increased in UT/Mtz, these fish did display a higher instance of enlarged,
abnormally shaped nuclei – a potentially more reliable method of analyzing Müller glia
compared to quantification of cell number alone.
Finally, adult fish eyes are much less difficult to flat mount, which is ideal for
vasculature imaging. With fish on the Fli1:GFP transgenic line, we can flat mount,
image, and analyze for signs of diabetic retinopathy. This is an important future direction,
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given that one of our initial questions for this entire dissertation was whether onset of
photoreceptor damage and reactive gliosis phenotypes are before vasculature damage,
parallel to, and/or exacerbate one another. Aberrant vasculature in Mtz/UT or
Mtz/DMSO adults would be indicative of vasculature damage that did not recover after
embryonic hyperglycemia, calling to the importance of therapeutics early in development
to prevent long-term damage. Additionally, widened, branching, and/or sprouting
vasculature in UT/Mtz, DMSO/Mtz, and Mtz/Mtz would be interpreted as the month of
oscillating hyperglycemia is sufficient for inducing diabetic retinopathy, or at least initial
stages.
Together, Chapter 3 provides the foundation for understanding the long-term
impacts of embryonic hyperglycemia on the retina. The various combinations of
treatments and techniques are key in elucidating how and when the retina is altered as
well as lays out potential for therapeutic targets. These studies are key in that the
zebrafish is such an accessible, high sample number yielding, and relatively quickly
maturing model – all ideal traits for “second hit” experiments

4.4

Conclusion
Zebrafish are a powerful model for studying hyperglycemia both short and long

term. From their ability to develop diabetes to retinal complications, they can provide the
foundation for molecular analysis which may be used in developing targeted therapeutics.
In Chapter 2 and 3 of this dissertation, phenotypes linked to embryonic hyperglycemia
were identified and analyzed at a cellular level which cannot be done in humans and is
difficult to study in mammals such as mice. Additionally, we identified a potential
mechanism by which these phenotypes occur: ROS production and slowed retinal cell
differentiation. Although it is well documented that ROS is produced at higher levels in
diabetic adults, this is the first study to show that it is also in hyperglycemic larvae. Further,
this is the first to link cell differentiation timing in vivo to hyperglycemia. Finally, we
provide sufficient evidence to support a significant role of hyperglycemia in developmental
programming of the retina through long-term, second hit studies. Overall, we now have a

114

better understanding of hyperglycemia and the development and maintenance of the retina
on a cellular level.
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4.1

Abstract
Congenital retinal dystrophies are a major cause of unpreventable and incurable

blindness worldwide. Mutations in CDHR1, a retina specific cadherin, are associated with
cone-rod dystrophy. The ubiquitin proteasome system (UPS) is responsible for mediating
orderly and precise targeting of protein degradation to maintain biological homeostasis and
coordinate proper development, including retinal development. Recently, our lab
uncovered that the seven in absentia (Siah) family of E3 ubiquitin ligases play a role in
optic fissure fusion and identified Cdhr1a as a potential target of Siah. Using two-color
whole mount in situ hybridization and immunohistochemistry, we detected siah1 and
cdhr1a co-expression as well as protein localization in the retinal outer nuclear layer
(ONL), and more precisely in the connecting cilium of rods and cones between 3-5 days
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post fertilization (dpf). We confirmed that Siah1 targets Cdhr1a for proteasomal
degradation by co-transfection and co-immunoprecipitation in cell culture. To analyze the
functional importance of this interaction, we created two transgenic zebrafish lines that
express siah1 or an inactive siah1 (siah1DRING) under the control of the heat shock
promoter to modulate Siah activity during photoreceptor development. Overexpression of
siah1, but not siah1DRING, resulted in a decrease in the number of rods and cones at 72
hours post fertilization (hpf). The number of retinal ganglion cells, amacrine and bipolar
cells was not affected by Siah1 overexpression, and there was no significant reduction of
proliferating cells in the Siah1 overexpressing retina. We did however detect increased cell
death, confirmed by an increase in the number of TUNEL+ cells in the ONL, which was
proteasome-dependent, as proteasome inhibition rescued the cell death phenotype.
Furthermore, reduction in rods and cones resulting from increased Siah1 expression was
rescued by injection of cdhr1a mRNA, and to an even greater extent by injection of a
Siah1-insensitive cdhr1a variant mRNA. Lastly, CRISPR induced loss of Cdhr1a function
phenocopied Siah1 overexpression resulting in a significant reduction of rods and cones.
Taken together, our work provides the first evidence that Cdhr1a plays a role during early
photoreceptor development and that Cdhr1a is regulated by Siah1 via the UPS.

4.2

Introduction
According to the World Health Organization (WHO), in 2015 more than 253

million people worldwide were visually impaired, of which 36 million were blind. This
number is predicted to increase to 703 million visually impaired people by 2050[144].
Retinal congenital disease is a major contributor to blindness disorders, affecting 4.5
million people worldwide. Congenital retinal blindness is known to be associated with
mutations in over 280 different genes[145]–[147]. While these mutations encompass
various portions of the eye, aberrant development and improper maintenance of the retina
are major causes of visual impairment and loss of sight.
The retina, an extension of the central nervous system, is responsible for not only
detecting incoming light, via photoreceptor cells, but also ultimately conveying that signal
through the optic nerve and to the brain to be interpreted as vision[148]. Retinal structure
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and development are fairly well conserved across vertebrates from human to mouse and
zebrafish[149]. There are 7 cell types within the retina, which populate 3 nuclear layers.
Differentiation of the neural retina generally begins with the innermost neurons of the
retina: ganglion cells within the ganglion cell layer (GCL) closely followed by or in parallel
with amacrine, horizontal, and bipolar cells of the inner nuclear layer (INL). Müller glia
are the last cells of the INL to differentiate[150]. The light-sensing rod and cone
photoreceptor cells, which are responsible for distinguishing light and dark as well as color,
respectively, are relatively late-born retinal cell types[151]. In zebrafish beginning at 50
hours post fertilization (hpf), expression of rhodopsin and red cone opsin are detectable
specifically in the ventronasal region of the retina[73], [152], [153]. Cone photoreceptor
differentiation then spreads from the ventro-nasal to the dorso-temporal retina in a wave,
whereas rod photoreceptor differentiation proceeds more sporadically across the
retina[154], [155]. Photoreceptor outer segments are initially detected at 60 hpf in the
ventral region of the retina[156] Cone and rod photoreceptors have largely completed
differentiation by 5 days post fertilization (dpf), at which point cone photoreceptor function
can be detected by electrophysiology and behavioral assays[126], [157]. Photoreceptors
populate the outer nuclear layer (ONL) and play a critical role in detecting light using the
outermost portion of the cell, the outer segment[84]. Outer segments are comprised of
hundreds of stacked disks which contain the molecular machinery to detect and process
light signals via phototransduction[158]. Phototransduction is a highly metabolically
demanding process which produces toxic photo-oxidative compounds, requiring outer
segments to shed after a period of time and be replenished to maintain proper cell
length[159]. Although photoreceptors are imperative for visual system operation, the
function of many genes hypothesized to play a role in their development and maintenance
have yet to be tested in vivo. Mutations in these various genes can lead to the development
of a wide spectrum visual impairment, including the commonly known cone-rod
dystrophies.
Cone-rod dystrophies are a group of inherited retinal diseases that first affect cone
photoreceptors, then rod photoreceptors, or in some cases they are affected
simultaneously[160]. Generally, the photoreceptors begin to degenerate, causing
progressive loss in visual acuity, color and central vision, and light sensitivity[161]. In
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order to develop therapeutics for cone-rod dystrophies, understanding the currently
unknown mechanism as to how of each of the over 30 genes[162] implicated in its onset
and progression is imperative. To do this, most studies have aimed to elucidate the role of
these genes in retinal development and maintenance in vertebrate models such as mouse
and zebrafish[163]–[167]. A well-established candidate gene associated with cone-rod
dystrophy which has yet to be explored in a developmental context is photoreceptor
specific cadherin CDHR1.
Several clinical studies[146], [168]–[178] have described mutations in CDHR1
associated with inherited cone-rod dystrophy. Conserved among vertebrates, CDHR1
belongs to the cadherin superfamily of calcium-dependent cell adhesion molecules but is
exclusively expressed in photoreceptors of zebrafish, chickens, mice and humans[179].
CDHR1 encodes an intracellular domain, a transmembrane domain in addition to six
cadherin repeats[175]. Previous studies using tomography, electron microscopy and
immunohistochemistry have unequivocally defined CDHR1 localization to the base of
outer segment of photoreceptor cells[179]–[181]. Additionally, to further determine its
precise location in the junction in between the inner segment (IS) and the outer segment
(OS), Burgoyne and collaborators[180] used nanogold cryo-EM to illustrate that CDHR1
forms fibers connecting immature discs at the base of the outer segment. This group
hypothesized that CDHR1 is necessary to stabilize and control the disc evagination process
during photoreceptor cell outer segment assembly and/or maintenance[178]. A CDHR1
knockout mouse partially supports this hypothesis as well as the correlation of CDHR1 loss
of function and cone-rod dystrophy. CDHR1 knockout mice were born with shorter and
disorganized photoreceptor outer segments, followed by a progressive loss of
photoreceptors (50%) in the next 6 months of life[181].
While previous studies of CDHR1 have confirmed its importance for photoreceptor
development and homeostasis[173] we lack any understanding of its regulation during
these critical events. Interestingly, we have recently characterized a ubiquitin-proteasomal
system (UPS) pathway involved in retinal morphogenesis[182]. We observed that the E3
ligase enzyme, Siah1, was expressed throughout the retina during early development and
specifically targeted a transcriptional regulator, Nlz2, for degradation. This process ensured
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timely and precise fusion of the optic fissure of the early retina. When searching for other
targets of this E3 ligase based on its well established degron-motif (Pro-[ARTE]-X-ValX-Pro), we identified zebrafish Cdhr1a as a potential hit. This suggested to us that Siah is
a candidate for regulating the turnover of this protein and therefore controlling its function
during photoreceptor development or outer segment maintenance.
In our present study we aimed to investigate the Siah-mediated post-translational
regulation of Cdhr1a during development of the zebrafish retina. Taken together, our data
indicate that stability of Cdhr1a is necessary for zebrafish photoreceptor development and
survival and it is subject to regulation through the UPS by Siah1. In particular, we observe
significantly reduced photoreceptor number upon induced expression of Siah, but no
significant effects on any other retinal cell type. We show these effects are UPS dependent
and can be rescued with a proteasome inhibitor (MG132), with cdhr1a mRNA, as well as
a Siah1 insensitive Cdhr1a variant. Our work provides an in-vivo example of vertebrate
photoreceptor cell development modulated by UPS-mediated regulation of a gene known
to be associated with inherited cone-rod dystrophy.

4.3

Results
4.3.1

Siah and cdhr1a are co-localized in the outer nuclear layer during retinal
development.

As mentioned above, numerous studies have demonstrated cdhr1 expression in
retinal photoreceptor cells and potentially implicated in photoreceptor
development38,39,41. In contrast, siah gene expression during zebrafish retinal
development had yet to be described. As such, we sought to investigate siah expression
and cellular localization during the later stages of retinal development when
photoreceptors are maturing. Siah1 and 2l are known to be expressed throughout the
central nervous system during zebrafish development but in this study we carried out a
comprehensive expression analysis of both siah homologues, siah1 and siah2l specifically
during retinal development. Using two color fluorescence whole-mount in situ
hybridization (FWISH) we examined simultaneous expression of siah1 or siah2l and
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cdhr1a in the zebrafish retina at 3, 4 and 5 days post fertilization (dpf) (Fig 1). Zebrafish
also encode a cdhr1 paralogue, cdhr1b, however it does not exhibit retinal expression
(data not shown). Starting at 3 dpf we observed co-expression of cdhr1a and both siah1
and siah2l specifically in the outer nuclear layer (Fig 1A, D). Siah1 and 2l expression was
also seen throughout the INL and GCL. This pattern of expression was observed up to
and including 5 dpf (Fig 1C, F). Co-expression of siah1 and cdhr1a in the ONL indicates
that siah1 and cdhr1a are both present and potentially active during photoreceptor cell
maturation. This further suggests that Siah1 may have a functional role in regulating
Cdhr1a protein stability in photoreceptor cells. Since siah1 and 2l both target the same
degron sequence, we focused solely on siah1 for the rest of this study.

4.3.2

Siah1 localizes to the base of the outer segments in rods and cones.

In order to validate our FWISH results, we next examined Siah and Cdhr1a
protein localization during photoreceptor maturation. To do so we first obtained zebrafish
specific polyclonal antibodies against Siah1 and Cdhr1a. When tested by
immunohistochemistry (IHC) in 3-5 dpf retinal sections we observed signal that
correlated with our FWISH results (Fig 2A-L). In particular, we observed specific
localization of Cdhr1a signal in the outer nuclear layer where the rods and cones reside,
while Siah1 signal was detected throughout the retina, including strong signal in the outer
nuclear layer (ONL) (Fig 2D-F). To confirm that Siah1 is localized in photoreceptor
cells, and to determine to which subcellular region, we performed IHC on retinal sections
from transgenic embryos expressing rod and cone reporter constructs, Tg[XOPS:GFP]
and Tg[TαC:eGFP] respectively11,43. Our IHC results indicate that Siah1 protein
localized to the synaptic terminals of rod (XOPS:GFP) and cone (TαC:eGFP)
photoreceptors, as well as in the connecting cilium from 3 to 5 dpf (Fig 2D’-F’, J’K’,C”,F”,I”,L”). We observed a similar pattern of localization for Cdhr1a, in particular at
the connecting cilium of rods (XOPS:GFP) and cones (TαC:eGFP) (Fig 2A’-C’, G’-H’).
Cdhr1a localization to the primary cilium at 3 dpf, exhibited low signal, which increased
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progressively up to 5 dpf (Fig 2C”,F”,I”,L”). In addition to the ONL, Siah1 protein
staining was also observed in the inner nuclear layer (INL) and ganglion cell layer (GCL)
during the period analyzed. This again corelated with our FWISH data. Collectively, our
analysis of mRNA and protein localization for Siah and Cdhr1a indicated that both
proteins are expressed in photoreceptor cells and may functionally interact.

4.3.3

Siah1 targets Cdhr1a for proteasomal mediated degradation.

Siah E3 ubiquitin ligase interaction with target proteins is a well-characterized
process and it involves interaction through an evolutionarily conserved amino acid motif
termed a degron. Zebrafish Cdhr1a protein encodes a Siah degron starting in the 857th
amino acid. In vertebrates, CDHR1 is highly conserved, with similarity ranging around
60% when comparing human to zebrafish Cdhr1a. This includes the degron motif,
suggesting that this conserved feature plays an important role in the regulation of Cdhr1a
through the UPS (Fig 3A). To examine whether Siah regulates Cdhr1a protein
degradation, we transiently co-transfected HEK 293T cells with Cdhr1a-FLAG and GFP
(control) or Cdhr1a-FLAG and Siah1-myc. Protein levels were subsequently determined
by Western blot. As shown in Figure 3B, lysates from cells co-transfected with Cdhr1aFLAG and Siah1-myc, completely lacked Cdhr1a-FLAG signal while the control cotransfection resulted in the presence of a strong Cdhr1a-FLAG band (Fig 3B), indicating
that Cdhr1a is targeted for degradation in the presence of Siah1. To demonstrate a direct
effect of Siah1 E3 ligase activity we also co-transfected Cdhr1a-FLAG with an
inactivated Siah1 construct (Siah1DRING-myc) which is missing the RING domain and
therefore cannot perform the E3-mediated ubiquitin transfer onto its targets. Cell lysate
from Cdhr1a-FLAG and Siah1DRING-myc co-transfection also contained a strong
Cdhr1a-FLAG band. Furthermore, inhibition of the proteasome using MG132 treatment
resulted in the retention Cdhr1a-FLAG signal compared to no treatment (Fig 3B). These
results demonstrated that Siah1 is directly responsible for the loss of Cdhr1a-FLAG due
to proteasomal degradation. To determine whether Cdhr1a targeting by Siah1 requires the
degron motif, we constructed a Cdhr1a variant in which the VmP motif of the degron
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sequence was altered to LmA (cdhr1aLmA). The mutations had no effect on the level of
expression of Cdhr1aLMA-FLAG compared to Cdhr1a-FLAG (Fig 3B-C). As shown in
Figure 3C, Cdhr1aLmA-FLAG was completely insensitive to the effects of co-expressing
Siah1-myc. Finally, using co-immunoprecipitation (co-IP) we showed that Siah1-myc, or
Siah1DR-myc, can be pulled down by Cdhr1a-FLAG (Fig 3D). To ensure the specificity
of our co-IP, cells were transfected with Siah1DRING-myc alone, showing no pull-down
with FLAG antibodies after the co-IP (Fig. 3D). Taken together, these results strongly
suggest that Siah1 directly targets Cdhr1a for proteasomal mediated degradation through
the degron motif found in Cdhr1a. In light of our findings, we next sought to determine
whether Siah-mediated regulation of Cdhr1a protein stability plays a role in zebrafish
photoreceptor development.

4.3.4 Misregulation of Siah1 activity leads to reduced numbers of photoreceptors.

Based on our characterization of siah1 and cdhr1a expression and localization in
photoreceptor cells, specifically the connecting cilium, and our confirmation that Siah1
targets Cdhr1a for degradation in vitro, we next wanted to determine whether this
interaction plays a functional role during photoreceptor cell development. In order to
overexpress Siah1 during retinal development, we generated two zebrafish transgenic
lines in which Siah1 or the inactive Siah1ΔRING were placed under the control of the
heat shock inducible hsp70 promoter (Fig. 4A). We designed an experimental heat shock
approach that would induce Siah1 expression during the developmental window of
photoreceptor genesis, between 48 and 72 hours post fertilization (hpf). To ensure
continuous activity of the transgene, we performed the initial heat shock at 48 hpf,
followed by a repeat heat shock at 60 hpf, and finally fixation at 72 hpf, by which time
photoreceptor differentiation is largely completed (Fig. 4B). The efficiency and
specificity of the heat shock (HS) system were assessed by whole-mount in situ
hybridization (WISH) (Fig. 4C). In the absence of elevated temperature examination of
siah1 expression did not suggest any leaky expression from the hsp70 promoter. Upon
heat shock siah1 and siah1 RING expression were significantly and ubiquitously
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elevated (Fig 4C). Importantly, heat shock mediated induction of siah1 but not
siah1 RING expression led to a decrease of cdhr1a levels in the ONL as observed using
IHC (Fig 4D). Tg[hsp70:siah1] and Tg[hsp70:siah1 RING] were next crossed onto the
Tg[XOPS:GFP] and Tg[TαC:eGPP] transgenic lines to assess rod and cone photoreceptor
development, respectively. At this timepoint in development, rod photoreceptors are
largely concentrated in the ventral portion of the retina with some sporadic differentiation
in the dorsal retina. In contrast, cone photoreceptors, which complete differentiation
faster than the rods, have spread fairly uniformly across the outer nuclear layer by 72 hpf.
Double transgenic embryos were subjected to the HS protocol. Collected embryos were
either imaged whole using confocal microscopy, or cryosectioned for IHC analysis.
Confocal imaging of whole-mount embryos clearly indicated a significant decrease in rod
and cone cells in Siah1 overexpressing embryos at 72 hpf relative to controls (Fig S1).
Quantification of retinal sections confirmed a decrease in the number of rods (Fig. 5A-C)
and cones (Fig. 5E-G) in Siah1 HS embryos compared to wildtype and siah1 RING HS
(Fig. 5). The decrease in mature rod photoreceptors in the Tg[XOPS:GFP] line was most
evident in the ventral portion of the retina (Fig. 5A-C’), where rod photoreceptors
initially differentiate44 (Fig 5D). Rods in the wildtype HS embryos displayed an
elongated cell shape with partially visible outer segments (Fig 5A’) whereas rods in the
Siah1 HS embryos appeared wider and without visible outer segments (Fig 5’C’). Rods in
Siah1ΔRING HS embryos retained wildtype numbers and morphology (Fig. 5B’, D).
Some rods appeared stunted in shape, but most had an elongated structure with visible
outer segments, comparable to wildtype HS. When examining Siah1 HS in the
TαC:eGFP background we observed a decrease in cones both dorsally and ventrally (Fig
5E-G, H). The most striking decrease was again observed in the ventral portion of the
retina (Fig. 5G’). Having observed a negative effect of Siah1 overexpression on
photoreceptor development, we next sought to determine the extent of these effects in
development of other retinal cell types.
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4.3.5

Inner retinal neurons are not affected by elevation of Siah1 activity.

Since Siah1 can potentially target several proteins and localizes to other regions
of the retina (Fig 1), we investigated if overexpression of Siah1 could also impact the
development of other cell types in the retina. Ganglion and amacrine cells are among the
first retinal neurons to differentiate, a good portion having done so prior to the first HS at
48 hpf45. Immunostaining of retinal sections from Siah1 HS embryos with HuC/D
indicated that morphology and cell number of ganglion and amacrine cells was
unaffected by Siah1 over activation (Fig S2A-D). Similarly, bipolar cells, visualized
using PKC

immunostaining, were also found to be unaffected by Siah1 overactivation

(Fig S2E-H). Horizontal cells, visualized by Prox1 immunostaining, line the outermost
part of the INL and have an oblong shape. The Prox1+ horizontal cells within the Siah1
HS embryos had normal morphology (Fig S2E-G) but were decreased in number
compared to wildtype and Siah1 RING HS (Fig S2H). This phenotype was not as severe
as what we observed for rods and cones and was therefore not a focus of our investigation
going forward. In summary, from our analysis of ganglion, amacrine, bipolar and
horizontal cells, we concluded that the functional consequences of Siah1 overexpression
during the 48-72 hpf stage of retinal development is mostly confined to photoreceptors.
Our data suggests that high levels of Siah1 activity can specifically alter photoreceptor
maturation. As such, we next began to address the potential mechanisms for how Siah1
activity impacts photoreceptor development.

4.3.6

Siah1 misexpression does not affect cell proliferation

To determine whether the decrease in rod and cone photoreceptors at 3 dpf in
Siah1 HS embryos was due to a delay in differentiation or cell death, we first assessed
cell proliferation in the retina. Immunostaining for cells in S phase using PCNA and cells
in mitosis with PH3 was conducted to detect potential differences in cell proliferation and
cell cycle progression between wildtype, Siah1ΔRING, and Siah1 HS. Our results show
no difference in PCNA+ cells in the ciliary marginal zone (CMZ) , an area of the retina
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containing stem and retinal progenitor cells that supports continuous retinal growth46,
between wildtype, Siah1 RING, and Siah1 HS embryos (Fig S3A-C). While
photoreceptors do not come from this pool of progenitors, it is an indicator of the rate of
cell proliferation in the retina. PCNA was strongly expressed across genotypes and
spanned a similar area in the dorsal and ventral portion of the retina. We followed up
PCNA analysis with PH3 immunostaining to visualize cells in mitosis, rather than S
phase. While there was variation when quantifying PH3+ cells in all genotypes, we found
no significant difference in the total number of PH3+ cells when comparing all of our
groups (Fig S3G). Interestingly, the distribution of the PH3+ cells did vary across
experimental groups (Fig S3H). In the wildtype and Siah1 RING HS lines, the majority
of PH3+ cells were in the ONL (Fig S3D, E). In contrast, in the Siah1 HS embryos, most
PH3+ cells were found in the CMZ and the INL. Taken together, we conclude Siah1 does
not regulate cell proliferation or cycle progression, which led us to pursue cell death as a
potential mechanism for Siah1 mediated aberrant photoreceptor development.

4.3.7

Siah1 overexpression results in a proteasome-dependent increase in retinal
apoptosis.

We used TUNEL staining to label apoptotic cells in the retina of all genotypes
following HS. Additionally, we utilized MG132, which inhibits proteasome activity in
order to assay whether the phenotypes observed are dependent on Siah1’s E3 enzymatic
activity (control embryos were treated with DMSO). We noted retinal cell death in the
retinas of wildtype and Siah1 RING HS embryos (Fig. 6A, C). In wildtype and
siah1 RING embryos only a handful of apoptotic cells were observed, primarily located
in the INL bordering the CMZ. In contrast, Siah1 HS embryos showed a significant
increase in cell death when compared to wildtype and Siah1ΔRING (Fig. 6F). Apoptosis
was increased in the GCL, INL, and ONL of the retina (Fig. 6D). An increase in retinal
apoptosis due to induction of Siah1 was first observed to occur between 60 to 66 hpf (Fig
S5). To determine whether increased apoptosis was dependent on the proteasome we also
treated heat shocked embryos with MG132. Previous work in our lab has shown that
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12.5 M of MG132 is effective for embryonic inhibition of the proteasome without
toxicity42. Cell death was significantly reduced in Siah1 HS embryos treated with
MG132, bringing down the average number of TUNEL+ cells to one, which was
comparable to wildtype (Fig. 6E, F). After MG132 treatment, any remaining apoptotic
cells in Siah1 HS embryos were primarily located in the INL (Fig. 6E). Based on these
results, we suspect that reduction of cone and rod photoreceptors upon Siah1
overexpression results from increased cell death of rod and cone progenitors or immature
photoreceptors. This effect appears to be dependent on the E3 ligase activity of Siah1 as
proteasome inhibition was able to rescue the phenotype. Based on these findings, we next
investigated whether Siah1targeting of Cdhr1a contributes to the photoreceptor
phenotype of Siah1 overexpressing retinas.

4.3.8

Siah1 targeting of Cdhr1a for proteasomal degradation regulates photoreceptor
development and survival.

Having shown that MG132 could rescue Siah1 induced apoptosis in the retina, we
next examined whether inhibition of apoptosis by MG132 would also rescue
photoreceptor development. Treating Siah1 HS embryos with MG132 for 24 hours not
only decreased cell death throughout the retina, but also rescued the number of mature
and immature rod photoreceptors (Fig 6G-K). Quantification of immature and mature
rods, visualized by 4C12 immunostaining[98], indicated a significant increase in the
number of rod cells upon MG132 treatment (Fig. 6L). Mature and immature rod
photoreceptors were present in the dorsal and ventral portion of the retina in Siah1 HS
MG132 treated embryos (Fig. 6K). The average number of rod photoreceptors was
slightly lower in the Siah1 HS MG132 treated embryos compared to wildtype but
increased by over 50% when compared to Siah1 HS DMSO treated embryos (Fig. 6L).
We observed similar results when examining consequences of MG132 treatment in
Tg[XOPS:GFP]/Tg[hsp70:siah1] HS embryos (Sup Fig 4A-E). Importantly, cone
photoreceptor numbers were also increased upon MG132 treatment, as observed in
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Tg[TαC:eGFP ]/Tg[hsp70:siah1] HS embryos (Fig S4F-J). Quantification of cone
photoreceptors in these embryos showed MG132 treatment led to significantly more cells
compared to DMSO treatment (Fig S4J). We therefore conclude that excess Siah1 E3
ligase activity likely leads to increased apoptosis in the ONL and may drive the reduction
of both rod and cone photoreceptors.
Having shown that Siah1 and Cdhr1a can interact in cell culture, and that Siah1
can regulate Cdhr1a levels, we next examined whether Siah1 targeting of Cdhr1a was
responsible for the observed photoreceptor phenotypes. As outlined previously, CDHR1
is known to have an established role in photoreceptor maintenance, in particular turnover
of outer segment disks[180]. What is less clear is whether CDHR1 plays a role during
development of photoreceptors. As such, we hypothesized that Siah1 targets Cdhr1a and
the reduction in Cdhr1a protein levels leads to apoptosis and subsequent reduction of
photoreceptor progenitor cells. To test this hypothesis, we injected single cell stage
Tg[hsp70:siah1] embryos with wildtype (WT) cdhr1a mRNA, performed our HS
treatment and analyzed rod and cone photoreceptors at 72hpf. Injection of mRNA had no
observable effect on WT or Siah1DRING HS embryos, however, in Siah1 HS embryos
we observed a significant increase in the number of both rod and cone photoreceptors
compared to Siah1 HS alone at 72hpf (Figs 7, 8). Both mature and immature rod cells
were increased in number when Siah1 HS embryos were injected with WT cdhr1a
mRNA (Fig 7A-E). Similar outcomes were observed when using
Tg[XOPS:GFP]/Tg[hsp70:siah1] embryos (Fig 7F-J). Not only were the number of cells
increased, but the rod cells appeared elongated, contained outer segments and were
evenly spaced. When examining cone cells using the Tg[TαC:eGFP ]/Tg[hsp70:siah1] we
also documented that injection of WT cdhr1a mRNA rescued the number of cone cells to
levels comparable to wildtype or siah1DRING HS embryos (Fig 8). Our results show that
an excess of Cdhr1a can overcome the Siah1-mediated targeting for proteasomal
degradation and therefore protect development of photoreceptor cells.
To further extend our analysis, we also attempted rescue of the Siah1 HS
phenotype using the Cdhr1a degron mutant construct, cdhr1aLmA. Based on the
insensitivity of Cdhr1aLmA to Siah1 activity we predicted it would have an enhanced
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rescue effect. Single cell embryos were injected with cdhr1aLmA mRNA and subjected
to our HS protocol. Strikingly, cdhr1aLmA was more efficient at protecting rod (Fig 7C,
G) and cone cells (Fig 8A-D) from the effects of Siah1 overexpression than WT cdhr1a.
In particular, injection of cdhr1aLmA resulted in significantly more XOPS:GFP+ mature
rod photoreceptor cells compared to WT cdhr1a (Fig 7D,H). Both WT and LmA were
able to rescue the number of TαC:eGFP positive cones, but with LmA having a much
tighter distribution (Fig 8E). Taken together, we show that deficiencies in rod and cone
photoreceptor development upon induction of Siah1 activity correlate with levels of
Cdhr1a protein. We therefore conclude that Siah1-mediated regulation of Cdhr1a protein
levels is important during photoreceptor development.
Finally, to directly ascertain a functional role for Cdhr1a during photoreceptor
development, we analyzed rod and cone status upon inactivation of Cdhr1a using
CRISPR/Cas9. In order to achieve high efficiency cutting in the F0 generation we
injected two Alt-R-CRISPR crRNAs targeting adjacent regions of cdhr1a coding
sequence. Genomic PCR analysis indicated a cutting success rate of 75%+ in our injected
embryos (Fig S6). Cdhr1a crRNAs were injected into Tg[XOPS:GFP] or Tg[TαC:eGFP ]
embryos, grown up to 72 hpf, screened for CRISPR cutting and analyzed for rod and
cone phenotypes (Fig 9). Embryos predicted to harbor insertions or deletions were
analyzed for cdhr1a levels in the ONL via IHC. As expected, we failed to detect Cdhr1a
signal in the ONL of embryos injected with cdhr1a crRNAs while seeing no effect in
embryos injected with control Golden crRNA (Fig 9A). Similar to Siah1 over activation,
CRISPR-induced loss of Cdhr1a function led to a significant decrease in cone and rod
cells (Fig 9B-E). This result further supports our findings that Cdhr1a is necessary for rod
and cone development and/or survival and that Siah enzymes may regulate this process.

4.4

Discussion
Several studies in the past decade have associated mutations in the human CDHR1

gene with cone-rod dystrophies [146], [168]–[170], [172]–[178], [183]. While the
mechanism as to how loss of CDHR1 function affects pathogenesis of cone-rod
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dystrophies is unknown, several studies have reinforced its importance to photoreceptor
cell biology by characterizing its protein localization [179]–[181] and necessity for
photoreceptor disk renewal [178]. In particular, it has been shown that CDHR1 links
immature disks to the inner segment prior to their incorporation into the outer
segment[180]. However, none of the current studies examined in detail whether CDHR1
had any involvement in vertebrate photoreceptor cell development. This is of particular
note, especially when considering possible inheritable associations with cone-rod
dystrophy predisposition. In this study we describe a post-translational modification
mechanism, controlled by the Siah1 E3 ubiquitin ligase, which regulates the stability of
Cdhr1a to mediate vertebrate photoreceptor cell maturation, and survival. Our work
outlines the first observation of a functional role for Siah1 and Cdhr1a during
photoreceptor development, which may in future studies be utilized to examine the
mechanism of cone-rod dystrophy pathogenesis.
Cdhr1 encodes a photoreceptor cell specific cadherin; a single-pass transmembrane
glycoprotein with calcium-dependent adhesive abilities as well as signaling functions.
Cadherin extracellular domains contain several tandem repeats of negatively charged
amino acids which are responsible for interaction with extracellular molecules including
other cadherins [184]–[186]. During eye development, cadherins have been implicated in
the separation of the invaginated lens vesicle from the surface ectoderm [185], initiation
and elongation of the RGC axons and dendrites [186]–[189], differentiation of RGC and
amacrine cells [184], [186], activation of proliferation in the eye primordium [186],
[188], [190] and retinotectal axon projection [184]. In line with previous studies [179]–
[181], we confirmed cdhr1a gene expression and protein localization to be specifically in
the base of the outer segment of zebrafish rod and cone photoreceptor cells. Zebrafish
Cdhr1a protein localized to a narrow stalk region, known as the connecting cilium of the
photoreceptor cell. The connecting cilium bridges the outer segment with the cell body
and is critical for proper trafficking of proteins, like rhodopsin, from the cell body to the
outer segment[191]. This region is also the site of new disk assembly and release during
maintenance of rod outer segments. Mutations in structural proteins of this region are
known to associate with juvenile Retinitis Pigmentosa[191], highlighting its relevance in
photoreceptor cell development. Furthermore, cadherins, through their cytoplasmic
130

domains are able to link with the cytoskeleton by interacting with catenins[185]. These
interactions are responsible for maintaining polarization of the highly stratified epithelial
tissues, such as the retina [184]. When cells of epithelial tissues have blocked their ability
to maintain cellular adhesion with the surrounding cells or the extracellular matrix by the
loss of cadherin function, for example, they undergo a process of apoptosis called anoikis
[185].
Our observation that zebrafish Cdhr1a protein localizes to the connecting cilium as
soon as photoreceptor cells are formed reinforces the notion of CDHR1’s importance to
photoreceptor biology. However, we lacked an understanding of its regulation. Our
FWISH results indicated that expression of siah1 and siah2l co-localizes with cdhr1a in
the ONL from 3 and up to 5 dpf of the zebrafish retina. Furthermore, using a cell culture
model, we were able to demonstrate direct interaction, via co-IP experiments, and
showed that Siah1 targets Cdhr1a for proteasomal degradation. In addition, we show that
inactivation of the Siah1 E3 domain (siah1DRING), proteasomal inhibition (MG132), or
mutation of the Siah1 degron motif (cdhr1aLmA) prevents Cdhr1a degradation. Taken
together, our data strongly supports that Cdhr1a is a direct target for Siah1 and that both
are expressed in the same place and at the same time.
To examine the consequences of Siah1-mediated regulation of Cdhr1a stability
during photoreceptor development we used a heat shock mediated overexpression
approach. This enabled us to control the timing and extent of Siah1 overactivation. In
particular we wanted to avoid interfering with early embryonic development so as to
prevent non-specific phenotypes. Siah1 overexpression resulted in a significant decrease
in the amount of rod and cone photoreceptor cells. All other retinal cell types were
unaffected by Siah1 overexpression. The reduction in rods and cones coincided with a
significant increase in TUNEL+ apoptotic cells in the retina, and in particular in the ONL
(Fig. 6D). As expected, inhibition of proteasome activity rescued the Siah1 overactivation
phenotype. The cell death we noted could result from cellular loss of contact with the
extracellular matrix and/or neighboring cells mediated by Cdhr1a in photoreceptor
precursor cells. Recently, a mouse conditional double knockout for E and N-cadherin had
increased number of TUNEL-positive cells in the lens[185]. Cell death was also noted in
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the retina of cdh11 and cdh4 morphants[184], [186]. Interestingly, when we injected WT
or the LmA Siah insensitive cdhr1a mRNA and overactivated Siah1, rod and cone
photoreceptor numbers were rescued. We therefore propose that Cdhr1a stability in the
presence of excess Siah1 is critical for photoreceptor cell survival during development.
TUNNEL positive cells were observed not only in the ONL, but also in other retinal
regions. This may represent apoptosis of progenitor cells that are in the process of
migrating to the ONL. The fact that overactivation of Siah1, which will lead to a decrease
in Cdhr1a protein levels, leads to increased apoptosis and ultimately significant reduction
in rods and cones partially supports this hypothesis. In addition, results from Alt-RCRISPR crRNA injections, which have been shown to be highly efficient in generating
biallelic indel mutations and therefore enable examination of phenotypes in F0s, indicate
that loss of Cdhr1a function also leads to a decrease in rods and cones (Fig 9).
When comparing our results to those of previous studies[179]–[181], we propose
three potential roles for Cdhr1a during photoreceptor development. First, based on its
cadherin function, Cdhr1a may be required for the organization of cytoskeletal elements
at the base of newly forming outer segments. In its absence, failure of outer segment
formation may trigger apoptosis and subsequent reduction in photoreceptor cells. Second,
Cdhr1a, via its extracellular domains, could interact with extracellular matrix in the ONL.
In this proposed role, Cdhr1a contributes to either photoreceptor precursor migration and
targeting or subsequent photoreceptor adhesion required for survival. The absence of
Cdhr1a function could therefore either reduce the number of photoreceptor precursors
reaching the ONL leading to reduction of mature rods and cones or may affect maturing
rod and cone survival due to absent or improper cell-cell adhesion. Both of our
hypotheses are supported by results from our Siah overexpression experiments, which
lead to a reduction in Cdhr1a function. Furthermore, our model finds clear support from
the transcriptomic analysis recently employed by Kaewkhaw and collaborators[192]
showing increased levels of CDHR1 in photoreceptor progenitor cells during
differentiation in 3D human retina cultures. Lastly, based on its localization, Cdhr1a is
predicted to regulate the release of newly formed outer segment disks to ensure proper
function of rods and cones[180]. One could imagine that assembly of the very first disks
would also require Cdhr1a function and in its absence this process might fail and lead to
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apoptosis. Upon decrease of Cdhr1a levels, the connection between the innermost outer
segment disks and the inner segment of the photoreceptor could weaken, preventing outer
segment disk formation and eventual death of the photoreceptor prior to maturity (Fig. 8).
Interestingly, it currently remains unknown as to how Cdhr1a releases the disks. It may
be possible that Siah1 targets Cdhr1a for degradation and this regulates the timely release
of the disks. Investigating Siah1 function in juvenile and adult photoreceptors will need
to be performed to assess these possibilities.
In conclusion, we provide the first direct evidence that Cdhr1a plays a critical role
during photoreceptor development, maturation, and survival. Furthermore, we show that
Cdhr1a is directly regulated by the UPS via interaction with Siah1. Our findings have
new implications for examination of Cdhr1a-associated cone-rod dystrophy as well as the
role of UPS during photoreceptor development. Future studies will focus on the exact
mechanism of Cdhr1a function in both photoreceptor progenitors as well as immature
rods and cones. Furthermore, it will be important to assess the role of Cdrh1a and Siah1
during retinal regeneration and adult photoreceptor outer segment maintenance.
Understanding these mechanisms will be imperative to identifying therapeutic strategies
for the growing population of individuals suffering from sight-threatening diseases such
as cone-rod dystrophy.

4.5

Materials and Methods
4.5.1

Zebrafish husbandry and embryo maintenance

Zebrafish husbandry used in all procedures were approved by the University of
Kentucky Biosafety office as well as IACUC Policies, Procedures, and Guidelines
(IACUC protocol 2015-1380). The AB strain was used as wildtype. Transgenic lines used
to visualize rod and cone photoreceptors were: Tg[XlRho:EGFP] (XOPS:GFP)[73] and
Tg[3.2TαC:eGFP ] (TαC:eGFP)[193] respectively. Embryos were kept at 28oC in E3
embryo media. At indicated times, embryos or larvae were anesthetized in tricaine and
fixed with 4% PFA in PBS overnight at 4oC.
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4.5.2

Fluorescent whole-mount in situ hybridization (FWISH)

Fluorescence whole-mount in situ hybridization was performed as a modification from
previously described[194]. Embryos were permeabilized with 10mg/mL Proteinase K for
30 minutes for 3 dpf embryos, 60 minutes for 4 dpf embryos, and 75 minutes for 5 dpf
larvae. Digoxigenin (DIG) and fluorescein labeled (FITC) probes were synthesized by
using DIG and FITC RNA labelling kit (Roche). Primer sequences are listed in Table S1.
Anti-Digoxigenin-AP, Fab fragment (ROCHE) and anti-fluorescein-AP, Fab fragment
(Roche) antibodies, Fast blue (SIGMA) and Fast-red (SIGMA) were used to detect the
hybridization signal. 20-30 embryos were analyzed at each timepoint in 2-3 independent
experiments. Images presented are representative of the results observed.

4.5.3 Cryosectioning and Cell Counts

Embryos were fixed in 4% paraformaldehyde then washed overnight in 10% then
30% sucrose overnight at 40C. Transverse, 10µm, sections collected, beginning just
anterior to and ending posterior to the eye. For imaging and cell quantification, sections
containing an optic nerve were used for consistency. All photoreceptors in the dorsal,
central, and ventral portions of the retinal outer nuclear layer were quantified. Retinal
size did not vary between conditions and was therefore not used for normalization. For
the HuC/D, PKCα, and Prox1 quantification, counts were conducted on 50µm wide
regions of interest, 50µm dorsal to the optic nerve for consistency. Images presented are
representative of the results observed.
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4.5.4

Heat shock inducible transgenic zebrafish lines

Tg[hsp70:Siah1], Tg[hsp70:Siah1ΔRING], were generated by amplification the
full coding region (Siah 1: Ensembl transcript ID: ENSDART00000026679.8) from
72hpf zebrafish cDNA. The dominant negative Siah1 construct, Siah1ΔRING, was
previously described[182]. Both constructs were amplified with primers (Table S1)
containing attB for Gateway cloning into pDONR221 using BP Clonase II (Invitrogen).
pDONR221 clones were verified by sanger sequencing (eurofins). Using Gateway LR
Clonase II, according to the manufacturer's protocol, (Invitrogen), pDEST constructs
pDestTol2CGred (red heart marker) (gift from Dr. Allison, University of Alberta) were
combined with pDONR221 plasmids, the 5’ element heat shock promoter plasmid (p5Ehsp70) and the 3’ element (p3E-polyA) plasmid. Positive clones were verified by sanger
sequencing (eurofins). Verified constructs were injected (50pg) along with Tol2 mRNA
(100pg) and dextran-red into zebrafish zygotes. Transgenic founder embryos were
screened at 48-72 hpf for heart marker fluorescence. Founders were outcrossed to wildtype and screened for germline transmission to create the F1 generation.

4.5.5

Heat shock experiment design

For heat shock at all developmental stages, groups of 50 embryos were incubated
at 38oC for 30 minutes using a recirculating water bath. Embryos were then removed
from the water bath and placed back in the 28oC incubator in fresh EB media according
to the time schedule outlined in Figure 4B. In short, embryos were shocked twice, once at
48 hpf and once at 60 hpf.
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4.5.6

Immunohistochemistry and TUNEL Assay

Immunohistochemistry was conducted as previously described[71] and imaged on
a confocal microscope (Leica SP8, Leica). The following antibodies were used: antizCDHR1a (CDHR1a, rabbit, 1:100, Bosterbio, Pleasonton, CA), anti-zSiah1 (Siah1,
rabbit, 1:100, Bosterbio, Pleasonton, CA), anti-Huc/D (ganglion and amacrine cells,
mouse, 1:40, ), anti-PKCα (bipolar cells, mouse, 1:100, Santa Cruz Biotechnology,
Dallas, TX), anti-Prox1 (horizontal cells, rabbit, 1:1000, Acris, San Diego, CA), antiPCNA (cells in S-phase, mouse, 1:100, Santa Cruz Biotechnology, Dallas, TX), and
activated caspase 3 (apoptotic cells). Alexa fluor conjugated secondary antibodies
(Invitrogen, Grand Island, NY) and Cy-conjugated secondary antibodies (Jackson
ImmunoResearch, West Grove, PA) were used at 1:200 dilution and DAPI to label nuclei
(1:10,000, Sigma, St. Louis, MO). TUNEL assay was conducted with ApopTag
Fluorescin Direct In Situ Apoptosis Detection Kit (Millipore, Billerica, MA) on retinal
cryosections according to manufacturer's instructions.

4.5.7

MG132 treatment

30 embryos were transferred at 52 hpf (3 hours post heat shock) into a 35 mm
petri dish containing 5 mL E3 embryo media plus 12.5 mM MG132 (Sigma-Aldrich), or
an equal volume of vehicle (DMSO, ~0.01%) until 72 hpf. The treatment was refreshed
at 61 hpf, immediately after the second heat shock. At 72 hpf, embryos were anesthetized
in tricaine and fixed with 4% PFA in PBS overnight at 4oC and washed with PBS with
0.5% Tween-20 (PBS-T) 3 times for 10 minutes.

4.5.8

DNA constructs, mRNA synthesis and microinjections

All primers used are catalogued in Table S1. Full coding domain sequences for
CDHR1a (Ensembl transcript ID: ENSDART00000026679.8) were amplified and cloned
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into PCS2+. Cdhr1aLMA was generated by site directed mutagenesis of the WT cdhr1a
construct and verified by sequencing (eurofins), then cloned into pCS2+. pCS2-CDHR1a
and CDHR1a LMA plasmids were linearized with NotI (NEB). mRNA was synthesized
using SP6 mMessage mMachine kit (Ambion) and purified using YM-50 Microcon
columns (Amicon, Millipore). mRNA concentration was quantified using
spectrophotometry. The mRNA was diluted using nuclease-free water and embryos were
injected into the yolk of the embryo at single-cell stage. 100pg of mRNA was used as
indicated in the results section.

4.5.9

Transfection, co-immunoprecipitation and western blotting

For HEK 293 cells transfections, full coding domain sequences for Siah1,
Siah1ΔRING, CDHR1a and CDHR1a LMA were amplified and cloned into pCIG2 using
In-Fusion HD cloning Plus (Takara). Primers for Siah1 and Siah1DRING included a
MYC tag while primers for CDHR1a and CDHR1aLMA included a single FLAG tag. All
constructs were verified using sanger sequencing. The HEK 293 cells were cultured at
37oC in DMEM media until they 80% confluency and transfected using TransIT®-LT1
Transfection Reagent (Mirus) at 37oC for 24h. Where indicated, treatment with 10μM of
MG132 for the last four hours of transfection was performed. Co-IP was performed using
lysates from cells treated with MG132 for 6 hours prior to lysis. Western blotting and coIP were performed as previously described[182].

4.5.10 Microscopy and quantification.

For the FWISH, embryos were mounted in 1% low-melting agarose in a glass
bottom fluorodish (World Precision Instruments)) prior to imaging using Nikon C2
confocal under the 20X (0.95na) objective. For Immunohistochemistry, the slides were
mounted in 40% glycerol (PBS) with coverslips and then imaged using either a Nikon C2
confocal under the 20X (0.95na) and 60X (1.4na) objectives or Leica SP8 confocal under
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the 20x (0.7na) objective. Images were adjusted for contrast and brightness using Adobe
Photoshop. Quantification of XOPS:GFP and TαC:eGFP positive cells was performed
from 3D stacks of specifically the ventral retina using a standardized area of interest that
included all the cells in the region. Stacks were collected at 3um intervals to generate a
volume that encompasses all of the fluorescent signal. 3D rotation software (Elements,
Nikon) was used render the images and quantify the number of cells in the volume.
Images presented are representative of the results observed.

4.5.11 Statistical analysis

Two-factor analysis was done by Unpaired Students t-test using GraphPad
(https://www.graphpad.com). Data are shown as mean ± St. dev. By conventional
criteria, a P value of less than 0.05 was considered significant. ANOVA analysis was
performed using Prism8. * = p<0.05, ** = p<0.001, *** p<0.0001

4.5.12 Alt-R-crRNA CRISPR injections

Alt-R cdhr1a and golden crRNA, tracrRNA was pre-designed and synthesized by
IDT. crRNAs used were: Dr.Cas9.CDHR1A.1.AB and Dr.Cas9.CHDR1A.1.AE. Golden
crRNA was custom synthesized by IDT according to sequence from Hoshijima et al
2019. Duplex formation and dilution with Alt-R Cas9 v.3 enzyme was carried out as
described by Hoshijima et al. 2019.
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4.7

Figures

Figure A. 1 Siah1 and cdhr1a are co-expressed in the outer nuclear layer of the retina.

Retinal cryosections from two color fluorescent whole-mount in situ hybridization
of siah1 (green) and cdhr1a (red) in zebrafish embryos from 3-5 dpf. Magnified images
correspond to region of the dashed outline. Siah1 expression was noted in the outer
nuclear and inner nuclear layer from 3-5 dpf (A’-C’). Siah2l expression was also detected
in the outer and inner nuclear layer from 3-5 dpf (D’-F’). cdhr1a expression was
restricted to and throughout only the outer nuclear layer (A”-C”). Siah1 as well as siah2l
was observed to co-express with cdhr1a specifically in the outermost part of the outer
nuclear layer (A-F). DNA was stained with DAPI (blue). L: lens, ONL: outer nuclear
layer, INL: Inner nuclear layer, GCL: ganglion cell layer. Large scale bar = 100mm,
small scale bar = 25mm.
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Figure A. 2 Siah1 and Cdhr1a localize to the photoreceptor primary cilium.

Siah1 and Cdhr1a protein localization was determined using IHC in 3-5dpf old
Tg[XOPS:GFP] or Tg[TαC:eGFP ] retinal cryosections. Cdhr1a signal (red) was detected
in the ONL (A-C, G-I) and within rod photoreceptors (green) marked by XOPS:GFP
expression between 3-5dpf (A’-C’). Siah1 signal was also detected in the ONL (D-E, J-L)
and within rod photoreceptors (D’-E’). Cdhr1a signal (red) was detected within cone
photoreceptors (green) marked by TαC:eGFP expression between 3-5dpf (J’-L’). Siah1
signal was also detected within cone photoreceptors (D’-E’). Both Cdhr1a and Siah1
localization within photoreceptors was strongest at the junction of the inner and outer
segments, connecting cilium (C”,F”,I”,L”). DNA was stained with DAPI (blue). L: lens,
ONL: outer nuclear layer, INL: Inner nuclear layer, GCL: ganglion cell layer. D: Dorsal
and V: Ventral, OS: outer segment, CC: connecting cilium, IS: inner segment. Large
scale bar = 100mm, small scale bar = 10mm.
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Figure A. 3 Siah1 targets Cdhr1a for proteasomal degradation.

Alignment of CDHR1 degron motif sequence from different vertebrates:
Xenopus, chicken, mouse, rat, human and zebrafish outlining overall protein sequence as
well as motif conservation (A). Western blot analysis of cdhr1a protein stability in
response to Siah activity. cdhr1a-FLAG signal is significantly decreased by cotransfection of siah1-myc, but not siah1ΔR-myc or upon MG132 treatment. Alpha/betta
tubulin was used as a loading control. N=3 independent transfection experiments (B).
Western blot analysis of Siah1 targeting specificity. cdhr1a-FLAG signal is significantly
decreased by co-transfection of siah1-myc. Signal of cdhr1aLMA-FLAG, a cdhr1a
variant encoding a non-recognized degron motif, does not decrease upon co-transfection
of siah1-myc. Alpha tubulin was used as a loading control. N=3 independent experiments
(C). Co-immunoprecipitation of cdhr1a-FLAG co-transfected with siah1-myc or
siah1ΔR-myc probed for FLAG (green), MYC (red). Cdhr1a-FLAG is able to pull down
both siah1 and siah1DRING. N=2 independent experiments (D).
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Figure A. 4 Siah overexpression experimental design.

Heat shock line construct schematic (A). The experimental design included heat
shock for 30 minutes at 48 and subsequently 60 hpf with fixation and analysis at 72 hpf
(B). Whole-mount in situ hybridization (WISH) for siah1 to confirm the effect of heat
shock in wildtype, Tg[hsp70:Siah1] and Tg[hsp70:Siah1ΔRING] embryos. Heat shock
induced a significant increase in siah1 gene expression in the transgenic lines but not in
wildtype (C). Cdhr1a protein localization (red) was determined using IHC in retinal
cryosections from 3 dpf old heat shocked wildtype, Tg[hsp70:Siah1] or
Tg[hsp70:Siah1ΔRING] embryos. DNA was stained with DAPI (blue). Scale bar =
50mm. L: lens, ONL: outer nuclear layer, INL: Inner nuclear layer, GCL: ganglion cell
layer
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Figure A. 5 Siah1 overexpression leads to a reduction of rod and cone photoreceptors.

Retinal cryosections of Tg[XOPS:GFP] (wildtype),
Tg[hsp70:siah1]/Tg[XOPS:GFP] (siah1), and Tg[hsp70:siah1DRING]/Tg[XOPS:GFP],
(siah1ΔRING) embryos were analyzed for GFP fluorescence after heat shock (HS) (AC). The number of rod photoreceptors (green) was significantly decreased in siah1 HS
embryos at 72 hpf compared to wildtype and siah1DRING (D). Compared to wildtype
and siah1DRING differentiated rod photoreceptors in Siah1 HS embryos have stunted
outer segments (A’-C’). Retinal cryosections of Tg[TαC:eGFP ] (wildtype),
Tg[hsp70:siah1]/Tg[TαC:eGFP ] (siah1), and Tg[hsp70:siah1DRING]/Tg[TαC:eGFP ],
(siah1ΔRING) embryos were analyzed for GFP fluorescence after heat shock (HS) (E-G).
Compared to wildtype and siah1DRING, siah1 HS resulted in a significant
decrease in the number of cone photoreceptors (green) present the ventral portion of the
retina of (E’-G’, H). DNA was stained with DAPI (blue), scale bar = 50 mm and 10 mm
(A). L: lens, ONL: outer nuclear layer, INL: Inner nuclear layer, GCL: ganglion cell
layer, ON: optic nerve, D: Dorsal and V: Ventral. Each point on the graph represents total
counts from an individual embryo.
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Figure A. 6 Proteasome inhibition can rescue the decrease in rod photoreceptors and
increased apoptosis resulting from Siah1 overactivation.

Retinal cryosections from wildtype, Tg[hsp70:siah1] (siah1), and
Tg[hsp70:siah1DRING] (siah1DRING) embryos heat shocked (HS) and treated with
DMSO or MG132, were analyzed using IHC for cell death using TUNEL staining (A-E)
as well as mature and immature rods using 4C12 antibodies (G-K). Number of TUNEL
positive cells measured significantly higher in siah1 HS +DMSO embryos compared to
all other treatments (F). Treatment with MG132 significantly decreased cell death in
siah1 HS embryos compared to DMSO to an average comparable to wildtype (F).
Numbers of mature and immature rod photoreceptors were significantly decreased in
Siah1+ DMSO HS embryos treated with DMSO but not with MG132 (L). DNA was
stained with DAPI (blue). Scale bar = 50mm. L: lens, ONL: outer nuclear layer, INL:
Inner nuclear layer, GCL: ganglion cell layer, ON: optic nerve, D: Dorsal and V: Ventral.
Each point on the graph represents total counts from an individual embryo
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Figure A. 7 Rod photoreceptor development relies on sufficient levels of Cdhr1a.

Retinal cryosections from wildtype or Tg[hsp70:siah1]/Tg[XOPS:GFP] (siah1),
injected with wild type cdhr1a or cdhr1aLMA mRNA were heat shocked (HS) and
analyzed for immature and mature rod cells using IHC for 4C12 (red) (A-D’). Injection
of both cdhr1a and cdhr1aLMA mRNA increased the number of immature and mature
rod cells compared to siah1 HS alone (E). Retinal cryosections from
Tg[hsp70:siah1]/Tg[XOPS:GFP] (siah1), injected with wildtype cdhr1a or cdhr1aLMA
mRNA were heat shocked (HS) and analyzed for GFP signal (green) (F-I’). Injection of
both cdhr1a and cdhr1aLMA mRNA increased the number of GFP+ rod cells compared
to siah1 HS alone, with cdhr1aLMA giving a significantly stronger response (J). DNA
was stained with DAPI (blue). Scale bar = 50mm. L: lens, ONL: outer nuclear layer, INL:
Inner nuclear layer, GCL: ganglion cell layer, ON: optic nerve. Each point on the graph
represents total counts from an individual embryo.
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Figure A. 8 Cone photoreceptor development relies on sufficient levels of Cdhr1a.

Confocal stacks of heat shocked (HS) Tg[TαC:eGFP ] (wildtype) and
Tg[hsp70:siah1]/Tg[TαC:eGFP ] (siah1) embryos or those injected with cdhr1a mRNA
or cdhr1aLMA mRNA were analyzed in 3D for GFP fluorescence. Quantification was
restricted to the ventral retina (A-D). Injection of both wildtype and the LMA variant of
cdhr1a mRNA resulted in numbers of GFP+ cone cells comparable to that of wildtype
(E). Scale bar = 50 mm.
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Figure A. 9 CRISPR-induced loss of Cdhr1a function hinders rod and cone cell
development.

Cdhr1a protein localization (red) was determined using IHC in retinal
cryosections from 4 dpf old Golden crRNA or cdhr1a crRNA injected embryos (A).
Confocal stacks of Alt-R-CRISPR crRNA injected Tg[TαC:eGFP ] embryos analyzed in
3D for GFP fluorescence at 96 hpf. Golden crRNA, targeting non-coding sequence is
used as a negative control (B). Quantification of whole retina fluorescence intensity
normalized to retinal area. Each point on the graph represents an individual embryo (C).
Confocal stacks of Alt-R-CRISPR crRNA injected Tg[XOPS:GFP] embryos analyzed in
3D for GFP fluorescence at 4 dpf. Golden crRNA, targeting non-coding sequence is used
as a negative control (D). Quantification of XOPS:GFP positive rod cells in the ventral
retina. Each point on the graph represents an individual embryo (E). DNA was stained
with DAPI (blue). Scale bar = 50 mm. L: lens, ONL: outer nuclear layer, INL: Inner
nuclear layer, GCL: ganglion cell layer.
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Figure A S. 1 Siah1 overexpression decreases the number of rods and cones.

Confocal stacks of heat shocked (HS) Tg[XOPS:GFP] (wildtype),
Tg[hsp70:siah1]/Tg[XOPS:GFP] (siah1), and Tg[hsp70:siah1DRING]/Tg[XOPS:GFP],
(siah1ΔRING) embryos were collected analyzed in 3D for GFP fluorescence (A-C).
Region analyzed and presented is outlined in yellow. Overexpression of Siah1 resulted in
significantly fewer GFP+ rod cells (G). Confocal stacks of heat shocked (HS)
Tg[TαC:eGFP ] (wildtype), Tg[hsp70:siah1]/Tg[TαC:eGFP ] (siah1), and
Tg[hsp70:siah1DRING]/Tg[TαC:eGFP ], (siah1ΔRING) embryos were analyzed in 3D
for GFP fluorescence (D-F). Region analyzed and presented is outlined in yellow.
Overexpression of Siah1 resulted in significantly fewer GFP+ cone cells (H). Scale bar =
50mm.
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Figure A S. 2 Inner retinal neurons are not affected by Siah1 overexpression.

Retinal cryosections from wildtype, Tg[hsp70:siah1] (siah1), and
Tg[hsp70:siah1DRING] (siah1DRING) embryos heat shocked (HS) and analyzed for
effects on retinal inner neurons using IHC. Retinal ganglion and amacrine cells were
visualized and quantified using Huc/D staining (A-D). Bipolar cells were visualized and
quantified using PKCa (E-H). Horizontal cells were observed and quantified using prox1
staining (I-L). DNA was stained with DAPI (blue). Scale bar = 50mm. L: lens, ONL:
outer nuclear layer, INL: Inner nuclear layer, GCL: ganglion cell layer, ON: optic nerve,
D: Dorsal and V: Ventral.
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Figure A S. 3 Siah1 does not affect retinal cell proliferation or cell cycle progression.

Retinal cryosections from wildtype, Tg[hsp70:siah1] (siah1), and
Tg[hsp70:siah1DRING] (siah1DRING) embryos heat shocked (HS) and analyzed for cell
cycle status using PCNA (A-C) and PH3 (D-F) IHC staining. Number of PCNA or PH3
positive cells did not significantly change upon Siah1 overexpression (G-H). DNA was
stained with DAPI (blue). Scale bar = 50 mm. L: lens, ONL: outer nuclear layer, INL:
Inner nuclear layer, GCL: ganglion cell layer, ON: optic nerve, D: Dorsal and V: Ventral.
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Figure A S. 4 Proteasome inhibition rescues Siah1 overexpression phenotype.

Confocal stacks of heat shocked (HS) Tg[XOPS:GFP] (wildtype),
Tg[hsp70:siah1]/Tg[XOPS:GFP] (siah1), and Tg[hsp70:siah1DRING]/Tg[XOPS:GFP],
(siah1ΔRING) embryos treated with DMSO or MG132 were collected analyzed in 3D for
GFP fluorescence. Quantification was restricted to the ventral retina (A-D). Treatment
with MG132 prevented a significant decrease in GFP+ rod cells compared to DMSO in
siah1 HS embryos (E). Confocal stacks of heat shocked (HS) Tg[TαC:eGFP ] (wildtype),
Tg[hsp70:siah1]/Tg[TαC:eGFP ] (siah1), and Tg[hsp70:siah1DRING]/Tg[TαC:eGFP ],
(siah1ΔRING) embryos treated with DMSO or MG132 were analyzed in 3D for GFP
fluorescence. Quantification was restricted to the ventral retina (F-I). Treatment with
MG132 prevented a significant decrease in GFP+ cone cells compared to DMSO in siah1
HS embryos (J). Scale bar = 50 mm.
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Figure A S. 5 Time course of retinal apoptosis following siah1 or siah1DRING heat
shock.

Retinal cryosections from heat shocked Tg[hsp70:siah1] (siah1), and
Tg[hsp70:siah1DRING] (siah1DRING) embryos were analyzed using IHC for apoptosis
using TUNEL staining (red) at various time points (A-E’). DNA was visualized using
DAPI (blue). Heat shock induction of siah1DRING expression had little effect on
induction of retinal apoptosis between 52-72hpf (A-F). Heat shock induction of siah1
153

resulted in a significant increase of apoptotic cells in the retina beginning at 60hpf and up
to 72hpf compared to siah1DRING (A’-E’, F). Each point on the graph represents counts
from individual embryos (F).

Figure A S. 6 Genomic PCR screen for CRISPR induced insertion or deletion.
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Genomic DNA collected from injected embryos was used to amplify ~250bp amplicon
from cdhr1a coding sequence. Golden crRNA control injected embryos all display a
strong 250bp band (embryos 1-3, 14-16). When examining PCR products from cdhr1a
crRNA injected embryos various combinations of insertion or deletion products were
amplified (embryos 4-13 and 17-26).
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